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Abstract 
Viridenomycin 11 is a polyene macrolide possessing a wealth of biological 
activity. As part of an ongoing program examining the stereoselective synthesis of 
polyene natural products, a strategy was explored to effect the total synthesis of 
viridenomycin 11. 
As a consequence of the adopted retrosynthetic strategy, the project was 
naturally divided into three main areas: efforts directed towards the southern (E, E, E, 
Z)-tetraene 210, towards the northern (E, Z, Z)-triene 209, and towards the core 
cyclopentenone 211. 
Both polyenic sections 209 and 210 were tackled with a view to utilizing 
palladium-coupling methodology developed in the group, whereby vinylboronates of 
type 122 undergo Heck coupling with alkenyl halides, affording polyenyl boronates that 
may then be converted into polyenyl iodides via stereoselective iodo-deboronation. The 
geometry of the new double bond is determined by the order of reagent addition during 
the iodo-deboronation. Vinylboronates such as 122 may thus be regarded as a vinyl 
dianion equivalent, permitting ready access to either alkene geometry, and allowing a 
polyene chain to be built up via an iterative process. 
Efforts towards 209 gave rise to a surprising reaction, in which it was discovered 
that iodoacrylates 214 are problematic Heck coupling partners due to a propensity to 
undergo novel Michael addition-elimination reactions with most amine bases, instead 
affording amino acrylates in excellent yields. 
Efforts towards 210 called for the development of new and robust methods for 
the elaboration of the amino acid phenylglycine, ·providing greatly improved procedures 
for its conversion to the corresponding N-protected ~-amino alcohol, N-protected ~ 
amino-0-sulfonylates, N-protected ~-amino iodides and N-protected ~-amino nitriles, 
all valuable synthetic intermediates in their own right. An advanced synthon en route to 
210 was prepared by Heck coupling of (Z)-iodide 214 with vinylboronate 272, 
representing a considerable in-road into the synthesis of this fragment. 
Markedly different chemistry was required to synthesize 211. Its retrosynthetic 
strategy called for a stereoselective aldol reaction, and as a consequence of this work it 
was found that novel oxazaborolidinone mediated Mukaiyama aldol additions between 
diene 4-(tert-butoxy)-2,4-bis[(trimethylsilyl)oxy ]-1 ,3-butadienyl methyl ether 335 and a 
wide range of electrophiles gave aldol products in isolated yields of up to 90%. 
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Introduction 
1.0 Introduction 
Natural products containing conjugated alkenyl units represent a large and 
structurally diverse group of compounds. 1 Particularly significant are those possessing 
biological activity, including the eicosanoids (the arachidonic acid derivatives such as 
the leukotrienes and lipoxins),2 the retinoids,3 and the polyene macrolides4, a large 
group comprising over 200 members. There are also a considerable number of relatively 
unexplored polyenes derived from a variety of sources, including marine organisms, 
fungi, slime-moulds and plants; these polyenes are often produced as a means of 
chemical defense, and thus also possess potentially useful biological activity. 
This review covers the literature from 1971 to the present date. It begins with a brief 
survey of the major sub-categories of polyene natural products, before focussing on 
methods used to bring about their synthesis. Heavier emphasis will be given to the 
synthesis of the polyenes themselves and owing to the vast number of natural products 
containing multiple double bonds, this review will concentrate only on natural products 
that contain at least a) three all-trans conjugated double bonds, or b) cis, cis or cis, trans 
dienyl units. 
1.1 Polyenes derived from bacteria 
Typically isolated from the Streptomyces genera of actinomyces soil bacteria, 
the polyene and oxo-polyene macrolides5 are relations of the more familiar macrolide 
antibiotics (for example, the erythromycins) and represent the most important sub-
category of polyene natural products. Structurally, they are very large macrocyclic 
lactones with 22 to 44 membered rings commonplace. The polyenic section usually 
incorporates between 4 and 8 conjugated double bonds. Oxo-polyene macrolides such 
as roxaticin6 1 are characterized by having the polyene in conjugation with the lactone 
linkage (fig. 1). Several members of the polyene macrolide family find service as 
clinically important anti-fungal drugs, notably pimaricin 2,7 nystatin A1 38 and 
amphotericin B 4,9 dubbed 'amphoterrible' due to its high nephrotoxicity. 
The ansamycin 10 antibiotics are a growing family of Streptomyces metabolites, 
and many of them possess antibacterial, antifungal or antitumour activity. Ansatrienine 
A (mycotriene) 511 is one of the first isolated examples, and may be taken as a 
representative member. Also isolated- from Streptomyces sp., the manumycins12' 13 (for 
example, 6 and 7) are a fairly large and we_ll-studied group of polyenes. This family of 
antibiotics has attracted considerable attention due to their promising biological activity; 
11 
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manumycin A 6, the first to be isolated, shows activity towards fungi and L1210 
leukemia stem cells in addition to its antibacterial properties. 
Isolated in 1994 from the fermentation broth of the gliding bacteria Sorangium 
cellulosum, the disorazoles, 14 of which disorazole F2 8 is typical, are a group of 29 anti-
fungal and cytotoxic macrocyclic dilactones. They are all dimer-like, and are 
differentiated by the positions and stereochemistries of the double bonds, and in the size 
of, and nature of the substituents on the macrocyclic core. 
12 
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Aside from these major classes, there are a host of other bacterially derived polyenes 
(fig 2). Xanthomonadin I 9, responsible for the vivid yellow colours of Xanthomonas 
colonies, is a rare example of a compound synthesized by a terrestrial organism that 
Figure 2 
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contains bromine. 15 Linearmycin A1 1016 is an unusually long polyene contammg 
thirteen double bonds, whilst the structurally complex polyenes viridenomycin 11 17 (an 
antifungal, antibacterial and antitumour macrolide) and rapamycin 1218 (an antibacterial 
and immunosuppresive agent) are further examples of Streptomyces metabolites. 
1.2 Polyenes produced by fungi 
Figure 3 
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0 ..---::: 
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Pigments derived from fungi tend to be ofisoprenoidal origin, not arising from 
the polyketide metabolic pathways that usually give rise to polyenic compounds. There 
are a few examples however, and a prominent one is that of fumigillin 1319 ' 20 (fig. 3), a 
13 
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metabolite of Aspergillus fumigatus that possesses a wealth of biological activities 
including amebicidal, anticancer, antiparasitic and antibacterial properties. Also 
important are the rhizoxins,21 a family of 16-membered macrolactones isolated from the 
plant-pathogenic fungus Rhizopus chinensis. Rhizoxin 14 is a tubulin binding anti-
mitotic agent possessing antifungal and antimicrobial activity in addition to potent in 
vitro cytotoxicity and in vivo antitumour activity. It is more potent, yet less toxic than 
vincristine and has undergone extensive clinical trials. The didesepoxy analogue 
rhizoxin 0 22 has equal potency, but is isolated as a minor component. 
1.3 Polyenes derived from slime-moulds and plants 
Figure 4 
HO 0 
15 
Fuligrobin A 
NHAc 0 ~02H 
HO ~~NH2 
0 16 
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Slime moulds, often found amongst moist decaying wood and litter in forests, produce 
yellow cytotoxic substances such as fuligrobin A 1523 and physarachrome A 1624 (fig. 
4 ), either as a means of chemical defence, or to function as photoreceptors. Plants 
synthesize a vast array of polyenic compounds, most familiar of which are the 
carotenoids25 (e.g. y-carotene 17), the most prevalent of all the naturally occuring 
pigments (fig. 5). The deoxyphorbol ester derivatives 18 and 19 isolated from the 
caustic sap of the pencil tree, are purported antitumour agents.Z6 Also shown are several 
unusual polyenes containing mixed alkene geometries 20-22.27 
1.4 Polyenes derived from marine organisms 
Naturally derived polyenes are typically toxic, and often vividly coloured. These two 
facets are exploited well by many marine organisms which are without the defensive 
capabilities of many of their larger aquatic cousins. 
14 
Figure 5 
0 
18 
y-carotene 
17 
Introduction 
~ ": 
20 ~ 
ixoric acid 0 
21 
C02H 
HO 
Navanones 
~R 
lJ 
N 
A 
23 
19 
Aurantosides 
Cl 
Keronopsins 
Br 
~ 
Rz 
~ 
B 
24 
~ ~ 
r(YR 
HO~ 
OR 1 
c 
25 
22 
a-parinaric acid 
0 
R=~
RI R2 
S03Na H 
S03Na Br 
H H 
H Br 
R= Me, Aurantoside A 26 
R=H, Aurantoside B 27 
Keronopsin 
At 28 
Az 29 
Bt 30 
Bz 31 
Opisthobranchia for example, a sub-class comprising the sea-slugs and their allies, lack 
the protection provided by the hard shell typical of most members of the gastropod 
class, and secrete brightly coloured polyenic ketones, such as the yellow navanones A-C 
23-25 (named after Navana.\ inermis, an ornately coloured sea-slug found off the 
Californian coast) which act as alarm pheromones.28 The cytotoxic aurantosides A and 
B (26 alld 27, fig. 5), obtained from sponges and isolable as orange amorphous 
powders, are N-trisaccharide tetramic acid derivatives possessing activity against P388 
and L1210 leukemia cells.29a Aurantosides C29b and D-F29c have also been recently 
15 
OH 
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isolated and found to possess biological activity. The antibiotic keronopsins 28-31 are 
produced by Pseudokeronopsis rubra, a marine ciliate known for its deep red colour, 
and are used as chemical weapons against other ciliates and flagellates. 30 Marine 
dinoflagellates, a type of unicellular aquatic organism possessing both animal and plant 
characteristics, provide a rich source of structurally diverse natural products with 
highly specific bioactivity. Certain species produce powerful nerve toxins, and it is 
these toxins that give rise to the so-called red-tides, formed when the creatures 
reproduce en mass or bloom in shallow waters. The genus Amphidinium has been 
exploited as a source of novel secondary metabolites with unique chemical structures,31 
and amphidinol 3 32 (fig 6), an antifungal polyene whose structure was recently 
elucidated,32 is a prominent example. 
Figure 6 
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1.5 Polyenes produced by animals 
The retinoids3 33-37 (fig. 7), a collective term for the various synthetic and 
natural analogs of retinol (vitamin A) 33, are vitally important during embryo 
development and throughout post-natal life in humans. The biological roles they play 
are dependent both on the nature of the R group and on the geometry of the polyene 
chain. These factors are the reason that they have been the focus of much synthetic 
attention, and are often used as the first test of a new polyene-assembling methodology. 
Another important group of polyenic biomolecules are the eicosanoids,2 
comprising the structurally related prostaglandins, prostacyclins, thromboxanes and 
leukotrienes, which are derived from polyunsaturated fatty acids such as arachidonic 
acid. These compounds are found in minute quantities in most animal cells, and elicit 
diverse biological responses in most animals. These effects, together with their small, 
but complex structures, have made them appe-aling targets for total synthesis; indeed the 
only means of obtaining sufficient quantities of eicosanoids for evaluation is through 
chemical synthesis. Lipoxin A 38 (fig 7) possesses similar biological properties to the 
16 
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unstable intermediate leukotriene B4, and has been synthesized and evaluated 
biologically. 37 
1.6 Synthesis of polyenes-general strategies 
Figure 8 outlines the most common general strategies taken to date in order to 
access polyenes. 
Figure 8 
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A few fundamental issues need to be considered when synthesizing 
polyunsaturated compounds. As a general rule, polyenes of the all trans nature are 
more stable than ones containing cis-alkenyl uni!s,_ hence the latter tend to be more 
difficult to construct, and especially prone to isomerization. Additionally, when a 
specific isomer is required, as is usually the case, a method that leads to mixtures of cis 
l7 
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and trans isomers will invariably reqmre a tedious and yield-reducing separation, if 
separation is possible at all. 
The principal requirements for polyene synthesis are thus 1) a reliable 
olefination procedure that produces alkenes in high geometric purity, 2) a procedure that 
allows ready access to either isomer, whilst at the same time being mild and functional 
group tolerant. 
1.7 Wittig olefination and Horner-Wadsworth-Emmons procedure. 
The Wittig reaction33 has proved historically to be the reaction of choice for the 
formation of alkenes. It suffers however from a number of disadvantages, the principal 
one being that it invariably leads to a mixture of isomers, necessitating separation, or 
isomerization of the unwanted isomer. It also requires preparation of an appropriate 
ylide, typically requiring a strong base to generate the carbanion, and usually a laborius 
purification procedure necessary to remove the stoichimetric phosphine oxide by-
product. The closely related Homer-Wadsworth-Emmons34 (HWE) procedure 
circumvents a number of these problems, and is now increasingly used in all areas of 
natural product synthesis. 
Scheme 1 
o~Jl 0 
MeOH,MeO-
OH 
42 43 
The BASF synthesis of vitamin A, one of the leading methods of production, 
utilizes Wittig chemistry on a huge scale to produce the precursor retinyl acetate 40 
(scheme 1). A double Wittig reaction was recently employed by Tode's group in the 
first synthesis of the marine- carotenoid crassostreaxanthin B ~1 (scheme -1).35 
Condensation of aldehyde 43 with Wittig salts 42 and 44 led to 41 after deprotection. 
Wittig chemistry was also employed in the synthesis of the side chain of the novel 
18 
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neuritogenic agent epolactaene 45 (scheme 2),36 with the requisite ylide 47 being 
prepared in six steps starting from known iodoalcohol 46. Various conditions were 
examined in order to give the highest EIZ ratio for the Wittig coupling of 47 and 48a 
(Table 1); use of the tributylphosphonium salt 47b gave the highest proportion of theE 
isomer which was separated from the Z isomer by flash chromatography. 
Table 1: Factors affecting the EIZ ratio in the Wittig coupling of 47 and 48a 
Ylide 
47a 
47a 
47a 
47b 
Ylide (equivalents) 
2.4 
2.4 
5.0 
5.0 
CHO 
Additive 
none 
18-crown-6 I MeCN 
18-crown-6 I MeCN 
18-crown-6 I MeCN 
"determined by 1H NMR 
47 
H,N 
tBuOK, additive, THF • o 
E I Z ratio 
-78 
-46 1:1 
-46 1:1 
-46 10:1 
48a 48b 
Yield(%) 
trace 
27 
68 
69 
As mentioned previously, arachidonic acid metabolites are important due to their 
intriguing biological properties, and Yadav and eo-workers have developed a 
convergent synthesis of lipoxin A 38 (scheme 3), with Wittig chemistry being used to 
install the tetraene portion. 
Their synthesis involves a specialized ylid_e 49, prepared from propargyl alcoho1.37 In 
1991 Pattenden reported the total synthesis of all-trans citreomontanin 52, a hexaene 
19 
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Scheme 4 
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isolated from Penicillum pedemontanum and the putative precursor to citreoviridin and 
citreoviridinol. This was achieved via an iterative sequence involving Wittig coupling 
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between aldehyde and triphenylphosphoranyl propanoate 50, propanoate reduction, and 
oxidation to regenerate an aldehyde 51 (scheme 4).38 
There are numerous applications of the HWE procedure towards polyene 
synthesis. A prominent example can be seen in Nicoloau' s landmark total synthesis of 
amphotericin B 4, in which three HWE reactions were used to construct the polyene 
section (scheme 5).39 
The first two employed the functionalized phosphonate 53 leading to the acyclic 
hexaenal 54, before the third reaction was used to induce ring closure, giving the cyclic 
heptaene 55. A similar approach was taken by Mori's group in their recent synthesis of 
roxaticin 1.40 
The rhizoxins have attracted considerable attention owing to their remarkable 
biological activity,21 and many efforts have been directed towards rhizoxin and its 
congeners.41 Burke's partial synthesis of rhizoxin41 e 14 (scheme 6) used two HWE 
reactions to form the trisubstituted £-olefin 56. 
Scheme 6 
~0 
,,,OPMB 
.. ,,, 
OMe 
56 OMe 
OTBS OTBS 
-<~~ N CHO 0 T!PSO,,, 
-------~ \ 
N 1. Ba(0Hh.H20 (85%) 
2. H2SiF6, i-PrOH, -40°C 
(Et0)2~ 
0 0 
···.,,, -0 -;?' -01 
19 
57 0 
Leahy' s total synthesis of rhizoxin D utilizes a similar approach.42 They explored 
various routes to the tricky triene oxazole fragment 57 before settling on a HWE 
reaction between C18 and C19. Ley's group used HWE reactions to install the 
acyltetramic acid portion of the antibiotic erythroskyrine 63 (scheme 7).43 '44 They 
coupled the phosphonate ester 58 with the ~-tributylstannyl aldehyde 59 under 
optimized conditions, giving the dienyl stannane 60 quantitatively as a >30: l mixture of 
EIZ isomers. 
21 
Introduction 
Subjection of trienal 61 and phosphonate 58 to HWE reaction under identical conditions 
provided the tetraene 62 with high yield and high selectivity (>30: 1 E/Z). 
Scheme 7 
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Phosphorous ylide based reactions played a pivotal role in the construction of the 
macrocyclic lactam cyclamenol A 66 (scheme 8), recently reported by Waldmann.45 
Scheme 8 
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In devising their synthetic strategy, the authors paid particular attention to the polyene 
section, which comprised one Z and six E double bonds. It was feared that the Z double 
bond would isomerize, or the polyene skeleton would react further to give a fully 
conjugated octaene. For this reason, construction of the polyene system was left until 
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late in the synthesis, and the final Z double bond was introduced via a pinacol coupling, 
allowing both ends of the acyclic precursor to be tied together through template control. 
A HWE procedure involving crotonyl phosphonate 64 was used to construct the dienal 
65, whilst a Wittig reaction exploiting the phosphonium salt 67 derived from sorbic acid 
was used to provide the southern triene. 
So far, only examples of the Wittig and HWE reactions leading to all E polyenes 
have been examined; this is mainly due to the inherent £-selectivity of these processes. 
It is possible however, either by changing the nature of the phosphonium 
salt/phosphonate or by varying the reaction conditions, to bias the outcome towards 
either alkene isomer. In the first reported synthesis of myxalamide A 68 (scheme 9), the 
most abundant of the four myxalamides46 isolated from the gliding bacteria Myxococcus 
xanthus, Heathcock and eo-workers opted to complete the synthesis via a Suzuki 
coupling (see 2.2) between dienylboronic acid 69 and iodotriene 70.47 
Scheme 9 
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In order to prepare the enyne precursor that would undergo hydroboration to give 69, 
they initially attempted to install the triple bond via a HWE reaction between aldehyde 
71 and phosphonate 72. However, EIZ selectivities were not good, and use of the 
bulkier phosphonate gave greater selectivity, but in the wrong direction. Use of the 
stabilized ylide 73 gave the unsaturated ester 74 in an improved 2:1 (E!Z) ratio. 
Synthesis of the triene portion of iodotriene 70 (scheme 1 0) required formation of an 
(E,E,Z)-alkenyl unit 75, with insertion of the Z-alkene being accomplished under kinetic 
conditions through the Stork-Zhao modification of the Wittig reaction.48 Unfortunately, 
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although the ratio of isomers was acceptable, separation by a variety of methods proved 
impossible, and the authors were forced to use an alternative approach to this fragment. 
Scheme 10 
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This modification48 was also employed in Meyer' s synthesis of the monomeric unit of 
diorazole C 1 76 (scheme 11).49 
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Here, a palladium coupling reaction was also chosen as the final bond-forming reaction, 
which retrosynthetically led back to an oxazole containing dienyl iodide 77 and a cis-
alkenyl stannane 78. Iodide 77 was assembled from readily available ester 79, via 
Wittig homologation to insert the trans double bond, followed by the Stork-Zhao Wittig 
modification. This strategy was used again to furnish alkenyl iodide 80, which gave 78 
after the Stille coupling. 
The same group also recently reported studies towards the total synthesis of 
viridenomycin50 11 (scheme 12), a large polyene macrolide containing two mixed 
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geometry tetraenes. In their second generation approach, the authors chose to disconnect 
11 into three key fragments, allowing these two potentially problematic units to be 
synthesized in isolation. 
Scheme 6 
+ R3P~ n 
81 yJ 
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It was envisaged that 81 would be joined to the core cyclopentenol fragment 82 
using phosphonate chemistry and 81 was prepared accordingly, with a kinetic Wittig 
reaction being used to insert the required Z-alkene with good selectivity. The original 
strategy to use a phosphonate to join 81 and 82 failed in studies using model aldehydes 
(entries 1 & 2, table 2), as rearrangement to give a ketone was observed. Use of the 
semi-stabilized ylide described by Tah1ura51 gave poor EIZ selectivity (entries 3 & 4). 
In the end, the authors used trimethylphosphonium salt 81 (R=Me) to prepare 84, which 
gave high selectivity towards the desired E isomer. A kinetic HWE reaction was 
employed to synthesize the trienyl stannane 83 (scheme 13); use of the electrophilic 
Still-Gennari phosphonate52 under kinetic conditions that favour rapid elimination leads 
to Z-alkenes in excellent isomeric purity. Unfortunately, removal of both t-Bu 
protecting groups proved impossible, and cyclization of 84 was not realized. 
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Table 2: E/Z selectivities in the HWE reaction between various ylids 81 and model aldehydes 85-87. 
Entry R PL3 
I Me PO(OEth 
2 Me PO(OEth 
3 H PBu3 
4 H PBu3 
5 H PMe3 
6 H PMe3 
7 H PMe3 
Base Aldehyde 
KOt-Bu 85 
n-BuLi 85 
KOt-Bu 87 
n-BuLi 87 
KOt-Bu 87 
n-BuLi 87 
n-BuLi 85 
Product 
86 
86 
88 
88 
88 
88 
89 
Ratio (E:Z) 
2.6: I 
2.9: I 
3.0: I 
30: I 
10:1(90%) 
o~or(< or or(< 0~ ~ 
0 0 
~or(< 
0 
85 
Scheme 13 
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61% for R = tBu 
58% forR= Me 
88 89 
I~ 
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Taylor' s group recently disclosed a procedure that enables elaboration of 
haloenals 90 without the need for their isolation.53 This is useful because whilst such 
compounds are potentially valuable as polyene building blocks, they are also unstable, 
difficut to isolate, and have a severe ~rritant effect on mucous membranes, particularly 
the bromo and chloro-enals (both isomers of iodopropenal can be prepared readily, but 
retain lachrymatory properties). Their protocol involves in situ manganese dioxide 
haloenol oxidation, followed by direct Wittig homologation, giving dienyl haloesters 91 
that are themselves useful polyene buildings blocks, given that partial reduction of the 
ester function would allow the process to be repeated (scheme 14). 
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Scheme 14 
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1.8 Transition metal based strategies 
Representative of these strategies are the palladium cross-coupling reactions, 
allowing single bond formation between two sp2 centres with excellent stereoselectivity 
and often under very mild conditions, and without some of the problems encountered 
with more traditional approaches. The mildness and functional group tolerance of these 
reactions makes them an ideal way to insert the final 'stitch' in a polyene chain, thus 
allowing this often troublesome section to be assembled last. The Stille reaction54 is 
particularly useful, and typically proceeds with retention of configuration of the alkenyl 
halide, leading to polyenes of exceptionally high geometrical purity. This reaction has 
been exploited many times, for example, in Nicolaou's synthesis of rapamycin 1255 and 
Panek's synthesis of mycotrienin I and mycotrienol 9256(scheme 15), and in the 
previously discussed syntheses of myxalamide A 68, viridenomycin 11, erythroskyrine 
63, and the monomeric moiety of disorazole C1 76. 
Scheme 15 
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Duchene and Parrain have successfully applied Stille methodology to a variety of 
retinoids, including the trifluoromethyl retinoate 96,57 useful as a biological probe 
(scheme 16). Their methodology uses enyne precursor 94 derived from ~-ionone,58 
which may either be converted into dienylstannane 95a by treatment with the Lipshutz 
reagent59 in the presence of methanol, or into the trisubstituted vinylstannane 95b by 
t~apping the inte~~ediate vinylcuprate . with methyl iodide. Stilfe cou-plin-gs of ~­
iodovinylic acids 98 derived from tetrolic acid via iodides 97, with stannanes 95 gives 
the retinoids stereoselectively (table 3).6° Fluorine substituted polyenes have 
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traditionally been obtained via HWE or Julia reactions, but these methods are hampered 
by poor EIZ selectivity, particularly when forming the 9-trans trisubstituted double 
bond common in many retinoids. Yosihara has recently described a preparation of 9-
trans-9-desmethyl-9-fluororetinal 101 and analogues based upon a four component 
coupling approach.61 Due to the failure of the 4-hydroxybutynoate 100 to undergo 
fluorination under reported conditions, the second approach utilizing Wittig, HWE and 
Stille chemistry was successfully adopted (scheme 17). 
Scheme 16 
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95b 
Table 3: Stille couplings between cores 95 and iodides 98 to access a variety of mixed geometry retinoic acids 
core 
9Sa 
9Sa 
9Sb 
9Sb 
a see fig 7 for retinoid numbering. 
iodide 
(E)-98 
(Z)-98 
(E)-98 
(Z)-98 
retinoic acid 
all rrans-9-nor-retinoic acid 
( 132)-9-nor-retinoic acid 
all-trailS retinoic acid 
( 132)-retinoic acid 
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50 
45 
73 
70 
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De Lera and eo-workers have also exhaustively examined applications of the Stille 
reaction for the synthesis of retinoid skeletons. They studied various disconnections 
and then developed optimized approaches for each strategy, providing useful 
information regarding the influence of steric factors on the Stille reaction, as well as 
useful retinoid building blocks.62 
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The first complete synthesis of a manumycin antibiotic was achieved by Taylor 
with alisamycin 113 (scheme 18).63 Fundamental to this synthesis was the introduction 
of the unsaturated 2-arnino-3-hydroxycyclopentenone forming the lower polyene chain. 
This moiety is present in many Streptomyces sp. metabolites, notably in many of the 
manumycin antibiotics. Taylor chose to insert this portion via Stille reaction of 2-
amino-3-hydroxycyclopentenone halides and vinylstannanes, thus treatment of known 
acyl chloride 102 with key amine hydrochloride 103 (prepared from cyclopentanedione) 
leads to vinyl bromide 104. Higher vinylogues 107 and 109, suitable for synthesizing 
the manumycins, can be prepared via HWE homologation of bromodienal 105. 
Elaboration of the quinone 110 with the Corey-Wollenberg reagent64 111 gave a 
mixture of enantiomeric vinylstannanes; Stille coupling of these with bromodiene 109 
led to alismaycin and ent-alisamycin. Taylor' s group have successfully applied this 
strategy to a great number of the manumycin antibiotics and related polyene natural 
products.65 
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Like the Stille coupling reaction, the closely related Suzuki reaction66 has found 
utility in polyene synthesis. Earlier work towards polyene synthesis was carried out by 
Suzuki, who successfully applied the reaction to the stereoselective synthesis of triene-
containing natural products,67 and later to the synthesis of trisporol B.68 The Suzuki 
reaction can operate under extremely mild conditions making it an ideal way to 
synthesize potentially unstable polyenes. An example of this has already been seen in 
the total synthesis of myxalamide A, in which the synthesis was completed via Suzuki 
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coupling of 69 and 70.47 De Lera's group have also presented a detailed study of highly 
stereoselective retinoid syntheses achieved via the thallium-accelerated Suzuki reaction 
carried out under ambient temperatures. These mild conditions were chosen to be 
compatible with the known instability of vitamin A and its derivatives. Their approach 
illustrates the great flexibility offered by the palladium coupling reactions, in that the 
choice of which moiety to derive from the alkenyliodide or alkenylboronic acid is 
dictated by relative ease of preparation. Preparation of retinol and its 9- and/or 11-
desmethyl analogues (scheme 19) was achieved through coupling of either boronic 
acids 116 with iodide 114 (also derived from enyne 94), or with boronic acid 119 and 
iodides 117, with total retention of the geometries of the coupling partners. The group 
have also used Suzuki chemistry for the stereocontrolled preparation of 9-
desmethylretinoids, useful for bio-organic studies into protein-chromophore steric 
interactions involved in bacteriorhodopsin photocycles,69 and more recently have 
applied Suzuki chemistry to the synthesis of 7 -cis-retinoids. 70 
Several groups have been involved in applying Suzuki coupling methodology to 
leukotriene synthesis, including Sato's method for the preparation of LTB3 and LTB4.71 
Using similar conditions, Nicolaou has described the synthesis of a range of leukotriene 
A4 derivatives.72 Meyers and eo-workers have been involved in the preparation of 
trisporic acids, a class of C 18 isoprenoidal fungal hormones, utilizing Suzuki chemistry 
late-on to access the trisporol system (scheme 20).73 
Scheme 20 
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Recently, Henaff and Whiting reported a highly stereoselective approach to 
racemic phthoxazolin A 133 using a combination of palladium coupling reactions.74 
Their approach employs the vinylboronate 122 as a useful two-carbon building block 
for the synthesis of polyenes (scheme 21 ).75 
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Thus, coupling of 122 with suitable halides leads potentially to Heck or Suzuki 
products 123 and 124, the ratio of which is dictated by many factors, including catalyst, 
solvent, temperature and the presence of additives. 
Brown showed that vinylboronic acids could provide a stereocontrolled route to vinyl 
iodides, using iodide and sodium hydroxide to effect iodo-deboronation. 76 (and see 
2.4.1.3). The stereochemical course of the process is dictated by the order of addition of 
the reagents. Pinacol esters were found to be resistant to these conditions, requiring the 
use of ICl and sodium methoxide.77 This provides access to vinyl iodides 125, which 
may undergo coupling with alkenes or alkenyl metals, leading to dienes 126. 
Subsequently, coupling of 126 with 122 leads to trienes if the iodo-deboronation 
procedure is repeated. Overall, 122 can be considered a vinyl dianion equivalent 
allowing rapid construction of stereodefined polyene systems. Application of this 
methodology to the herbicidal agent phthoxazolin A is outlined in scheme 22. 
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Here, coupling of 122 and amide 129 (prepared from iodide 127 via an aldol reaction) 
demonstrates the functional group tolerance of these reactions, and gave the desired 
Heck product as the major product. Apart from this notable example, the Heck reaction, 
in its conventional guise, has found little utility in polyene synthesis. This is partially 
for the reason that, whilst the Stille reaction usually occurs with retention of 
stereochemical integrity of the coupling partners, the same cannot be said of the Heck 
reaction. Pattenden recently compared the Heck and Stille reactions in his synthesis of 
pateamine A, a macrolide containing a (Z, E)-diene acrylate moiety in its macrocylic 
core, and found the Stille reaction superior for this very reason.78 
In contrast, applications of the alkyne coupling variant of the Heck reaction towards 
polyene synthesis, the so-called Sonagashira coupling,79 are numerous. Alami's group 
have devised techniques for the stereocontrolled synthesis of polyenes by sequential 
coupling of 1 ,2-dichloroethylenes 134 with a variety of acetylenes; selective reduction 
of the acetylene then leads to geometrically pure polyenes 135-138 (scheme 23). 80 
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This methodology was applied to a short synthesis of lipoxin B 39 (scheme 24). 
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The same group have also developed a related protocol for accessing all-E polyenes. 
This protocol is based around a.-chloro-w-substituted hexatrienes 140, obtained by two 
different approaches (scheme 25). 
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The first uses palladium catalyzed rearrangement of bis-allylic acetates, formed via bis-
allylic alcohols 139, whilst the second is based on th~ stereoselectiye reduction of 
homopropargylic alcohols 149 into (E)-homoallylic alcohols 142, followed by 
elimination. Alcohols such as 142 may also be oxidized to give trienones and trieneals, 
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providing useful polyene building blocks having two reactive terminal functions, as the 
chlorine atom is able to participate in coupling reactions, with, for example, Grignard 
reagents, providing isomerically pure (E,E,E)-diaryl hexatrienes 143. The coupling 
partner may be acetylenic, as illustrated in a brief, high-yielding synthesis of navanone 
B 24. 81 
An obvious necessity for the palladium coupling reactions, when stereodefined 
polyenes are desired, is a feedstock of geometrically pure alkenyl halide or alkenyl 
metal. Many techniques giving access to these coupling partners have already been 
mentioned in this review. 
Scheme 26 
RT 
=-yOEt TBAF 
OEt 
I~OEt 
OEt 
l. Pd(MeCNhC12, Cl!, 
piperidine 
2. TMS-acetylene 
3. H20 
TMS~OEt 
OEt 
l. Bu3Sn(Bu)CuCNLi2, THF, -78°C 
2. aq. NH4Cl, -78°C 
+ 
Quintard has done work on the regioselectivity of organotin cross-couplings, 
tuning the reaction conditions in order to obtain the requisite (E,E) dienyltin acetals 144 
that may then be used to construct polyenic systems (scheme 26).82 
Uenishi's group have examined the stereoselective hydrogenolysis of 1,1-
dibromoalkenes, providing access to (Z)-1-bromo-alkenes 145 that are useful for (E,Z)-
diene synthesis.83 Reduction of conjugated 1, 1-dibromoalkenes affords 2-alkenyl or 2-
alkynyl-substituted (Z)-1-bromo-1-alkenes 146, useful synthons for polyene 
construction (scheme 27). 
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~ 
Ph 148 
These may then undergo coupling with boronic acids, giving stereodefined 
trienes such as 148; coupling with alkynes is also possible. The validity of this 
approach to polyene synthesis was demonstrated by the synthesis of the unstable 
polyenes ( llZ)-retinal and (2Z, 4£, 6£)-dehydrodendrolasin. The same group has also 
reported the nickel catalysed coupling of bromoalkenes 147 with Grignard reagents, 
giving potentially useful allylsilanes 150 when TMS-substituted Grignard reagents are 
employed, or alkylated 1,3-dienes e.g. 149 (scheme 27). 84 
Lipshutz has reported two highly specialized building blocks for the preparation 
of polyene systems. The first, stannylated dienyne 153, is readily prepared through 
reaction of enal 151 with known Wittig salt 152 (scheme 28). 
Scheme 28 
~OEt 
OEt 
TMS -
152 
I. Bu3Sn(Bu)Cu(CN)Li2 
2. TsOH, acetone/H20 
NaN(TMSh. THF, RT 
Dienyne 153 undergoes cross-coupling at the vinylstannane end with a variety of 
halides under different conditions, producing trienyne or tetraenyne products (table 4).85 
Elaboration of the alkyne terminus of these products may be carried out either through 
initial hydrozirconation, trans_r:n~tallation with alu_mjnium, and trapping of the alane 
with a suitable electrophile, or via direct Negishi carboalumination followed by 
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method A, B or C 
!53+ halide Product 
Table 4: Different methods for the coupling of alkenyl halides with lynch pin 153 to yield polyenynes. 
Halide Method Product Yield(%) 
Cl~l A Cl~ 83 
TBDSO~I 
A TBDSO~ 74 
TIPSO~I A TIPSO~ 80 
BnO~Br 
A BnO~ 82 
TMS~Br B 
TMS ~ 72 
~Br c 91 PhS 
PhS 
a method A: i). BuLi, THF, -78°C; ii). ZnCh, 0°C; iii) Pd(PPh3) 4 ; iv) K2C03, EtOH. method B: i)l.Seq. CuCN, Pd 2(dba)3, AsPh 3, NMP, 50°C; 
ii)K2C03, EtOH. method C: i)l.Seq. CuCN, Pd2(dba)3, P(Furh. NMP, 50°C; ii)K,C03, EtOH. 
Table 5: Elaboration of acetylenic substrates to yield polyenic products 
Substrate 'Yield(%) metallation I electrophile product Yield(%) 
OTIPS OTIPS 
~ 70-A Cp2Zr(H)Cl, DCM, Me,AlCl, ~ 71 0°C, ClC02Et ""'- ""'- ""'- "'""- co,Et 
Cp2Zr(H)Cl, DCM, Me2A1Cl, 0 73-A ~ 82 Ph 0°C, ClCOMe Ph 
~ :;?" 74-A Cp2Zr(H)Cl, DCM, Me2AICl, 0°C, CSHIICOCl "'"- "'"- "'"- "'"- "'"- c,H, 80 
~ 75-A 
Cp2Zr(H)Cl,DCM, Me2A1Cl, ~
0°C, ClCOMe ~ ~ "'""- ~ 83 
PhS~ ~ 91-B Me3Al, Cp2Zr(H)CI, l'hS~J('""'w, ClCH,CH2Cl, ClC02CH,CCh o 73 
a prepared from 153 and the corresponding vinyl halide by methods A or B, cf. table 4 
quenching. Both processes give rapid access to a variety of all-E polyenes (table 5). A 
synthesis of navenone B 24 is a noteworthy example. 
The method has further applications to natural products, for instance, 
preparation of the oxopentaene 156 common to the mycoticins 154-155 (scheme 29). 
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Scheme 30 
R = i-Pr Mycoticin A 154 
R = s-Bu Mycoticin B 155 
OT!PS 
1.~1 
TMS ~ ~ ~ Pd(PPh3)4 ~ ClZn~/ T!PSO 
2. K2C03, EtOH 
Cp2Zr(H)Cl, ooc Me2A1Cl, ooc 
ClC02Et 0 
4.1 eq KOH 
-20 to 35°C 
OEt 156 
0 
N KO~CHO 
[ 
so3 
PPh3, NBS 
DCM 
Br~ CHO 
NaN(TMSh. THF, RT gTMS 
~/ 
TMS - \ Br 
PPh3Br 
157 
86%, >85: 15 E:Z 
lntrod11ction 
OTIPS 
Access to vinylogs of retinoic acid is also possible. Their redesigned trienyne 
(scheme 30) 157 incorporates an inversion of polarity relative to 153 due to replacement 
of the stannyl diene moiety by vinylic bromide. 157 can thus undergo coupling with 
vinyl and dienylzinc reagents (table 6). Elaboration of the alkyne terminus in the usual 
manner, either prior to, or after an initial coupling at the vinyl bromide terminus, leads 
to oxopolyenes, and this approach was applied to a short synthesis of the oxohexaene 
159, common to the dermostatins, of which dermostatin A 160 may be taken as a 
typical member (scheme 31). 86 
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2. K1C03, EtOH 
polyenynes 158 
I. CP2Zr(H)CI, Me2AICI or 
Me3AI, cat Cp2ZrCI2 
2. CIC02Et or CICOR 
lmroduction 
oxopolyenes 159 
Table 6: Functionalization of polyenynes to yield oxopolyenes 
Polyenyne 158 (from 157) Yield(%) Metalation/Electrophile Oxopolyene 159 (from 158) Yield(%) 
~ 78 Cp2Zr(H)Cl ~ 68 ?" Me2A1Cl CO!I:-:1 
ClC02Et 
 73 Cp2Zr(H)Cl ~ 73 Me2A1Cl "' ;/"'" C,HII ClC02Et 
PhS~ 80 cat. Cp2Zr2CI ~~oy 75 ~ Me3Al 0 
ClC02-i-Bu 
~ 85 Cp2Zr(H)Cl 0 70 Me2A1Cl ~~ Cl COMe M eO h M<O 
OTIPS 73 cat. Cp2ZrCI, OTIPS 74 
Me3Al 
ClC02Me 
0\te 
Scheme 31 
TIPSOI 
[~ 
I. 2eq. t-BuLi ~TIPSO ~ 2. 0.5eq. ZnC1 2 
:::::-..... :::::-..... 
Zn 2 
157 cat. Pd(PPh3)4, then 
K2C03 
Dermostatin A 
160 
I. Cp2Zr(H)Cl 
2. Me,AlCI 
3. CIC02Et 
OTIPS 
OTIPS 
Negishi has formulated a highly efficient and stereoselective procedure for the 
preparation of both symmetrical and unsymmetrical carotenoids. This procedure is 
based upon Zr-catalyzed carboalumination of conjugated oligoenynes followed by 
palladium and zinc catalyzed cross-coupling of the resultant alkenylalanes and allows 
ready access to members of the retinoids family. The procedure utilitizes the two and 
four carbon synthons 162 and 163 respectively. Accordingly, dihaloalkene 162 is 
readily converted to 163; with these in hand the authors were able to prepare a variety of 
carotenoids e.g. P-carotene 165 was prepared in 41% overall yield in three linear steps 
from 94. In a similar fashion y-carotene 17 and vitamin A 33 were prepared in good 
yields- (scheme 32). It is-noteworthy that--in all cases, ~99% stereoselectivity towards 
the drawn isomer was observed, leading to~ 99% isomerically pure polyenes.87 
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164 
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~ i-iv ~--i--iv _ _,.. 
166 
i,ii, vi 
164 
167 
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i, ii, viii, ix 
Conditions: 
75% 
169 
33 67% 
vii 
17 53% 
167 
69% 
i. Me3AI (2eq.), Cp2ZrCI2 (Ieq.), (CH2CI)z, 23°C, 4h; ii. evaporation at50°C and <0.5mmHg; iii. 163 (1.05eq.), ZnCI2 (leq.) in THF, 
2.5mol% Pd2(dba)], !Omol% P(Fur)3, DMF, 23°C, 6h; iv. K2C03, MeOH, 23°C, 3h; v. 162 (0.5eq), ZnCI2 (leq.) in THF, 2.5mol% 
Pd2(dba)], !Omol% P(Fur)J, DMF, 23°C, 8h; vi. 162 (1.05eq), ZnBr2 (leq.) in THF, 5mol% Pd(PPh3)4, DMF, 23°C, 2h; vii. ZnCI2 
(Ieq.) in THF, 2.5mol% Pd2(dba)], IOmol% P(Fur)), DMF, 23°C, 6h; viii. THF, n-Buli (Jeq.), 23°C, 0.5h; ix. (CH20)0 , 23°C, 5h. 
Wipf's group have prepared members of the manumycin family, using 
organozirconocene methodology to build the polyene sections.88 
Scheme 33 
Cp2Zr(H)Cl 
~COz TIPS Me2Zn 
170 ~0 
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Cp2Zr(H)Cl 
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i-Pr2NEt, RT, 2.5h V 171 
60% 
TFA-imidazole., THF, 
pyridine ~C02TII 
Bu3Sn 
75% 
172 
This approach involves hydrozirconation of a functionalized alkyne e.g. 170, 
followed by transmetalation with zinc, and in situ 1 ,2-addition of the organozinc reagent 
to a,~-unsaturated aldehydes. The approach is convergent and can be used to 
synthesize dienyland trienyl side chains common to the manumycins, and facilitates 
analogue preparation. Scheme 33 exemplifies this protocol through the synthesis of the 
eastern side chain of asukamycin 171 and southern side-chain of nisamycin 172. 
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Two recent applications of organoiron methodology towards polyene synthesis 
have been disclosed (scheme 34). 
Scheme 34 
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180 
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The first, aimed at stereoselective retinoid synthesis, uses a Peterson reaction between 
~-ionylideneacetaldehyde-tricarbonyliron complex 173 and a range of trimethylsilyl 
derivatives to access retinoid precursors 174-177. Iron complex 175 was subsequently 
transformed into 112-retinal 37 by conventional means.89 The second application 
employs stoichiometric acyclic dienyl iron complexes. Accordlingly, macrolactin A 
178 was disconnected into fragments 179 and 181, with a view to joining them together 
via nitrile oxide-olefin cycloaddition methodology. The (E, Z)-diene segment of 179 
was prepared through addition of the strongly nucleophilic lithium anion of 2-
(trimethylsilyl)ethyl nitroacetate to the isolable cisoid cation 180, giving an initial 
mixture of diastereomers that rearranges completely to the (E, Z) complex upon 
standing in chloroform.90 
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1.9 Miscellaneous methods 
Several new methodologies have emerged recently for the preparation of 
polyenes. Naso and eo-workers have successfully used bis(trimethylsilyl) derivatives to 
construct a variety of natural products, including the potent leukotriene B3 methyl ester 
186 (scheme 35). 
Scheme 35 
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lOO% 
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Chemoselective acylation of bis(TMS) enyne 182 followed by enantioselective 
chemical reduction and catalytic hydrogenation of the triple bond leads to (E, Z)-diene 
183 which is transformed into broinodiene 184. A similar sequence applied to 
bis(TMS) acetylene gives 185 which undergoes hydroboration with catecholborane to 
generate a vinylic boronic ester in situ; Suzuki-Miyaura coupling of this with 184 
affords, after deprotection, 186 in 41% yield.91 
In a comparative study of several methods of polyene synthesis, including HWE 
strategies, an iterative strategy based upon the Wollenberg reagent 18792 was found to 
be superior for the synthesis of the hexaene section of amphotericin B 4 (scheme 36).93 
This reagent is readily prepared and undergoes transmetalation to give either the 
lithiated species 188, or Grignard-type reagents such as 191, used recently by 
-- - -
Rychnovsky's group to install four of the five double bonds of Filipin Ill 190 (scheme 
36).94 
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Scheme 36 
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Solladie's group have enjoyed much success using reductive elimination as a 
means of synthesizing polyenes in a stereoselective manner. Their strategy was recently 
exemplified by the first enantioselective synthesis of the alarm phermomone haminol-1 
192 (scheme 37). Diyne 194, obtained through condensation of diacetylene with the 
appropriate aldehydes, yields the precursor dibenzoate diene 193 under standard 
conditions, with 192 attained as a single isomer following the reductive elimination 
step.95 
A pericyclic approach to the 9-cis-retinoids was recently put forward by de Lera 
and eo-workers (scheme 38). 
Scheme 37 
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A domino sequence, involving a reversible [2,3]-allyl sulfenate to allyl sulfoxide 
rearrangment (196-197), followed by propargylic sulfenate to vinyallene sulfoxide 
rearrangment (199-200), and finally, an irreversible, doubly stereoselective [1,5]-
hydrogen shift to give 201. Desulfuration according to Okamura, and deprotection, 
affords 9-cis-retinoids 36 and 203.96 
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Taylor's group have used pyrylium salts to effect polyene synthesis; treatment 
of pyrylium tetrafluoroborate 204 with suitable organometallics allows access to a 
variety of retinoids, including the novel dehydro-demethyl-retinoid 206.97 (scheme 39) 
Scheme 39 
Li ~ 204 -78°C, THF 
Conclusion 
As can be seen from this review, much progress has been made in the area of 
polyene natural product synthesis over the last 30 or so years, and new methodology is 
constantly emerging. However, the ability to reliably construct polyenes with absolute 
control over alkene geometry, particularly for those systems possessing cis-alkenyl 
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units, remains an elusive goal. The increasing usage of polyene natural products in 
medicine, as drugs and as biological probes, as well as the general interest in polyenes 
for other applications, e.g. non-linear optics, should serve to fuel the continuing interest 
in this area, and help to achieve this goal. 
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2.0 Results and Discussion 
2.1 Aims and overview of the project 
As is hopefully evident from the introductory literature survey, there is still a 
requirement for a procedure able to reliably construct polyene systems in a mild, high 
yielding and highly stereoselective manner. As has already been mentioned, work 
carried out in these laboratories, building on methodology developed specifically to 
overcome this shortfall75 · 98 has successfully demonstrated that a protocol employing a 
vinylboronate (functioning as a vinyl dianion equivalent) can be used to construct 
sensitive polyenes with a high level of stereoselectivity; this was exemplified by the 
recent synthesis of phthoxazolin A 133 (see section 1.8, scheme 21 and onwards). 
Although the assembly of this natural product was far from trivial and its (Z, Z, 
E)-triene moiety posed a significant trial of this new methodology, it was felt that a 
more challenging candidate for total synthesis should be sought as a definitive test. A 
formidable target having the requisite mixed geometry conjugated polyene moieties is 
found in viridenomycin 11 (see fig. 2), a bacterially derived polyene macrolide, and it is 
the explorations into the stereoselective total synthesis of viridenomycin that will be 
presented in this thesis. 
2.2 Biological activity and structural considerations of the target 
viridenomycin. 
Figure 9. Structure of the polyene macrolide antibiotic viridenomycin 
NH 
Viridenomycin, shown in fig. 9 and annotated with the numbering system 
adopted in the paper first reporting its isolation and_ characterisatism, 17 is a novel 2~­
membered macrocyclic polyene lactam. During the course of a screening program 
carried out in 1990 to find new antitumour antibiotics, a compound was isolated that 
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was found to prolong the survival period of mice afflicted with B 16 melanoma cells. 
The compound was designated AL081 after the strain it was isolated and cultured from, 
and on the basis of physiological and morphological features, strain AL081 was itself 
classified as belonging to the genus Streptomyces. It was noted that the properties of 
strain AL081 were concordant with many of those exhibited by Streptomyces 
gannmycicus, and thus the eponymic compound AL081 was imputed as a metabolite of 
this bacterial species. Structural elucidation of compound Al081 was sought, and 
brought forward an interesting finding from preliminary investigations. Table 7 shows 
a comparison between some physico-chemical properties of AL081, and another 
compound isolated and reported by the same group sixteen years previously, termed 
viridenomycin. 
Table 7 
Appearance 
Melting point 
[a]o 
UVA.max nm (in MeOH) 
MW (m/z) 
Elemental analysis: 
Found: 
Calculated: 
Molecular Formula 
Viridenomycin 
Colourless fine plates 
168-170°C (dec) 
+893 (32°C, c 0.5 in CHCh) 
310 
566 (vapour pressure 
osmometry) 
C 72.09 H 7.01 N 2.42 0 
18.48% 
AL081 
White powder 
185-190°C (dec) 
+ 195 (25°C, c 0.5 in CHC13) 
309 
556 (FD-MS, MH+) 
C 73.58 H 6.56 N 2.42 0 
17.44% 
C 73.49 H 6.71 N 2.52 0 
17.28% 
In light of these interesting similarities, the structures of both compounds were 
investigated more closely using a variety of spectroscopic techniques, with the final 
structures being determined using two-dimensional NMR methods. It was at this point 
that is was ascertained that AL081 and viridenomycin were one and the same 
compound, as testified by direct comparison, with both structures having physico-
chemical and spectroscopic properties fully consistent with the compound shown in 
figure 9, hereinafter referred to as viridenomycin. Viridenomycin had first been isolated 
from the culture broth of Streptomyces viridochromogenes as a weakly acidic and 
lipophilic compound which had strong inhibitory activity against Trichomonas vaginalis 
and certain gram-positive bacteria, but no anti-tumour activity had been described at the 
time. The activity of viridenomycin against murine tumoul]l (table 8) demonstrate_d_ in 
the later study showed that it possessed a wealth of biological activity, and it is this 
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activity, together with its challenging structural features, that make viridenomycin an 
appealing candidate for total synthesis. 
Table 8, showing the increases in life span (ILS) attributed to intraperitoneal inoculations with 
viridenomycin 
Dose P388 leukaemia / B 16 melanoma 
(mg I kg. I day) Survival ILS Survival ILS days (%) days (%) 
0 9.2 ± 0.42 14.7 ± 0.75 
5 11.3 ± 1.37 23 20.1 ± 1.15 37 
10 Toxic Toxic 
Viridenomycin is classified as a 24-membered polyene macrolide antibiotic, 
containing both a lactam and enollactone linkage. It features a (Z,Z,£,£)-tetraene in the 
northern hemisphere(C2-C9) and an (E,E,E,Z)-tetraene in the southern hemisphere (Cw 
C23). Other salient structural characteristics include a tetrasubstituted ~­
ketocyclopentane carboxylic acid substructure, which was shown by spectral means to 
exist in the enol form as drawn in figure 9. Also of note is that C10 in the cyclopentane 
ring is asymmetric and quaternary, and the stereochemistry at C25 (a constituent of the 
C23-C25 moiety which biochemically evokes a ~-phenylalanine derived pathway) is 
unknown (this will be discussed in 2.3.4). The cyclopentenol moiety alone makes 
viridenomycin an interesting target for total synthesis, but it was predominantly the 
construction of the awkward polyene units, which should thoroughly test the palladium 
coupling methodology developed in the group, that was of principal interest. A further 
point of interest concerning viridenomycin is its structural similarity to another 
Streptomyces metabolite, hitachimy~in 207, shown in fig. 10. Hitachimycin, a 
compound which has been synthesized and whose structure has been fully elucidated by 
comparison to the natural compound,99 is a novel 19-membered macrocyclic anti-
tumour antibiotic, and although lacking the tetraene systems and ester linkage of 
viridenomycin, the environment of its phenyl ring and its cyclopentene tether reveal 
pronounced structural similarities. 
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Figure 10. Structure of hitachimycin 207 
207 
0 
N 
H 
2.3 Retrosynthetic analysis of viridenomycin. 
Results a11d Discussio11 
During the studies into the isolation, biological evaluation and structural 
elucidation of viridenomycin, it was observed that the compound appeared particularly 
unstable, having a half-life of only a few hours even when stored below 0 °C under an 
inert atmosphere. This is most probably due to the chemical, thermal and 
photosensitivity of the polyene regions, and it would have been remiss to ignore these 
sensitivities when performing a retrosynthetic analysis. We were thus mindful of the 
fact these sections might pose the greatest problems in the synthesis, and accordingly 
we decided on an approach that would allow these polyene sections to be assembled in 
isolation. Three disconnections seemed obvious and satisfied the requirements 
suggested by the aforementioned considerations; these are shown below in fig. 11 and 
naturally lead to three fragments: a core cyclopentenol, the northern (E, Z, Z)-triene (C2-
C9), and the (E, E, E, Z)-tetraene of the southern hemisphere (CwC23). 
The key stages of rebuilding the macrocycle during the forward synthesis would then 
entail a Csp2 -Csp2 Suzuki-Miyaura cross-coupling across CrC8, amide bond formation 
to reinstall the C 1-C25 linkage, and an enollactonization to anchor the southern tetraene 
210 to the cyclopentenol tether 208. This raised the question of which of these 
particular ring-closing bond formations to make the final macrocyclization step, and 
additionally, the reliability and functional group tolerance of the palladium cross 
coupling reactions also meant it would no doubt be possible to apply them to the 
macrocyclization step; this allows for a flexible retrosynthetic strategy featuring 
disconnection across any one of the Csp2 -Csp2 bonds i.e., the so-called "stitching" 
technique mentioned in section 1.8, and illustrated in scheme 15. 
An alternative approach, with- considerable literature precedent, would be to 
make the final ring-closure step a macrolactonization. 
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Figure 11. Retrosynthetic analysis of viridenomycin 11. 
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2.3.1 Macrolactonization techniques 
210 
Southern tetraene 
There are several problems with this strategy that should be mentioned, firstly, 
the large negative entropy associated with large:-ring cyclizations means that very high 
reactivity is required in the ester-forming reaction. Secondly, the reactions need to be 
performed at high dilution, to prevent the occurrence of intermolecular ester formation. 
High dilution can cause problems in itself, and since high dilution is often achieved 
through slow addition of one reagent to a reaction-causing mixture, special design of 
reagents and highly reactive intermediates are required. Nevertheless, these problems 
can and have been circumvented, and consultation of the literature reveals that 
macrolactonizations have successfully been applied to a number of macrolide antibiotics 
and a number of reliable protocols exist by which to perform them. 
2.3.1.1 Carbodiimide techniques 
Representative of these techniques are the methods developed by Keck 100 which 
can be applied to the formation of large-ring lactones. One problem encountered here is 
the incidence of side reaction of the activated acylpyridinium intermediate; this is 
especially evident at high dilutions, as at normal concentrations reaction with the 
alcohol would be fast. For this reason, DMAP-HCl is a requirement (see scheme 40). 
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2.3.1.2 Double activation methods 
This strategy was originally presented by Corey and Nicolaou101 who developed 
it specifically for macrolide formation. The acyclic precursor is viewed as a m-hydroxy 
acid in which the carboxyl function is activated as a 2-pyridinethiol ester. 
Scheme 40 
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Proton transfer from the hydroxyl group to the pyridine nitrogen activates the hydroxyl 
as the alkoxide, and encourages hydrogen bonding between the charged oxygen and 
nitrogen, supposedly aiding intramolecularity (scheme 41). 
Scheme 41 
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Variations on this approach have appeared, including the use of more efficient reagents 
to effect formation of the thioestcr, such as the imidazoyl derivative102 shown in figure 
12. 
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Figure 12. Imidazoyl-derived thioester. 
Silver(!) salts are also employed to speed up the reaction, presumably through 
coordination to sulfur. These modifications allow the reactions to be performed at 
lower temperatures, and can offer higher yields. 
2.3.1.3 Mixed anhydride methods 
Activation of carboxylic acids as mixed anhydrides has proved to be an effective 
way to achieve lactonization. For example, in Y amaguchi 's syntheses of methynolide 
and neomethynolide103 the lactonization was achieved using 2,4,6-trichlorobenzoyl 
chloride (figure 13). 
Figure 13 
Bo 
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Inorganic mixed anhydrides have also proven to be effective, as in Masamune's 
synthesis of narbonolide, in which the carboxyl group is converted to the phosphoric 
acid mixed anhydride through treatment with diphenyl phosphochloridate. 104 This 
strategy requires lower temperature (less than 80 °C), since the intermediate phosphoric 
acid anhydride is unstable towards heat and prone to disproportionate. 
2.3.1.4 Mitsunobu method 
The Mitsunobu method105 allows the formation of medium and large ring lactones under 
mild, neutral conditions, using standard Mitsunobu reagents and conditions. 106 
2.3.2 Macrolactonization of viridenomycin 
The spectroscopic data for viridenomycin indicated that the lactone linkage is in 
fact an enol-lactone linkage; hence, we would need to perform an enol-lactonization. 
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Fortunately, there is literature precedent for this as both acetyl chloride and isobutyl 
chloroformate have been used successfully to generate mixed anhydrides which undergo 
cyclization to give enol-lactones. 107 The cyclization step is obviously extremely 
important, and needed special regard considering the certain sensitivity of the acyclic 
precursors. For this reason, the idea of employing other methods such as the C1-C25 
lactamization to ultimately close the ring was also entertained fairly early on in the 
project. 
2.3.3 Approaches to the major fragments 
As mentioned above, the retrosynthetic disconnections cleaved viridenomycin 
into three pieces, and by and large, these three pieces, each requiring widely varying 
chemistry to assemble them, naturally divide the discussion presented here into three 
major sections: efforts directed towards the synthesis of the core 208; towards the 
northern triene 209, and towards the southern tetraene 210. Although more detailed 
retrosynthetic analysis will be presented in the forthcoming sections that deal with each 
of these particular fragments, it is pertinent to give a broad outline of the strategies 
towards them first (fig 14 ). 
Figure 14. Outline retrosynthetic analysis of the major fragments. 
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The <J,pproach to be taken was to attach the northern tetraene 209 to the core 208 by 
means of a Suzuki-Miyaura coupling, a strategy requiring an alkenyl boron and an 
alkenyl halide partner. It seemed sensible to assume that a chelate-assisted Michael 
addition of a suitable acetylenic metal species (we envisaged a lithium organocuprate 
being ideal for this) to the enone precursor 211, followed by hydroboration of the 
alkyne functionality with catecholborane should provide us with 208, the requisite 
alkenylboron species, whilst it was imagined that it would be able to construct the 
halide partner through initial coupling of iodoacrylate 214 with vinylboronate 122, 
providing Heck diene 213; subsequent stereoselective iodo-deboronation of 213 (see 
2.4.1.3 for details of this procedure) should provide 209. Similarly, Heck coupling of 
122 with the protected iodoamine 216 should give dienylboronate 215 (fig. 15). 
Stereoselective iodo-deboronation to afford iodide 217, and Heck coupling of this with 
alkene 218 should provide us with 210, after unmasking of the carbonyl functionality. 
Figure 15. Assembly of the southern tetraene 
'-y/' ~ Heck coupling 
HO ~ 0 ====:l 
210 
2.3.4 The problem of absolute configuration. 
The absolute configuration of.viridenomycin is not known. During the studies 
carried out by Nakagawa and eo-workers that established the structure of 
viridenomycin, the stereochemistry at C2s were never determined, and thus there was 
the significant problem of not knowing which enantiomer of 216 was required to 
produce the biologically active diastereomer of viridenomycin. In the absence of an 
authentic sample of viridenomycin to probe spectroscopically or by chemical means, it 
was necessary to look towards molecular modelling to determine which configuration at 
C25 was more favourable on energetic grounds, and also to the literature, to compounds 
having similar structural features to viridenomycin, given that the particular section 
_ incorporating the stereocentre _of unknown _cQnfigurat~on W!!S _likely J_Q have _been 
derived from p-phenylalanine. Interestingly, there was another natural product that 
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showed certain homology with viridenomycin that provided a clue as to which 
enantiomer was more likely and it has already been mentioned in section 2.2. 
(+)-Hitachimycin 207, fig. coupling of this with alkene, is a macrocyclic 
antitumour antibiotic independently isolated in the early 1980's by Omura and 
Umezawa.99a-b The Omura group focused primarily upon structure elucidation using 
chemical degradation, NMR techniques, and biosynthesis experiments using 13C 
labelled precursors. Although they were able to deduce the bulk structure, the absolute 
stereochemistry at two of the four stereogenic centres remained undefined. Ten years 
later, Smith and eo-workers defined the complete relative and absolute stereochemistry, 
as well as the solid-state and solution conformation of ( + )-hitachimycin, using two-
dimensional NMR spectroscopy, single crystal X-ray analysis, and computational 
methods.99c-d They then followed this with the first reported total synthesis.99e 
The absolute stereochemistry at C2 1 of hitachimycin has been confirmed as (S), 
both from 13C labelling and X-ray crystal analysis, and it is believed that the ~­
phenylalanine moiety is incorporated via a polyketide pathway, with the natural a-
amino acid (S)-phenylalanine being converted through the action of an amino mutase 
enzyme. By analogy, it was postulated that the absolute stereochemistry at C25 of 
viridenomycin (also possessing this ~-phenylalanine moiety) is also (S), being derived 
from a natural a-amino acid in a similar fashion. To test this hypothesis, we carried out 
some preliminary modelling108, forcing both (R) and (S) stereochemistries at C25 in 
order to compare energy differences between the two minimized conformers. 
Unfortunately, although the (S)-form gave the lowest energy conformer, the computer 
calculated coupling constants for H24a - H24b, H2s - H24a and H2s - H24b (see fig. 16) 
differed significantly from the value·s obtained experimentally in the original paper 
(table 9). The calculated coupling constants for the higher energy (R) conformer 
showed even greater deviance from those derived experimentally. 
Table 9: Comparison between experimental and predicted 1H.lH coupling constants around C25 of 
viridenomycin. 
Proton's cou lin 
Hz4a-H24b 
Hz5-H24a 
Hz5-H2.tb 
13.5 
3.5 
4.5 
Hz J redicted• Hz. 
14.0 
4.5 
11.5 
This suggested either that the modelling was inaccurate, or that the original paper had 
incorrectly reported these coupling constants. To verify this, we contacted the research 
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group who reported the characterization of viridenomycin, but they gave assurance that 
the data was correct. 
Figure 16 
_H r4 a r H 
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1 I 
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This assurance prompted continued efforts to try to solve this problem using 
modelling, but by adopting a slightly different approach. The dependence of 3 J 
coupling constants on the dihedral angle 8 for a H-C-C-H fragment is represented by the 
Karplus equation (equation 1). Although the expression produces a well-defined cosine 
function, the actual range of experimental values of J often shows discrepancies of up to 
4Hz compared with the calculated values, producing the 'envelope' shown in figure 17 
when plotted against 8 as opposed to a discrete curve, and hence the empirical constants 
A, B and C, having values 7, -1, and 5 respectively, were introduced to attempt to 
correct for this. 
Equation 1 3 J = A + B cos 8 + C cos 28 
The second approach taken thus aimed to solve the equation for the values of 3 J 
presented in the original characterization paper (table 9), which were obtained from 
two-dimensional NMR analysis. Solutions to equation 1 yield two values for 8 in the 
range 0:::;8:::; 180°, thus giving two possible dihedral angles for each value of J. At this 
point of the project we participated in a brief collaboration with Peter Coveney's 
computational group at Queen Mary College, London, and they applied Monte Carlo 
conformation searches using the AMBER forcefield 109 (which is one of the more 
reliable forcefields when dealing with large biomolecules) to both diastereomers of 
viridenomycin, before using DFf methods to further optimise each lowest energy 
conformer. The H24a-C-C-H25 and H24b-C-C-H2s dihedral angles were then measured 
from the models, and compared to those obtained from the Karplus equation 
calculations. Unfortunately, no obvious correlations were apparent, and the results of 
this study were thus inconclusive, Interestingly however, -Coveney's~group tried <! 
number of different approaches using the original strategy, which attempted to correlate 
computer calculated J values to those obtained experimentally, and they obtained much 
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the same result as had been found before: the diastereomer having the (S)-configuration 
at C25 did indeed have a slightly lower energy than its (R) counterpart. 
Because the modelling studies had failed to establish conclusively which of the 
two diastereomers best matched the data presented in the characterization paper, we 
Figure 17. Karplus plot showing the relationship between the vicinal coupling 3J and the dihedral angle. 
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were forced to consider that either the modelling was wholly inaccurate, or the data 
reported was actually incorrect. The former is a possibility; even those force-fields 
better suited to modelling more complex biomolecules are not optirnized for polyenic 
systems; they show a tendency to force an overall flat conformation on molecules such 
as viridenomycin; nevertheless, the fact that ourselves and Coveney's group produced 
duplicate results using different modelling packages and force-fields, both suggesting 
that the (S)-C25 diastereomer was the more energetically favourable one, hints that the 
modelling may not be all that unreliable after all. The latter consideration, that the 
NMR data had been reported incorrectly despite the assertion otherwise, is impossible 
to verify in the absence of an authentic sample. 
Because of these difficulties and the lack of an obvious solution, there was little 
choice but to proceed with the synthesis, making the assumption that the configuration 
at C25 was (S), based on reasons stated earlier; and thus we initially sought to prepare 
the (S) enantiomer of 216. 
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2.4 Synthetic efforts towards viridenomycin. 
2.4.1 Routes towards the southern hemisphere tetraene 210 
A pivotal synthon in our strategy to construct 210 was the iodoamine 216. It can 
safely be said that more effort was directed towards the synthesis of this one seemingly 
trivial compound than towards any other single area of the project! A multitudinous 
host of methods were employed to elicit the preparation of (S)-216, which can be 
loosely grouped into three main areas according to the manner in which we attempted to 
install the asymmetric centre: firstly, by asymmetric reduction of an oxime ether 
according to Itsuno's methods; secondly, by asymmetric alkylation of an imine under 
phase-transfer conditions; and thirdly, and the strategy that proved most successful, by 
starting from a compound having the required stereochemistry already in place, in this 
case, from an amino acid. Because it roughly approximates to the chronological 
sequence of events that went into finally constructing 216, the discussions into the 
preparation of 216 will be presented in this self-same order. 
2.4.1.1 Strategy 1: Installation of the C-25 stereocentre by 
asymmetric reduction of an oxime ether (ltsuno 
reduction) 
Figure 18 shows all avenues explored m order to arrive at 216, or more 
precisely, routes taken to attempt to produce the requisite oxime ethers needed for 
asymmetric reduction. Although this retrosynthetic tree illustrates the convergent 
approach taken, not all routes suggest~d by it were pursued; as such, it represents both 
possibilities that could have been explored, as well as actual synthetic routes that were 
pursued. Although each of the avenues taken towards 216 start at different compounds 
and utilize different chemistry, they all have one thing in common, namely, the 
stereoselective reduction of an oxime ether as the means by which the (S)-
stereochemistry is introduced. 
In 1985, Itsuno described the stereoselective reduction of ketones and ketoxime 
0-alkyl ethers with reagents prepared from borane-THF or borane-DMS complex and 
chiral vicinal amino alcohols, with the best results being obtained from the reduction of 
acetopbenone 0-ID~lbyjoximes employing chir'!l QX<!?aborolidi~e -~25, know11 now as 
Its uno's reagent. 110 (fig. 19) 
58 
Results and Discussion 
Figure 18. Retrosynthesis tree showing routes taken to reach (S)-216 
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Its uno found that reductions carried out using reagents mixtures having a 1:2 
molar ratio of amino alcohol to borane gave the highest degree of selectivity (up to 99 
% ee.), whereas 1:1 mixtures gave disappointingly low results. 
In related work into the asymmetric reductions of ketones, Corey discovered that 
mixing a suitable chiral alcohol with two equivalents of borane gave a rapid reaction, 
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liberating two equivalents of hydrogen and forming the oxazaborolidine 225. 111 He 
found that although 225 itself did not reduce ketones directly, 1:1 mixtures of 225 and 
borane effected total reduction of acetophenone at rates comparable to those obtained 
using Itsuno's mixtures. 11 B NMR analysis of 1:1 mixtures of 225 and borane clearly 
indicated an active reducing species consistent with that shown in scheme 42, structure 
226, and a postulated mechanism for the reduction of ketoxime 0-alkyl ethers, 
analogous to that used to explain the asymmetric reduction of ketones using similar 
chiral oxazaborolidines, is shown in scheme 43. 
Scheme 42 
~ BH3 -)+ BH3 ~ Ph H Ph Ph + 
H2N OH HN, 8
/o 
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Scheme 43 
Given the usually impressively high yields and selectivities afforded by Itsuno 
reduction, and the experience within the group imparted through prior successful 
application of this methodology, 112 it was felt that this would be an ideal way to 
introduce the required stereochemistry into iodoamine 216, and accordingly efforts were 
directed towards preparing suitable Itsuno substrates. 
Early efforts to this effect commenced with hydroboration of propargyl bromide 
to give compounds of type 223, with a view to generating an organometallic species 220 
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capable of alkylating benzaldehyde in order to give alcohols 220a, or iodoalcohol 219a 
following stereoselective iodo-deboronation. Oxidation of such an alcohol should then 
provide ketones 219b or 220b, which should then be readily converted into the 
necessary oxime ethers 219c or 220c. 
Treatment of an 80% solution of propargyl bromide in toluene with neat 
catecholborane113 (CBH) for lh at 70 oc gave 223a in good yield (scheme 44). 
Scheme 44 
Br 
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Due to the propensity of such catecholboranes to undergo proto-deboronation 
under even mildly acidic conditions (for example, during silica gel chromatography) 
and their sensitivity towards moisture, 114 it was decided to attempt to trans-esterify 223a 
to the more hindered and thus more stable pinacol ester 223b, 115 employing standard 
conditions which had previously been found successful. 116 
Unfortumtely, in every instance, yields were extremely low, with boronic acid 
being isolated as the major product. The suspicion was that this could have arisen 
during the acidic work-up following transesterification, but even when this was omitted 
and replaced by thorough washes with water, the res~lt was still the same. A possible 
and tentative explanation is that the catechol liberated during the transesterification 
process is sufficiently acidic itself to effect proto-deboronation of 223b as soon as it 
forms, resulting in the isolation of its hydrolysis product; the water solubility of the 
latter also may account for the low yields. 
Suspecting the problem may be down to the choice of hydroborating agent, it 
was elected to try monoisocampheylborane (IPCBH2). Disappointingly, the use of the 
1:1 complex with TMEDA gave poor results under typical conditions (equation 2). 
This gave cause to seek an alternative to either CBH or IPCBH2. 
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Equation 2 
Br 
~ DCM, 40°C, 16h. mixture of products 
Since a stable pinacol boronic ester was desired and problems had been encountered 
previously in trying to perform the transesterification to reach this ester, the possibility 
of using pinacolborane (PBH) directly was examined. Initial reports of this reagent's 
utility by Knochel showed that PBH added rapidly to alkynes with excellent regia- and 
stereo-selectivity, and under very mild conditions (25°C, several hours). 117 Additionally, 
the derived alkenyl pinacolboranes can be purified by flash chromatography with no 
appreciable decomposition. The only disadvantage of this procedure was that a full two 
equivalents of PBH were needed to effect complete reaction, and unlike CBH, the 
reaction required solvent otherwise regioisomers were produced. By way of an 
improvement of this procedure, Srebnik and eo-workers developed a transition metal 
catalyzed variant of this reaction, initially employing zirconocene Cp2Zr(H)Cl as 
catalyst. 118 Although the results were good, the incompatibility of this zirconocene with 
many functional groups spurred them to seek an alternative catalyst, and it was found 
that rhodium and nickel gave excellent results, enabling ready access to either terminal 
or internal alkenyl pinacolboranes. Although at the time propargyl bromide had not 
been hydroborated under these conditions, the nearest suitable match in terms of 
functionality and outcome was propargyl chloride, where it was found that 1 mol o/o of 
Rh(PPh3) 3Cl (Wilkinson's catalyst) and 1.05 equivalents PBH gave a 40:60 mixture of 
terminal to internal alkene, in 99 % yield overall, whereas the catalyst Rh(CO)(PPh3hCl 
gave similar yields but with improved regioselectivity (99: 1 terminal to internal). 119 
Attempts to hydroborate propargyl bromide under these conditions were met 
with limited success. After first preparing pinacolborane according to the method of 
Knochel, attempts to effect hydroboration with the more esoteric and expensive catalyst 
Rh(CO)(PPh3) 2Cl were unsuccessful, whilst use of Wilkinson's catalyst gave the two 
regioisomers in roughly the inverse ratio of that reported to have been obtained from 
propargyl chloride, and in much lower yield (equation 3). 
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Rh(PPh3)).Cl 
DCM/PhMe, RT, 3h. ~0 
0-B 
~Br 
223b 
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+ 
40:60 
yield 58% 
223c 
Because of this disappointing result, it was elected to change strategy and try a 
direct propargylation, with a view to introducing the triple bond intact to provide a 
homopropargylic alcohol such as 219 or 220a. 
Homopropargylic alcohols have proven utility in organic synthesis. 120 Amongst 
the techniques employed to prepare them, nucleophilic additions of propargyl- and 
allenyl-organometallics to carbonyls represents the most popular and reliable 
method. 121 a 
Such techniques are not without drawbacks however; in almost ~11 cases, the problem of 
propargyl I allenyl tautomerization means that such nucleophiles lead to mixtures of 
homopropargylic and allenic alcohols 227 and 228, with the metal's Lewis acidity, 
solvent effects, and steric hindrance between electrophile and metal substituents all 
effecting the overall regiochemistry (scheme 45). 121 b-e 
Scheme 45 
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The first choice strategy was to employ a propargylaluminium species 224 (M=Al), 
generated through reaction of aluminium powder, mercuric chloride, -and propargyl 
bromide, according to the method first reported by Guedin-Vuong for the preparation of 
P' homopropargyl ethers. --
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i) Al, HgCI2- Et20 
ii) benzaldehyde, -78°C, 
then 40°C 
60% 
219 
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HOC c~ 
1"-': 
,..:; + 
<5% up to 5% 
In this method, a solution of propargyl bromide is slowly warmed with 
aluminium powder and catalytic mercuric chloride until the characteristic signs of metal 
C-H insertion are seen (effervescence, solution darkens in colour, aluminium powder 
was steadily consumed). It should be noted that without the mercuric chloride needed 
to 'clean' the aluminium surface of oxide, no reaction occured, and washing the 
aluminium powder with dilute acid first was insufficient as a means of activating it. 
After gentle warming to complete the formation of the propargylaluminium species, the 
reaction is cooled to -78 ac and benzaldehyde added slowly, before the temperature is 
raised to complete the reaction. The problems encountered with this reaction are evident 
from equation 4. 
Not only does the reaction yield the desired homopropargylic alcohol 219, but 
allenic alcohol (as expected) and benzyl alcohol were also produced. Thinking that the 
latter had arisen by reduction, perhaps effected by some form of transitory aluminium 
hydride species formed during the metal insertion process, an inverse addition was 
performed, adding the organoaluminium reagent dropwise to the benzaldehyde-solvent 
solution so as to keep the concentr<;1tion of any intermediate reducing species at a 
minimum, thus biasing the reaction towards propargylation. This strategy appeared to 
make little difference; with hindsight this is perhaps because the benzyl alcohol, which 
undoubtedly arises through reduction of benzaldehyde, was formed by action of 
aluminium amalgam, a reagent generated by the action of mercuric chloride on 
aluminium and which has been employed in the reductive amination of ketones. 123 
This method was fraught with other problems. Following work-up, besides the 
contaminants illustrated in equation 4, crude 219 contained a host of residual metal 
salts, particularly what is probably mercuric oxide judging by the deep red colour of the 
isolated product. Purification of _1.19 was attempte9 by vacuum distillation, but both 
219 and benzyl alcohol eo-distilled, and thus the two could not be separated. Attempts 
at chromatography were also unsuccessful as both alcohols had almost identical polarity 
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and eo-eluted, and even this technique failed to thoroughly remove the metal 
contaminants. Alcohol 219 is a known compound, and although not fully characterized, 
the racemic form has been reported as being both a pale yellow oil and a white 
crystalline solid! A more recent paper suggests the latter is correct, with . 
recrystallization from 1: 1 hexane/ether affording 219 as a colourless solid. 124 
However, in the absence of this information and with all attempts to purify 219 
unsuccessful, it was opted to attempt to oxidise the mixture (after a preliminary 
distillation to remove the residual metal salts) to ketone 221a. 
The first four oxidation methods of choice utilized, Swern, 125 Dess-Martin 126 
and PCC 127a or PDC 127b in DCM all proved highly efficient at oxidizing the trace benzyl 
alcohol back to benzaldehyde, yet left 219 untouched! 
At the time this work was undertaken, there was only one instance of 221a in the 
literature, where its synthesis from 219 was reported to have been achieved via Jones 
oxidation. 128• 129 
Although it was found that the procedure reported in this paper (which 
employed questionable quantities of dichromate and acid for the production of the Jones 
reagent) was unworkable, when the oxidation was attempted using a more contemporary 
preparation of the reagent, successful oxidation of 219 was achieved; unfortunately 
221a accounted for less than 10% of the product, with allenic ketone 229 present as a 
<5% contaminant, the major component being benzaldehyde. Two observations are 
worthy of mention: firstly, the amount of 229 recovered was entirely disproportionate 
with the amount of allenic alcohol present in the starting mixture, and secondly, if the 
reaction temperature was not maintained below 10 °C, the ratio of 229 to 221a 
increased; both observations indicate the propensity of 221a to rearrange to the more 
thermodynamically stable allene 229. 
Equation 5 
[0) c c; oc "-':: c~ I'-': I-& + lh + ..& various methods 
219 221a 229 
less than 10% less than 5 o/o major product 
The benzaldehyde produced, the large amount of which could not have solely 
arisen from oxidation of benzyl alcohol, suggests oxidative cleavage of 219 under the 
somewhat abrasive reaction conditions. 
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This scenano (equation 5) thus conferred a mixture of three carbonyl 
compounds, with a choice of either attempting separation at this stage, or separating a 
mixture of three oxime ethers later on. To further confound the situation, the small 
amount of 221a actually produced by the oxidation proved to be rather unstable on 
silica, and attempts to recrystallise or triturate it from the crude mixture were 
unsuccessful. 
Because of the persistent problem of propargyl I allenyl tautomerization, no 
doubt biased towards the allenyl form in the case of 221a due to conjugative 
stabilization, we investigated the possibility of taking out the triple bond via 
hydroboration prior to oxidation (giving 220a), or by employing a direct approach to 
install the alkenyl iodide functionality early on (219 ~ 219a) via a process involving in 
situ generation of HI and anti-Markonikoff addition (this process will be discussed in 
more detail in section 2.4.2). 
The first attempt employed CBH, under similar conditions used previously for 
the hydroboration of propargyl bromide (equation 6). Although the 1H NMR spectrum 
of the crude reaction mixture indicated alkene resonances due to 220a, the reaction 
appeared incomplete, and additionally, a mixture of uncharacterised compounds were 
clearly also being produced. 
Equation 6 
H~ i) 2 eq. catecholborane, H~0 8...--bO ~ 70°C, lh. . 1 'I '\ 
"-;:: 0 I : ______ _.,.. I ..& -
219 220a 
catecholate 
i) pinacol, Et20 H0~8...-o / 
ii) Na2C03, H20, 2h, RT. b ";(. 
X " " -;---~~ 
220a 
pinacolate 
Attempts to transesterify 220a under standard conditions once again met with 
failure, so transition metal mediated PBH hydroboration as tried earlier was attempted. 
Regrettably, this method also proved unsuccessful, as did attempts to synthesize 219a 
by direct iodination; it was later discovered that this process is only successful when 
applied to acetylenic esters or acids. 
Around this time, having largely thus far come up against several obstacles in 
attempts to prepare 216 via an oxime ether, a couple of methods to try to introduce the 
amine function early on were briefly examined. The first strategy-was to employ a 
Mitsunobu reaction between 219 and phthalimide, with a view to then converting the 
66 
Results a11d Discussio11 
phthalimide 230 to the free amine by treatment with hydrazine, after which the 
enantiomers could be separated by kinetic resolution. 
Equation 7 
219 
i) phthalimide, DEAD, PPh3 
THF,0°C, lh. 
ii) RT, 16h. 
X I> 
230 
Unfortunately, although 1H NMR spectroscopy indicated the presence of 230, the 
reaction was generally rather messy (a condition probably exacerbated by the number of 
impurities in the starting material 219), and this made attempts to isolate 230 all the 
more tedious. 
Since this was not a desirable set of circumstances so early on in the synthesis, it 
was decided to discontinue this approach and instead look at another means of 
achieving 216 by having the amine in place early on, namely, through an organometallic 
addition to an imine. 131 
Due to the weak electrophilicity of the azomethine carbon in imines, 
nucleophilic addition of organometallic reagents to C=N is often beset with problems 
such as competitive enolization, reduction, or coupling reactions. One solution to these 
problems is to activate the C=N bond towards addition through N-substitution; either 
with an electron-withdrawing group, or with a Lewis acidic metal, providing a metallo-
urune. 
This last approach seemed most appealing, as many of the commonly employed 
electron withdrawing N-substituents (for example, N-sulfonyl) are troublesome to 
remove; moreover, since it was desirable to utilize an aldimine, many of the N-
substituents required to render these inherently unstable species stable carry the price of 
diminished overall reactivity towards C=N addition. 132 
Accordingly, N-TMS benzaldimine 222 was selected as the candidate 
electrophile, a reactive yet stable and easily handled metallo-imine readily accessed in 
good yields via a modified literature procedure. 133 
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The first approach employed the propargylaluminium species 224 (M=Al) used 
previously with some degree of success, and the reaction was duly carried out in the 
same manner as illustrated in equation 8. Unfortunately, this reaction led to a mixture 
of products, and the 1H NMR spectrum of the crude reaction prior to work-up did not 
show obvious signs indicating the presence of 231, instead mostly starting material 222 
was evident. 
A recent paper reported an interesting finding that gave cause to revisit this 
reaction later on in the project; in this paper, Brown and eo-workers describe the 
critical importance of water in the asymmetric allylation of 222 by B-
allyldiisopinocampheylborane 232. 134 Curiously, and perhaps counter-intuitively given 
the instability of 222 towards moisture, they reported that unless one equivalent of 
water is added to the reaction, allylation did not take place, even after up to a week at 
room temperature! (scheme 46). 
Scheme 46 
i) 23i /233, -78°C i) H3o+ ~ uN-TMS 3h. ii)OH-
222 234 
@~ Ph):o .•..• ) 2B :s_J= 
Me ~ 
Ts 232: 70%, 73% ee. 
232 233 
233: 89%, 92% ee. 
They posited that during the reaction, 222 functions as a 'masked' version of the 
reactive aldirnine, liberated through reaction with water, and it is this free aldimine that 
rapidly reacts with the allylating agent. As a comparable reaction had been tried and it 
had- been observed that-the crude reaction-mixture pre-work-up consisted_largely of_ 
starting material, it was theorized that perhaps adding an equivalent of water to the 
reaction shown in equation 8 might induce formation of 231, freeing the aldirnine in a 
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similar manner, which should then react rapidly with the propargylalurninium 
nucleophile. 
However, when this was tried, a complex mixture of products was obtained; 
although 1H NMR spectroscopy indicated resonances attributable to both allenic and 
propargylic fragments, the presence of 234 could not be confirmed due to the number of 
components; furthermore, had 234 been present, isolation would have been laborious 
and the yield undoubtedly minute. 
In light of these further setbacks, it was decided to re-investigate the route 
centred around preparation of the oxime ethers. First however, the possibility of side-
stepping the problems encountered during the attempts to make 221a using the 
troublesome propargylaluminium additions by introducing an acetylene unit directly 
was briefly examined (equation 9). 
Equation 9 
C Br Li acetylide-EDA complex Et20, 0°C. I: ------~x~--~·~ 
221a 
A convenient means by which to introduce an acetylene unit is via lithium 
acetylide, a moderately hard nucleophile available as a 1:1 complex with EDA. 
However, problems were consistently encountered with this reagent throughout the 
project, and when it was reacted with 2-bromo-1-phenyl-1-ethanone, only starting 
material was recovered. 
It was next decided to try another method of preparing homopropargylic alcohol 
219, preferably one that would be cleaner than using the aluminium I mercuric chloride 
method since many of the problems encountered previously were probably due to the 
sheer number of contaminants (metals salts, by-products from side-reactions), and also 
one that would hopefully not give any of the unwanted allenic alcohol. 
In the paper preceding that reporting the oxidation of 219 to 22la, Henbest had 
reported the synthesis of p, y-acetylenic carbinols via Reformatsky reactions with 
propargylic bromides (scheme 47). 135 
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Although this reaction gave satisfactory results, the aqueous work-up advised gave rise 
to large quantities of voluminous zinc precipitates, necessitating repeated yield-
diminishing filtration and making the reaction generally unpleasant to perform. 
Scheme 47 
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It was discovered the most facile way to prepare 219 was via a tin-mediated process, as 
recently described by Masuyama and co-workers. 136 
The reaction, whose putative mechanism based upon 1H NMR studies is shown m 
scheme 48, shows marked dependence on both reaction medium and temperature. 
Scheme 48 
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The hypothesis put forward is that reaction of propargyl chloride 235 (X=Cl) 
with tetrabutylammonium iodide and tin(II) iodide leads to the reactive species 236, 
which in dry, polar solvents such as DMI and DMF, leads to carbonyl allenylation 
yielding 238, and varying amounts of the hydration product 240. Conversely, reaction 
of propargyl bromide 235 (X=Br) with tetrabutylammonium bromide and tin(II) 
chloride leads to 236, but in aqueous media and at higher temperatures, rearrangement 
of 236 to 237 is faster than carbonyl allenylation, leading to homopropargylic alcohol 
239 as the major product. 
This procedure was attempted and was found to provide results exactly in accord 
with those reported. The only obvious disadvantage this procedure has is its 
employment of tin salts, which proved extremely difficult to remove and persisted even 
after column chromatography. 
Nevertheless, with a relatively pure sample of 219 in hand, the Jones oxidation 
to 221a was re-attempted, but disappointingly, gave largely the same results as before, 
suggesting that the contaminants present in the first instance were not actually 
responsible for the poor results. After considerable effort and re-examination of 
reaction conditions (lower temperatures, shorter reaction times and different work-up 
procedures were all attempted), a clean sample of 221a was finally obtained, and the 
conversion to oxime ether attempted under standard conditions (equation 10). 137 
Equation 10 
221a 
NH20Me.HCI, py. 
Reflux in.MeOH Me ONe~ 
----------------- ~ lh 
221b 
produced in trace quantities 
Sadly (considering the effort that had gone into trying to obtain 221a) the crucial oxime 
was only produced in trace amounts, with NMR spectroscopy evidence again 
demonstrating the penchant for conjugated propargylic species to rearrange to the 
thermodynamically preferred allenes. 
Due to this further setback, and the time expended trying to prepare 216 via 
ltsuno's method, at this point an alternative strategy into this_key synthqn was sougbt. 
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2.4.1.2 Strategy 2: Installation of the C-25 stereocentre by 
asymmetric phase transfer catalysis. 
Phase transfer catalysis (PTC) plays an important role in organic synthesis. 138 
A thorough survey of the technique is beyond the scope of this discussion, but it 
suffices to say that as the technique grew in use since its emergence in 1965, much 
effort was directed towards development of an enantioselective variant, in which the use 
of chiral catalysts (commonly chiral quaternary ammonium salts, operating in exactly 
the same manner as their non-chiral counterparts) associate with the anion and carry it 
across the organic/aqueous interface, whereupon the anion reacts with the substrate. 
Tight interaction between the anion and the chiral catalyst generally allows reaction on 
only one face of the anion-catalyst complex, leading to non-racemic products. 
Advances in asymmetric PTC have been made in several key areas of organic 
synthesis; among these, epoxidations, 139 Diels-Alder cycloadditions, 140 Darzens 
reactions, 141 Michael additions, 142 aldol condensations, 143 and a-hydroxylation of 
ketones144 are notable as having provided some impressive results. Of particular 
interest for the purpose of this study were the examples of PTC involving 
enantioselective alkylation of carbon nucleophiles, an area in which many advances 
have been made through the pursuit of effective means to elicit the asymmetric 
h . f . 11 . 'd 145 146 synt es1s o opttca y pure a-ammo act s. · 
The first promising results in this area were disclosed by O'Donnell, who 
reported the racemic alkylation of prototypical glycine Schiff base esters such as 241. 147 
This was later followed by the first reported chiral phase transfer alkylation, which 
utilized a cinchona alkaloid (structure? having stereogenic centres both at nitrogen, and 
on the carbon skeleton), affording a-amino acid 244 with excellent enantioselectivity 
following recrystallization and deprotection (scheme 49). 148 
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Throughout the following years, several improvements to the alkylation of such 
Schiff bases were made, including the development of a second generation of chiral 
catalysts (N, 0-dialkylated salts of cinchona alkaloids) that gave higher initial 
selectivities in the case of 241 (up to 81% prior to recrystallization). 149 Then came a 
third generation of catalysts, independently developed by Lygo 150 and Corey. 151 
These N-9-anthracenylmethyl salts 245 and 246 mediated alkylation of Schiff 
base 241 with good to excellent ee (scheme 50), and from his work, Corey formulated a 
model to rationalize the stereochemical outcomes of these alkylation reactions. 
In the Corey model, the positive charge on the quaternary nitrogen (which is 
delocalized onto the carbon and hydrogen atoms surrounding it in ammonium salts) 
interacts closely with the enolate oxygen of 241, ensuring efficient transfer of 
stereochemical information (fig 20). 
Other catalysts employed in asymmetric PTC include chiral metal-salen 
complexes, 152 TADDOL, 153 catalysis using NOBIN, 154 C2-symmetric chiral quaternary 
ammonium salts, 155 and chiral derivatives of tartaric acid. 156 
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Considering the structure of the desired target (S)-216, one piece of work from 
the literature seemed propitious. Eddine and eo-workers recently reported an example 
of imine a-alkylation under phase transfer condition, employing an amino alcohol 
derived hydrazonium salt 251 as chiral catalyst. Using a range of electrophiles, they 
were able to access amines 250 with good to excellent ee; yields were in the range 65-
70% (scheme 51). 157 
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Although the authors had not attempted a propargylation, there was a singular 
documented early example from Favorskaya and eo-workers of a propargyl electrophile 
used under phase transfer conditions to give racemic 231 from imine 247, albeit in 
modest yield. 158 In light of this literature precedent, it was anticipated that 231 could 
be obtained via an asymmetric version of this procedure (figure 21), with the protected 
form (221c) then being elaborated as shown in figure 18. 
With a view to first attempting a non-selective propargylation to test the method, 
and perhaps a subsequent trial hydroboration on the racemic amine (221c-220d), the 
preparation of 247 was achieved as shown in equation 11. Having obtained 247, the 
phase transfer propargylation using propargyl bromide was undertaken; however, it 
should be noted that the experimental details given in the literature for this procedure 
(reference 157) are inutile since the stochiometries are clearly incorrect. Nevertheless, 
the procedure was attempted with what was estimated to be more sensible ratios of 
reagents, and surprisingly it was found that the reaction returned a mixture of mostly 
starting material imine 247, hydrolysis products propargyl alcohol (from hydrolysis of 
propargyl bromide) and benzophenone, plus a small quantity (<10 %) of the a-tautomer 
248 (equation 12) 
Figure 21 
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This result was duplicated exactly when the experiment was repeated. It was 
noted that when the reaction was performed, the mixture of the imine, salt and base 
gave rise to a deep violet colour, yet addition of a single drop of propargyl bromide to 
the reaction was sufficient to instantly neutralize this colouring, suggesting the 
colouring was due to a radical species present at low concentration. In order to probe 
the reaction, it was repeated on an NMR scale using d6-DMSO, and although the 
spectrum indicated a slight downfield shift in the acetylene C=C-H proton resonance 
from 8 3.60 to 8 3.67, there was no increase in complexity seen for the neighbouring 
methylene signal, suggesting the change was due to the formation of propargyl alcohol 
and not the propargylation of 247. Somewhat puzzled by this outcome, information was 
sought from the literature concerning general alkylations of imines of this type, and 
produced an interesting finding that seemed to conflict with the results disclosed by 
Favorskaya. 
Cainelli and Giacomini had reported that in the presence of base, imines such as 
247 and 248 are in equilibrium, with the azaallyl anion 252 representing the 
intermediate-species (scheme 52);.1 59 
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They had examined a range of N-diphenylmethanimine (254) derived imines and 
determined that in the presence t-BuOK, the acidic doubly benzylic proton was 
efficiently shuttled from the a-position in 248 to the a' -position in 247, with the 
difference in pKa between the two positions driving the equilibrium. The best result 
was obtained with 1.2 equivalents of t-BuOK, giving a 60:40 ratio of 247 to 248 post 
work-up. Moreover, if the isomerization reaction was performed in the presence of an 
electrophile, concomitant irreversible alkylation was observed, effectively driving the 
reaction towards the formation of imines 253, and affording Z-protected amines in 
excellent yields following iminolysis and N-protection. 
The clear advantage of this method was that the lower pKa of imine 248 negated 
the use of harsh bases such as 50 % hydroxide, which seemed to effectuate largely 
hydrolysis of starting materials in the previous attempt to alkylate 247. 
Accordingly 248 was prepared as shown in equation 13, and a tandem isomerization-
alkylation procedure attempted as described above. However, when this was tried using 
1.2 equivalents each of t-BuOK and propargyl bromide, a curious result was obtained. 
After work-up, the crude 1H NMR spectrum showed a mixture of the desired 
propargylimine 249, mostly a mixture of imines 247 and 248, and also a compound 
~h()se identifi~ation was somewhat ambiguous from the NMR data. 
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Purification of the reaction mixture was performed, and this unknown substance was 
isolated as a light brown crystalline solid that was subjected to XRD analysis. This 
brought prompt yet slightly surprising elucidation, and the result is shown in equation 
14, together with the crystal structure in figure 22. 
Equation 14 
~ 
i) 1.2eq t-BuOK, THF, RT. 
6N ii) 1.2eq propargyl bromide I ~ 247 + 248 + 249 + 
248 
255 
There are a few instances of 255 appearing in the literature, 160 but only one 
describes its preparation from 248 in a radical process involving elemental sodium! 161 
The supposition is that when using modest electrophiles like propargyl bromide, 
reprotonation of 252 is faster than alkylation, explaining both the low recovery of 
249 and accounting for the presence of mostly starting material and tautomerized 
starting material after work-up. An explanation for the synthesis of 255 as a 
consequence of this process is not immediately obvious, since this compound would 
have presumably have been reported as a by-product of such tandem-alkylation 
procedures. However, a possible explanation is a radical dimerisation, requiring a 
suitable oxidant (possibly molecular oxygen) to generate a reactive intermediate from 
the anion initially generated by the action of base on 248. 
In order to improve the yield of 219, a number of different conditions were tried, 
both varying the amount of t-BuOK (from 10 mol % to stoicfiioltfelric quantities) and 
electrophile (two equivalents and excess of propargyl bromide were tried), and also 
running the reaction at different temperatures. Unfortunately, none of these appeared to 
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have any significant bearing on the outcome of the reaction, and around this time in the 
project this method was discontinued as a more promising route to (S)-216 emerged. 
Figure 22: crystal structure of dimer 255. 
2.4.1.3 Strategv 3: Installation of the C-25 stereocentre using 
a chiral pool substrate. 
As the decision to synthesize ~he diastereomer of viridenomycin having the (S) 
stereochemistry at C25 had been made based on what is perhaps a rather slight analogy 
to a related compound, it was felt that a strategy that allows ready access to either 
enantiomer of 216 might be prudent. With this in mind, it seemed that an obvious 
starting place would be a compound having the requisite stereochemistry already in 
place, and also one readily available in both enantiomeric forms. Considering the 
structure of 216, a compound that fulfilled these requirements was the unnatural amino 
·acid phenylglycine 256, commercially available in both (R) and (S) forms. Thus, the 
approach to compound 216 that proved successful may be viewed as essentially a series 
of elaborations and hornologations of phenylglycine; the retrosynthetic strategy, 
beginning with the N-carbamate protected form of (S)-216, compound 266 is shown in 
figure 22. 
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In the above approach, phenylglycine is reduced and protected as the N-Boc-
amino alcohol257, before the hydroxyl function is converted to a suitable 0-sulfonylate 
leaving group (it was imagined that nosyl, tosyl or perhaps mesyl would be suitable for 
this purpose). Having displaced the leaving group with cyanide to obtain P-amino 
nitrile 263, a carefully controlled reduction with DIBAL-H to give aldehyde 264, 
followed by a kinetic Wittig reaction (the Stork-Zhao modification mentioned in section 
1.7) should afford the requisite (Z)-iodide 266. The full sequence of reactions and 
related side-reactions that were involved in the assembly of this iodide are shown in 
scheme 53. The first goal was to prepare 257, the N-Boc amino alcohol. Although this 
is a commercially available compound, the high cost per gram meant that it was 
infeasible to purchase this reagent, since it was needed so early on in the synthesis. It 
has to be said that much of the chemistry shown in scheme 53 had to be developed, 
either by improving existing literature methods, which proved to be at best low yielding, 
and at worst, somewhat capricious; in other cases formulation of novel procedures was 
required. 
Preliminary efforts towards compound 257 followed literature methodology, 
which advocates either a) N-protection of the commercial amino alcohol with di-tert-
butyl dicarbonate (Boc anhydride) which is again expensive due to the high cost of the 
amino alcohol precursor161 b) stepwise N-protection of the amino acid followed by 
reduction via the mixed anydride, 162 or c) a one-pot approach using LAH to first reduce 
the amino acid, followed by N-protection with Hoc-anhydride. 163 However, a- more 
current protocol that seemed advantageous was to first reduce the acid function, then 
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protect in a separate stage; using the aforementioned methods a-c, 257 was accessed in 
moderate yields, but the latter strategy offered the advantage of much higher yields, 
something that was deemed important given the early role of 257 in the synthesis. 
Scheme 53 
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There are numerous methods available for the reduction of amino acids to chiral 
amino alcohols, a reflection of the importance of these compounds in organic 
synthesis. 164 In recent times, reductions based upon activated borohydride techniques 
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have become the vogue, offering many advantages over other methods, particularly with 
regards to safety when performing large scale reductions. 
Especially popular is the method employing lithium borohydride and TMS 
chloride, 165 or the cognate procedure using iodine and sodium borohydride. 166 
Both these methods employ an oxidant to generate borane in situ and thus, the 
work-ups recommended are much the same as those suggested for an LAH reduction, 
where the use of strong hydroxide is necessary to break down the oxygen-metal 
complexes formed as a consequence of the reaction. Such extensive aqueous work-ups 
can lead to diminished yields, particularly considering the water-solubility of some 
amino alcohols, and it therefore seemed sensible to omit the work-up at this stage, 
instead choosing to perform a one-pot reduction-N-protection process, isolating 257 at 
the end of the sequence without the need to obtain the intermediate amino alcohol. 
Accordingly, following the reduction of (S)-phenylglycine 256 using the iodine-
borohydride system, the reaction was cooled, quenched with methanol to destroy the 
excess borane, and then 1 equivalent each of triethylamine and Boc-anhydride was 
added to the cooled reaction. After stirring for 3 hours at ambient temperature, 257 was 
obtained in virtually quantitative yields following work-up and recrystallization. 
It was in attempting the transformation of 257 to tosylate 258 that problems in 
the literature first emerged. Depending upon the temperature and base employed, 
adding p-toluenesulfonyl chloride (tosyl chloride) to a solution of 257 allows access to 
either the aziridine 259, the oxazolidin-2-one 261, or the tosylate 258, which as scheme 
53 illustrates, itself functions as an intermediate in the synthesis of both the other two, 
making 258 the most difficult to obtain with satisfactory yield and purity. 
Although the mesylate 262 w.as not utilized until later on in the project, it is 
fitting to discuss early attempts at its preparation now, since many of the problems 
encountered during efforts to obtain tosy late 258 were also met in trying to synthesize 
this mesylate, most of these problems stemming from contradictory experimental details 
in the literature. 
That both 258 and 262 show a great propensity to cyclize to the oxazolidin-2-
one 261 even at ambient temperature is clear; testimony of this is found from two 
sources. First, from the literature methods, which report either tosylation or mesylation 
of 257 and subsequent cyclization of the 0-sulfonylates as an expedient means to 
Qrepare these_ useful oxazolidin-2-ones. Tre'!tment of 256 with t9syl c;hloride or 
methanesulfonyl chloride at 0 °C, 167 treatment of 256 with tosyl chloride and subsequent 
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heating to 60 °C 168 or use of excess p-toluenesulfonyl chloride at 25 °C 169 all provide 
oxazolidin-2-one 261 in yields varying from 70% to quantitative. 
The second source was obtained from these studies; frequently, it was 
discovered that even if the temperature was kept low ( -10 oc and below) and reaction 
times were kept to a minimum, significant amounts of 261 were present along with the 
desired 0-sulfonylates. The problem was exacerbated at ambient temperature, where 
stirring 1 equivalent of tosyl chloride with 257 in DCM with either TEA or pyridine as 
base proved to be an easy route to obtaining oxazolidin-2-one 261 quantitatively! 
It was found that the transformation 257---+261 via 0-sulfonylation generally 
showed little dependence on either the reactant stoichiometries or dilution, the base 
employed, or the solvent used. Reactions in DCM or mixtures of DCM-Et20, using 
bases such as pyridine, HUnig's base and TEA, changing the reactant stoichiometries 
(excess sulfonyl chloride, excess base), or using different reactant concentrations all had 
little effect on the overall outcome. It was observed that the formation of 261 was 
particularly rapid when the reaction was performed in DMSO, as anticipated. 
It was also found that using 4-nitrobenzenesulfonyl chloride (in an attempt to 
prepare the nosylate derivative) was an even more efficient means of obtaining 261, 
perhaps not surprising given the hardness of this sulfonylating reagent and the leaving 
group ability of 0-nosyl. When using this reagent, it was noted that a threshold 
temperature at which the nosylate was formed and cyclization did not occur could not 
be found; lowering the reaction temperature to -18 oc effectively stopped the reaction 
completely, but warming it to -10 oc led to slow formation of the oxazolidin-2-one 
exclusively. In order to ascertain whether such a threshold temperature could indeed be 
found for the tosylation procedure, fl series of NMR experiments were performed. 
These showed that 1 equivalent of TEA and 1 equivalent of tosyl chloride in d-
chloroform slowly converted 257 to 258 with concurrent formation of 261 at 20 oc; 
both products were evident on the spectrum after 45 minutes. Lowering the temperature 
to 0 oc showed no conversion after this amount of time, and only after several hours 
were traces of both tosylate and oxazaborolidin-2-one seen. Conversely, addition of 
DMAP to either reaction led to accelerated formation of oxazaborolidin-2-one. 
Indeed, the facile preparation of 261 has been reported from 257 using DMAP 
and Bee-anhydride alone at 20 °C, 170 and it was discovered from work in these 
laboratories that employing DMAP when attempting ~o _ge~er~te 258 always led to 
cyclization, irrespective of the temperature, base, or solvent. 
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Given these observations and the conflicting accounts from the literature describing the 
syntheses of 261, the majority of methods put forward for the preparation of the 0-
sulfonylates seem questionable. 171 
After considerable trial and error, the best conditions for the preparation of 258 
were found to be treatment of 257 with 1.5 equivalents of tosyl chloride and 1.1 
equivalents of TEA at 10 oc in DCM; after around 24 hours, although TLC indicated 
the reaction was not complete (257 still remained), work-up after this time gave the 
tosylate in 70 % yield, after first removing the majority of the excess tosyl chloride by 
treatment with hot hexane (257 and 258 are insoluble in hot hexane, tosyl chloride is 
not), then subjecting the remaining mixture to column chromatography. 
Having obtained a reasonably satisfactory means of synthesizing 258, attempts 
to transform it to iodide 260 were made, utilizing adapted literature methods. 
Methods for the overall transformation of R-OH into R-I are few compared with 
the analagous transformations to R-Br or R-Cl; in most cases, R-OH must be activated 
as a suitable leaving group, either during the reaction, or via a suitable isolable 
intermediate. Activation by conversion to -OS02R', Cl or Br, and subsequent 
displacement by r in halogen-exchange (or Finkelstein) type reactions 172 are 
commonplace, as are in situ activation methods employing reagents such as 
triphenylphosphine, iodine and imidazole. 173 
With a suitable leaving group in place, a number of literature procedures were 
attempted, involving treatment of solutions of 258 in acetone or 2-butanone with excess 
sodium iodide at either ambient temperature or under reflux. 174 Although these 
procedures gave satisfactory yields of 260, total consumption of 257 was never seen, 
and heating in an attempt to push the .reaction to completion induced cyclization to the 
oxazolidin-2-one 261. Additionally, it has been found that 2-butanone, although 
superior as a solvent to acetone for this transformation, gave rise to a number of side-
products that were never isolated and identified. These side products and the 
incomplete reactions necessitated time-consuming purification by column 
chromatography, and since using excess sodium iodide failed to improve the turnover, a 
number of alternative solvents were investigated. After a brief study, nitrile solvents 
were found to be superior to ketones or ethers (THF), and the one that proved most 
satisfactory was anhydrous propionitrile, affording pure 260 in 88% yield, without 
incidence of side reaction or (,::y<;li?:~tiQ_n to the ox~zolidin-2-one. 
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At the same time these minor difficulties with the transformation 258-260 were 
being tackled, several means of preparing iodide 260 directly from 257 were assessed. 
The aforementioned method, employing triphenylphosphine, iodine and imidazole, is a 
valuable methods of converting alcohols into alkyl halides, but the notorious difficulty 
in removing the triphenylphosphine oxide by-product, which is often a time-consuming 
and yield-reducing endeavour and which is not always succesful anyway, can severely 
limit the utility of this reaction. An improvement to the procedure has been 
suggested. 161 In the method prescribed by Longobardo and eo-workers, polystyryl 
diphenylphosphine is used instead of triphenylphosphine; this material gives 
comparable yields, yet allows the phosphine oxide by-product to be simply removed by 
filtration, affording the alkyl iodide as pure compound. This method was used to good 
effect, and 260 was obtained in 91 o/o yield, however, there is sadly a serious drawback 
to this method, and it is not a synthetic consideration, but a financial one. The 
immoderate cost of polymer-bound triphenylphosphine (which puts a -£60 per gram 
price on 260) unfortunately precludes its use, even despite the tremendous advantages it 
offers. 
It is claimed that, in transformations that produce triphenylphosphine oxides as 
by-products (Mitsunobu reactions, Wittig reactions, or R-OH to R-X conversions using 
triphenylphosphine and C~ to name a few), the problem of removing the phosphine 
oxide can be alleviated through employment of tri-n-butyl phosphine instead, since tri-
n-butyl phosphine oxide is ostensibly water-soluble and hence is removed during work-
up .m 
Intrigued and encouraged by this, a small-scale (0.21 mmol of 257) study was 
undertaken to briefly investigate whe~her indeed there was any truth in this claim, and 
that using tri-n-butyl phosphine in place of triphenyl phosphine would make purification 
of 260 simpler by allowing the phosphine oxide to be simply washed out during the 
aqueous work-up. 
For the sake of completion, a selection of other phosphines were incorporated 
into this study, and the results are displayed in table 10 (and see equation 15). 
In this study, the reactions were performed in HPLC vials; although TLC was used to 
check for the appearance of 260 in the reaction, the disappearance of 257 could not be 
clearly observed by TLC since it coincided with the imidazole. For this reason, the 
reactio_ns were heated at reflu~ f9r an arbitrary 3 hours, a tin"!e:peiiod it was felt shol}ld 
be adequate to effect complete reaction given the phosphines employed. 
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Following this time, the presence of phosphine oxide in the 1H NMR spectra of 
the crude products made conversion difficult to determine, so for this reason, only 
isolated yields are reported. 
Equation 15 
xJ::COH 0 N 
H 
257 
2.2 eq. phosphine, 2.5 eq. imidazole 
2.2 eq. iodine, DCM, reflux, 3h. 
Table 10: relationship between yield and phosphine in the reaction shown in equation 15 
Significant 
phosphine oxide 
Entry Phosphine present after % Yield (al 
aqueous work-
u ? 
1 triphenylphosphine yes. 67 
polystyryl 
no. 90 diphenylphosphine 2 
3 tri-n-butylphosphine yes. 77 
4 tris- fury !phosphine yes. 59 
tri-o-toly !phosphine yes. 70 
tri-t-butylphosphine (b) 
5 
6 
7 tri -n-octylphosphine yes. 85 
8 tri-cyclohexylphosphine yes. 67 
<al isolated yield after column chromatography with gradient elution from neat pet. ether 60-80 to 6: 1 pet. 
ether 60-80 I ethyl acetate; <bJ no conversion to 260 was observed. 
The first thing to note is that,. at least in the case of the transformation of 257 
into 260, tri-n-butyl phosphine oxide is most definitely not removed during an aqueous 
work-up; indeed, the 1H NMR spectra showed little difference between the amount 
present in the crude product prior to work-up, and that after work-up. Second, it was 
found that tri-n-octylphosphine was an excellent substitute for triphenylphosphine; in 
subsequent larger scale reactions, it was noted that this phosphine reacts rapidly and 
exothermically with iodine, and the overall reaction time is reduced to just under 1 hour. 
In addition, the long alkyl chains of the phosphine oxide by-product mean that it can be 
more easily removed using column chromatography, by eluting first with a higher 
boiling fraction of petroluemether which drags the tri-n-octyl phosphine oxide_ through 
the column, yet fails to move 260. Changing the solvent mix after all trace of 
phosphine oxide had been removed gives pure 260. Apart from this time-consuming 
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practise, this method seems ideal; however, there is a disadvantage; the sheer molecular 
weight of tri-n-octylphosphine oxide and the fact that it is a greasy liquid and hence the 
bulk cannot be removed by recrystallization severely limits the scale this transformation 
can be performed on, as even small scale reactions produce relatively large quantities of 
this nusiance by-product. For this reason, tri-n-butylphosphine is perhaps the better 
alternative, although the claims made for it were found to be unsubstantiated; overall 
though, the procedure using the modified halogen-exchange was found to be superior, 
for reasons of experimental ease and consistency. 
A recently disclosed method for the direct transformation of R-OH into R-I 
which uses a CeCh.?H20 I Nal system was also attempted, but this gave no reaction 
even after prolonged periods of time, 176 and attempts to transform 257 into the 
corresponding alkyl bromide using CBr4 and PPh3 led to 261 every time. 177 
The reason it was deemed desirable to obtain 260 was because it was imagined 
that the displacement of iodide by a suitable acetylene nucleophile should give easy 
access to 267, allowing the route to 216 shown in figure 18 (in which 267 is simply 
22lb where P=Boc) to be resumed. This proved not to be the case; attempts to react 
260 with lithium acetylide-EDA complex (which continued to be a problem reagent), 
with TMS-acetylene and TBAF, and with the organocuprate generated from 
ethynylmagnesium bromide and copper iodide all failed to produce 267, either giving 
rise to multiple products, or returning starting materials. 
Continuing the theme of acetylidinations, the possibility of using aziridine 259 
was suggested by a recent paper detailing the effective ring-opening of aziridines by 
trimethylsilyl compounds as a facile route to P-amino acids and 1,2-diamine 
derivatives. 178 Because of their hig11 reactivity and capacity to function as carbon 
electrophiles, aziridine derivatives are useful synthetic intermediates and a number of 
ring-opening reactions on activated and unactivated aziridines have been reported. 179 
Hou showed that TBAF effectively triggers the reaction of nucleophiles TMS-X 
(X=N3, CN, Cl) with a range of N-substituted aziridines, and this seemed encouraging. 
N-Boc aziridine 259 was thus prepared according to a literature method, 180 and 
subjected to a range of nucleophiles. Neither lithium acetylide nor TMS-acetylene I 
TBAF gave any indication of successfully ring-opening 259 to give 267, and the only 
evidence of possible successful reaction was seen using an organocuprate, generated 
fro_m e_thynylmagn~sium bromide and copper iodide; although 11j: ~MR data showed the 
presence of a species having resonances at 8 2.3 (triplet with J 2.5 Hz) and 8 3.4 (double 
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doublet with J 6.8 and 2.5 Hz) which suggested 267, all other means of analysis were 
inconclusive and further endeavours to obtain 267 were suspended. 
During the course of investigations into literature methods for the transformation 
of N-Boc ~-amino alcohols into 0-sulfonylates, it had been noted that there was a 
reported procedure in the literature for the transformation of 257 to mesylate 258, 
although no experimental details were given. Vaultier's group had reported the 
sequence 257 to aldehyde 264 via the mesylate 262, 181 whereupon they then performed 
organometallic additions to this and other ~-substituted N-Boc-~-amino aldehydes, 
providing a facile and novel route to enantiopure 1 ,3-disubstituted N-Boc-1 ,3-
aminoalcohols.182 
It was thought that elaboration of tosylate 258 (which was already in hand) in a 
similar manner should also enable access to aldehyde 264, and then a kinetic Wittig 
reaction according to the method of Stork and Zhao48 should provide the requisite 
iodide 266. Accordingly, attempts were made to prepare the nitrile 263 via substitution 
reaction with sodium cyanide in DMF at ambient temperature over 24 hours, as 
described by Willis and Sutherland. 162 
The transformation 258-263 proved to be most capricious! Depite working perfectly 
the first time this procedure was undertaken, thereafter, numerous problems were 
encountered. The principal problem was one of incomplete reaction. Although the 
reaction completed with no trace of starting tosylate 268 after the prescribed time period 
the first time, every other time afterwards the reaction appeared to reach an equilibrium, 
returning a mixture of starting material and 263. Heating the mixture to drive the 
reaction was out of the question given the predilection of 268 to cyclize, and slightly 
elevated reaction temperatures (up to ~0 oq made little difference. 
The second serious issue encountered with this procedure was the the incidence 
of side-reactions; each time, the reaction would slowly change colour, taking on a red-
orange hue, which proved to be a sure sign the reaction had failed. The successful 
reaction remains colourless throughout. TLC examination of a coloured reaction 
revealed a large number of components, including the starting material 268, the nitrile 
263, and a number of other unidentified products. Time constraints meant there was 
little prospect for isolating these by-products in order to determine their origin and thus 
perhaps provide amelioration, so instead, a screen of various other solvents, cyanide 
soun:::es a_nd additives such as crown ethers was performe_9 (table 11). 
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Table 11: factors affecting the transformation of 258 to 263. 
Entry Cyanide Solvent Conditions I Result 
source Additives 
1 1 eq NaCN DMF 24h, RT. poor conversion. 
2 3 eq. NaCN DMF 24h, RT incomplete reaction, 
multiple products. 
3 3 eq. NaCN DMF 24h, RT, H20 added. incomplete reaction, 
multiple products 
4 3 eq.NaCN DMF 24h, RT, 5% incomplete reaction, diethylamine added multiple products 
5 3 eq. NaCN DMF 24h, RT, 5% acetic incomplete reaction, 
acid added multiple products 
6 3eq.NaCN DMF 24h, RT, 15-crown- slow conversion after 24h, 5, multiple products 
7 3eq. NaCN DMF 24h, RT , 15-crown- slow conversion after 24h, 5, MgS04 multiple products 
8 3 eq.KCN DMF 24h, RT , 18-crown- slower conversion than with 6. NaCN, multiple products. 
9 3eq. KCN DMF 24h, RT little conversion; product< 30% 
10 3 eq. CuCN DMF 24h, RT no conversion seen after 24h. 
11 3 eq. TBACN DMF 24, RT. poor conversion. 
12 3 eq. NaCN MeCN 24h, RT poor conversion after 24h 
13 1 eq. NaCN IPA 24, RT poor conversion, side products. 
14 3 eq. NaCN IPA 24,RT poor conversion, side products. 
15 1 eq. TBACN IPA 24,RT poor conversion, side products. 
16 3eq. TBACN IPA 24,RT no conversion. 
17 3 eq. NaCN acetone 24,RT no conversion 
18 3 eq. TBACN. acetone 24,RT no conversiOn 
19 3 eq. NaCN. IPA I Et20 24,RT no conversion 
20 3 eq. NaCN. IPA/DMF 24, RT poor conversion 
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The reasoning behind entries 3, 4 & 5, where the reaction had been deliberately 
'poisoned', came from the fact that the first time this reaction had been performed, a 
rather aging bottle of anhydrous DMF had been used. It is known that DMF slowly 
produces dimethylamine over time, and the supposition that trace amounts of base, acid 
or even water were having a detrimental effect on the reaction was thus tested by these 
entries. It was noted that entries 3, 4 & 5 all gave the 'dirtiest' reaction, giving rise to a 
red-orange solution and by far the most by-products on TLC. Other than demonstrating 
that other solvents, crown ethers and cyanide sources were either ineffectual or made no 
difference, the screen provided no elucidation as to why the transformation that had 
worked perfectly once never worked again. Magnesium sulphate was used in entry 7 to 
ascertain whether the presence of trace quantities of water were responsible; although 
care can be taken to exclude water during the reaction, and the solvent and 268 can be 
dried prior to use, drying large quantities of cyanide salts is a rather hazardous affair. 
Given the problems with this method, the decision was made to attempt to 
access nitrile 263 via the mesylate 262, but as mentioned previously, problems had been 
encountered in attempts to prepare 262 using literature methods. It should also be noted 
that the one time the transformation 258-263 ·had been successfully achieved, it had 
provided sufficient nitrile to attempt a large number of trial reductions using DIBAL-H 
and also Red-Al. All of these had failed, and as Vaultier's group had reported this 
reduction as part of a general sequence 257-264, it seemed pertinent to contact him 
and request experimental details, since they were at the time unpublished. 
Having obtained experimental details and some salient general advice 
concerning the chemistry involved in the sequence 257 to 264, 183 mesylate 262 and 
nitrile 263 were prepared in good yi~lds. The Vaultier procedure recommends slow 
addition of 1 equivalent of mesyl chloride as a solution in DCM to a cooled solution of 
TEA and 257, with the reaction then being allowed to stir at room temperature. In 
particular, the procedure also stresses the use of only freshly distilled mesyl chloride 
and TEA, and it was found that when this is done, the mesylate is formed almost 
quantitatively with no trace of oxazolidin-2-one 261. This procedure was also adapted 
for the synthesis of 258, where 1 equivalent of freshly recrystallized tosyl chloride 
(which was rendered acid-free by shaking a solution in Et20 with 5 % NaOH) was 
added slowly as a solution in DCM to a cold solution of TEA and 257; in exactly the 
same manner, pure 258 is isolated, and unlike before, the re(lction_go_es to completion, 
without incidence of side-product formation. The likelihood is that the formation of 
these 0-sulfonylates is highly acid sensitive, with protonation providing access to the 
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efficient leaving group R-S03H (R=Me or Tol) and hence encouraging cyclization to 
the oxazolidin-2-one. 
Vaultier' s procedure for the conversion of 263 to 264 utilizes a saturated 
solution of cyanide in DMSO; not a particularly pleasant mixture to handle, but 
nevertheless, one that proved to be effective. This reaction, performed at 45 oc over 18 
hours, leads to 264 without incident, and again, applying this method to the 
transformation 258~263 proved successful; none of the aforementioned problems were 
encountered. Vaultier also provided conditions for the subsequent reduction of nitrile 
263, and considering the procedure disclosed, it is no small wonder previous attempts 
had failed! The procedure calls for exactly 4 equivalents of DIBAL-H to be added 
rapidly over just 15 minutes at -40 oc; the reaction is then cautiously quenched with 
MeOH before being allowed to warm to room temperature; the whole mixture is then 
poured into a separating funnel containing saturated ammonium chloride solution, and 
the resultant gelatinous precipitates are carefully broken down with progressively 
stronger HCl solutions. Unless this procedure is exactly followed, poor results are 
obtained, and unless the DIBAL-H is added as directed, no conversion is seen. The 
need to quench at low temperature is apparent, but the explanation for use of 4 
equivalents of DIBAL-H and with such rapid delivery is elusive. 
Having now obtained aldehyde 264, the conversion to the (Z)-iodide by Wittig 
homologation with (iodomethyl)triphenylphosphonium iodide 265 was performed 
according to a procedure described in the literature, 184 and furnished 266 in moderate 
yield after chromatography. With this coupling partner finally in hand, the stage was 
set for a Heck reaction between 266 and a vinylboronate, which would provide 
dienylboronate 268, and allow elaboration to the southern tetraene 270 as discussed 
previously (see figure 23 below, and figure 15, section 2.3.3). 
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2.4.1.4 Vinylboronates and the methodology of sequential 
Heck coupling-iodo-deboronation: elaboration of 266 
Before discussing the synthesis of 268, it is pertinent to mention two related matters, 
concerning the preparation and use of boronates of general type 122, and the manner in 
which such alkenyl boronates are able to provide access to alkenyl iodides with high 
stereoselectivity, this latter consideration being the crucial principle behind the project. 
Vinylboronate 122 is readily prepared on multigram scale from commercial 
reagents by an adapted literature method. 185 In this procedure (outlined in scheme 53), 
trialkylborates are alkylated using a Grignard reagent, generating a tetrahedral borate. 
Use of triisopropyl borate instead of trimethyl borate confers a slight increase in yield 
due to the enhanced stability of this intermediate, but over the course of these studies 
this was found to be an insignificant advantage. Low-temperature quenching of this 
intermediate borate and subsequent transesterification with a diol affords the 
vinylboronate as an air- and moisture-stable product. In the case of 122, this Is a 
colourless liquid that can be distilled, but it is primarily this means of isolation that 
lowers the overall yield of 122. The Grignard required for preparation of these 
vinylboronates is vinylmagnesium bromide, which is sold solely as a solution in THF. 
The problem is that THF and 122 azeotrope; in performing the distillation, one thus 
obtains THF, a constant boiling mixture of THF-122, and finally pure 122, n~sulting in a 
loss of up to 30% of the total mass. Since vinylmagnesium bromide is only sold in THF 
solution, and since the prospect of making this Grignard reagent is unpalatable due to 
92 
Results and Discussion 
the toxicity and difficulty of handling vinyl bromide, this situation unfortunately had to 
be tolerated. However, a couple of other minor issues with 122 gave reason to seek an 
alternative vinylboronate. Firstly, it was noted that occasionally (and particularly with 
very pure batches of 122) the liquid would transform into a thixotropic material upon 
storage in the fridge; although a semi-liquid jelly-like consistency was most common, it 
was also observed that 122 would occasionally set almost solid. The obvious 
suggestion is polymerization, but aside from a brief examination of this material by 1H 
NMR spectroscopy and mass spectrometry (which proved difficult since the material 
proved to be virtually insoluble in all solvents) which provided no real elucidation, the 
composition of this polymer and its mode of formation is unclear. 
Scheme 54 
~MgBr 
Ph 
Ph+O, 
Ph-t-c/~ 
Ph 
5 
77% 
i) B(OR)), -78°C, THF 
ii) RT, 20% HCl 
iii) pinacol I Et20 
53% 
1 
6 
71% 
The second issue concerns the volatility of 122. It was noted that, when degassing Heck 
reactions by sparging with argon, it was possible to almost blow all the 122 out of the 
rea~tion (this was discovered accidentally, when Sg of 122 were reduced to about l.Sg 
in an attempt to degass the vinylboronate separately for the sake of convenience!). 
In seeking an alternative to 122, it was believed any diol that would give a 
hindered cyclic boronate woud be suitable, and accordingly, the vinylboronates from 
benzopinacol and racemic 2-methyl-2,4-pentanediol (hexylene glycol) were prepared as 
indicated in scheme 54. Both showed the immediate advantage of increased yields 
compared to 122; vinylboronate 271 is a grey solid and it thus easily obtained and 
purified by recrystallization, whilst 272 is a liquid, but fortunately one that can be easily 
distilled from THF solutions as a pure compound due to its much higher boiling point. 
Having obtained these new vinylboronates, a few trial couplings were attempted under 
classical Heck concl{tions i.e., aryl. iodides, witfi tri-n-butlylamine as base, and 
palladium acetate I triphenylphosphine as the catalyst. By way of a comparison, a 
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number of couplings were undertaken with alkenyl bromides, since previous work had 
shown these to be more reluctant partners in Heck couplings with vinylboronate 122.98 
The results of these reactions are shown in scheme 55 and table 12. 
Scheme SS 
Ph 
Ph+o, 
Ph~ oB~ 
Ph 
271 
R-X 
274: X =l 
275: X=Br 
Heck conditions 
1.2eq. 272 
5 mol% Pd(OAc)z 
12 mol% PPh3 
1.2 eq.nBu3N, PhMe, reflux, 20h 
274, 275, 276, 277 a: R =Ph 
b: R= p-MeC6H4 
c: R= p-MeOC6H4 
d: R= o-NH2C6H4 
e: R =!-naphthyl 
f: R = p-02NC6H4 
g: R = 2-thiophenyl 
Ph Ph 
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Table 12: Yields and Heck/Suzuki ratios in the reaction of vinylboronate 272 with various halides. 
Entry Halide Conversion 276 : 277 Yield of 276 
ratio 
1 274a 100%(100%) 1 00:0(1 00:0) 97%(100%) 
2 274b 100%(100%) 100:0(100:0) 77%(69%) 
3 274c 100%(100%) 80:20(80:20) 48%(50%) 
4 275b >95%(64%) 80:20(80:20) 77%(51 %) 
5 275c 95%(>95%) 82:18(69:31) 40%(24%) 
6 275d 40%(NA) 95:5(NA) 33%(NA) 
7 275e 100%(100%) 65:35(62:38) 50%( 57%) 
8 275f >90%(>90%) 85:15(87:13) 51%(48%) 
9 275g 100%(0%) 100:0(-) 77%(0%) 
reactions were performed in sealed tubes, using 5 mol% Pd(OAch, 12 mol% PPh3, 1.2 eq. vinylboronate 
272 and 1.2 eq. n-Bu3N; PhMe reflux for 8h (4 days for 27S). Figures in brackets are previous results 
obtained using vinylboronate 122. NA denotes no data exists for comparison. 
The first thing to note is that under Heck conditions, vinylboronate 271 gives 
only the pinacol reaction product ketone 273; this was perhaps to be expected, given the 
migratory aptitude of -Ph in this rearrangement. 
Inspe_ction of the r~~lts in table 12 reveals. wha~ may be considered normal 
Heck reactivity profiles, with the order of reactivity between iodides 274 and bromide 
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275 roughly in accord with that normally observed and indicative of a mechanism 
involving a rate-determining oxidative addition of Pd(O) to R-X. 187 
Although at first glance the data suggest 272 is an improvement over 122, it has 
to be said that some of the comparisons are invalid because the conditions employed 
previously were markedly different to the ones used here; for instance, in entry 5, the 
conditions that provided 276c were much milder (reflux in MeCN for 24h). The only 
signficant improvement is in the coupling of 2-Bromothiophene; previously, it had been 
found that 2-Iodothiophene afforded the Heck product in 46% yield (92:8 Heck/Suzuki) 
and then only if AgOAc was added; reaction without this additive gave poor ( <5%) 
conversion to the Suzuki product exclusively. 2-Bromothiophene had never been 
successfully coupled, but again, it must be said that the comparison is slight since such 
forcing conditions as used here were never tried in the previous study. 
Since 272 seemed comparable in terms of reactivity, and superior in terms of 
preparation, it was adopted as a replacement for 122 for the remainder of the project. 
The first successful deployment of it in a Heck coupling reaction of direct relevance to 
ths synthesis at hand was in its coupling with 266. It has been said that there are almost 
as many different conditions employed in the Heck reaction as there are examples of its 
use, and in the absence of an exemplary literature procedure, finding successful 
reactions conditions for a given transformation can amount to little more than trial and 
error, even in light of recent suggestions gleaned from mechanistic studies and a wealth 
of experimental data. 186b 
A good place to start is often with traditional Heck conditions (those employed 
in the study described in table 12), and fortuitously, such conditions turned out to be 
ideal in preparing 268. As illustrateq by equation 16, 268 was obtained in good yield 
following chromatographic purification, with only an accompanying trace ( <5%) of the 
Suzuki product. 
With this key dienylboronate in hand, efforts were directed towards its 
elaboration to the southern tetraene, which commenced with attempts to obtain dienyl 
iodide 269 via stereoselective iodo-deboronation of 268. 
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As was mentioned in the introduction, an efficient protocol enabling the 
preparation of (£)- or (Z)-iodides via boronates such as 268 has been developed (see 
scheme 21). This protocol builds upon Brown's methodology, where it was discovered 
that the geometery of the iodides produced was solely dependent upon the order of 
addition of reagents.76 In the original study, sodium hydroxide and iodine were used to 
elicit iodo-deboronation; as a consequence of later work in these laboratories, it was 
found that a more electropositive source of iodine was needed when dealing with bulky 
pinacol esters (the original study has examined vinylboronic acids 187 and their 
diisopropyl esters), 188 and iodine monochloride proved to be ideal.77 
A mechanism explaining the stereoselectivity of the iodo-deboronation process 
is presented in scheme 56. 
Reaction of styryl boronates 278 with ICl leads to the dihalo adduct 280, 
presumably via the intermediate cyclic iodonium ion 279. Addition of Meo- to this 
species generates the "ate" complex 281, which leads to rapid anti elimination of 282 
and inversion of stereochemistry, prod,ucing (Z)-styryl iodides 283. 
Conversely, pre-complexing 278 with Meo- generates the "ate" complex 284, which 
undergoes direct iodination by the I+ source with retention of stereochemistry, affording 
the (£)-styryl iodides 285. 
Unfortunately, when this iodo-deboronation sequence was applied to 268, 
adding first sodium methoxide at -78°C, then ICl as a solution in DCM, extensive 
decomposition was observed, evident from both the TLC of the reaction, and from the 
crude 1H NMR of the reaction mixture, which suggested (among other unexplained 
phenomena) what appeared to be partial cleavage of the N-protecting group (this was 
deduced by a resonance aJ 8 1.5, indicative of t-Bu group due to SN 1 Boc 
fragmentation). 
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Suspecting this to be perhaps down to the use of sodium methoxide, the reaction 
was repeated and the TLC taken prior to addition of ICl; however, this did not appear to 
indicate that methoxide alone had caused the decomposition of 268, and so it was 
Scheme 56 
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assumed that perhaps 268 was simply intolerant to the conditions necessary to effect 
iodo-deboronation; in particular, the functional group intolerance of iodine 
monochloride was mooted as being a possible cause of the problem. An alternative was 
briefly investigated; during the course of these studies a reagent came to light that was 
purportedly a potentially useful alternative to ICl, being somewhat more stable and 
easier to handle. This reagent, pyridine-ICl complex, 189 is simply obtained by stirring a 
cold solution of ICl in DCM with 1 equivalent of pyridine, and the resulting complex is 
then precipitated by the addition of hexane, and then isolated as a yellow powder after 
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filtration and drying. Although certainly easier to handle, it proved to be a very weak 
source of I+; too weak in fact to be of any utility in this synthesis. In a trial reaction, 
iodo-deboronation of 276b by ICl gave results exactly comparable to those previously 
disclosed,(see ref. 98 · compounds 73 &74) both in terms of yield and selectivity (scheme 57). 
Scheme 57 
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However, when pyridine-ICl complex was substituted for ICl, iodo-
deboronation was found to proceed very sluggishly indeed, with only around 10% 
conversion to iodides 286 and 287 being seen. Performing the reaction at ambient 
temperature led to a marginal increase in yield, but still this complex is seemingly a 
very weak source of I+ compared alongside ICl itself, and current research being carried 
out in the group bears testimony to this. 
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2.4.2 Routes into the northern hemisphere triene 209. 
Tackling fragment 209 proved to be the major stumbling block of the project, solely due 
to the problem of an unexpected side-reaction encountered right at the start of the 
planned synthesis towards 209, a problem that ultimately proved to be an intractability 
too difficult to circumvent. 
Before discussing this side-reaction, a review of the planned procedure to 
assemble 209 is fitting. As was first shown in figure 14, 209 was to have been 
assembled via a Heck coupling between known iodoacrylate 214 and a vinylboronate, to 
give a dienylboronate 213 that would then be subjected to iodo-deboronation with 
inversion, producing (Z, Z)-dienylester 288. A second coupling of this diene with 
vinylboronate, and subsequent iodo-deboronation with retention of olefin geometry was 
to provide triene 209 after deprotecting the ester to unmask the carboxylic acid group 
need for the attachment of 209 to the southern tetraene 210. 
Figure 24 
repeat sequence 
I~ c:===) 
OH 
209 
1U hxio-doboro••••ft H"' 
:. OM• lu 
OMe 
213 
I 0 
~OMe 
214 
+ 
122 or 272 
Regrettably, the synthesis described here did not get as far as 213, for reasons that will 
now be elaborated on. 
2.4.2.1 An unexpected and problematic result. 
Having prepared iodoacrylate 214 according to a literature procedure by 
treatment of methyl propiolate with sodium iodide in glacial acetic acid, 190 attempts 
were made to couple it with vinylboronate 122. 
Once again, it was elected to first try a coupling under rather traditional Heck 
conditions, using palladium acetate, triphenylphosphine, and tri-n-butylamine as base. 
The expected outcome of this is shown below in equation 17 below, where it was 
anticipated at worst a mixture of Heck and Suzuki products would be obtained. 
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Equation 17 
0 
0 5 mol % Pd(OAc)z M'O} MeOl =ro, PPh3, """'' MeCN, !6h + OB~ + 
I ~6 214 122 
Heck product Suzuki product 
Instead, following work-up, a new compound was isolated whose 1H NMR spectra 
possessed unexpected doublets having J 13.2Hz at 8 4.50 and 7.41 (compared with 
doublets at 8 7.55 and 6.91 with J 9Hz for acrylate 214), together with signals which 
showed the presence of only two n-butyl groups. This was tentatively assigned as 
methyl (E)-dibutylaminoacrylate 290b, which may have arisen from a Michael addition-
elimination sequence of tributylarnine on iodoacrylate 214, followed by loss of a butyl 
group. In order to confirm this series of events, further experiments were performed 
between both secondary and tertiary amines 289 and iodoacrylate 214. 
Scheme 58 
0 
M~J 
I 
214 
+ 
289 
a: R1=R2=R3=Et 
b: R1=R2=R3=nBu 
c: R1=Et, R2=R3=iPr 
289 
d: R1=R2=-(CH2)4-, R3=Me 
e: R 1=R2=-(CHzCH2)20-, 
R3=Me 
f: R1=R2=Et, R3=H 
g: R1=R2=iPr, R3=H 
h: R1=R2=-(CH2)4-, R3=H 
i: R 1=R 2=-(CH2CH2)zO-, 
R3=H. 
j: R1=R2=Bn, R3=H. 
k: R1=R2=-(CHz)s-, R3=H 
I: R1=R2=-(CH2)s-, R3=Me 
heat, solvent 
amino acrylate 290 
a: R,=Rz=Et 
b: R1=R2=nBu 
c: R1=Et, R2=iPr 
d: R,=Rz=-(CHzk 
e: R,=R2=-(CHzCHz)O-
f: R1=R2=Bn 
g: R1=R2=Bn 
h: R,=Rz=-(CHz)s-
+ 
290 291 
salt 291 
a: R 1=R2=R3=Et 
b: Rl=R2=R3=nBu 
c: R1=Et, R2=R3=iPr 
d: R1=R2=-(CH2)4-, R3=Me 
e: R1=R2=-(CHzCHzh0-, 
R3=Me 
f: R1=R2=Et, R3=H 
g: R1=R2=iPr, R3=H 
h: R1=R2=-(CH2)4-, R3=H 
i: R1=R2=-(CHzCHzh0-, 
R3=H. 
j: R1=R2=Bn, R3=H. 
k: R 1=R2=-(CHz)s-, R3=H 
I: R1=R2=-(CH2)s-, R3=Me 
The results of this study are shown in scheme 58, and the yields are given in table 13. 
Amino acrylates 290 were typically obtained in near quantitative-yields in -acetonitrile 
using 2 equivalents of base, after isolation from the 1: 1 mixture with the ammonium salt 
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291. The reaction was preferably carried out in toluene, since in most cases this 
allowed simple separation of the salt 291 (by filtration) from the amino acrylate 290. 
Table 13: yields in the reaction of amines 289 with iodoacrylate 214. 
Entry Amine 289 
1 
2 
3 
4 o-
5 o~ 
6 
7 
8 
9 
10 
11 ~ 
12 o-
13 0 
14 Et2NPh 
290 (Yield I%) 
in PhMe 
a (96) 
b (94) 
c (93) 
see a 
see a 
a (92) 
f (94) 
d (93) 
e (92) 
g (94) 
h (91) 
see a 
A 291 (Yield I 
%) in PhMe 
a (86) 
b (96) 
see a 
see a 
f (88) 
g (96) 
h (94) 
i (94) 
j (94) 
k (92) 
see a 
0 
290 (Yield I %) 
inMeCN 
a (95) 
b (94) 
c (91) 
d (92) 
e (94) 
a (93) 
f (90) 
d (91) 
e (93) 
g (95) 
h (93) 
h (94) 
291 (Yield I %) 
inMeCN 
a (77) 
b (79) 
e (86) 
f (83) 
g (77) 
h (72) 
I (72) 
j (90) 
k (91) 
I (88) 
"obtained the corresponding methyl cis-ammoniumpropenoate iodide 293 quantitatively. bSalt not 
isolated; yield was estimated from 1H NMR of crude reaction. ccomplex mixture of products results. dNo 
reaction observed. 
Assignment of the (E)-alkene geometry of the products was unambiguous by 1H 
NMR data; all of the amino acrylates exhibited a pair of doublets with coupling 
constants in the range 13.1-13.5 Hz. Additionally, analytical data was in full agreement 
with that reported in the literature for those amino acrylates that had been previously 
synthesized! 91 Our mechanistic rationale for the formation of these adducts is outlined 
in scheme 59, and involves a reversible addition of the amine 289 to the acrylate 214 
forming an intermediate ammonium propenolate zwitterion 292, analogous to the first 
step in the Baylis-Hillman reaction. 192 This zwitterion would rapidly lose iodide to form 
a methyl 1-ammoniumpropenoate iodide 293. 
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In both acetonitrile and toluene, subsequent reaction of iodide ion on salt 293 
accomplishes dealkylation, giving rise to an alkyl iodide, which in turn reacts with the 
second equivalent of amine 289 yielding the salt 291 in almost all cases (see Table 13). 
The exceptions to this are Entries 4, 5 and 12 (Table 13), where N-methylated cyclic 
tertiary amines are employed. For these cases, in acetonitrile, dealkylation occurs as for 
other amines, however in toluene, the methyl 1--ammoniumpropenoate iodide salt 293 
rapidly precipitates before dealkylation can occur allowing its isolation. In addition, it is 
interesting t~at loss of i-Pr over occurs in preference to loss of Et when using Htinig's 
base (Entry 3, Table 13), which suggests that in this case an SN 1 reaction is involved in 
the iodide-mediated dealkylation process. In contrast, the less nucleophilic base, 
diethylaniline, did not react under the reaction conditions employed, whereas pyridine 
did react resulting in a complex mixture of products. 
Reported uses for amino acryl~tes are quite scarce; there are a few examples of 
them being utilized in natural product chemistry, but in each case they have been 
prepared through reaction of a secondary amine with a propiolate ester. There are also 
reports detailing the preparation of trans-ammonium halides like 293 as stable 
compounds and there subsequent use as Diels-Alder dienophiles. 193 These salts are 
usually prepared by reaction of a quaternary ammonium chloride or bromide with a 
propiolate ester under slightly milder conditions and in these cases there were no reports 
of amino acrylate formation, suggesting that elimination of iodide leading to amino 
acrylate formation is a facile process compared with loss of chloride or bromide. 194 
Whilst the discovery of this side-reaction was an interesting dev_elopment, 195 it 
represented a significant problem for the planned synthesis of the northern triene; not 
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being able to use any of the commonly employed amine bases in a Heck reaction due to 
their reaction with the starting material is a severe limitation! 
Indeed, the above study had served not only to explore the scope of the Michael 
addition-elimination sequence, it had also illuminated which bases were unusable, and 
thus which amine bases remained that could potentially still be used. This left a limited 
number of possibilities if it was still wished to pursue this line of approach towards 213, 
but first, realizing that the root cause of the problem was the capacity of 214 to act as a 
Michael acceptor, the idea of using an alternative alkenyl halide at the same oxidation 
level, yet that was not a Michael acceptor was proposed. It would probably have been 
possible to reduce 214 to the iodoalcohol, perform the Heck coupling, and then re-
oxidize back up to the acid oxidation level at a later stage, but this was deemed 
inadvisable given the presumed sensitivity of the nascent polyene chain as the northern 
triene was elaborated, so the decision was made to remain at the acid oxidation level, 
which called for an acid protecting group. 
2.4.2.2 Explorations of orthoester chemistry to circumvent 
this problem. 
Suitable protecting groups that have found increasing utility in organic synthesis 
are the orthoesters; either the 2,6,7-trioxabicyclo[2.2.2] octane ring system (the so-
called OBO esters) of Corey, 196 or the more recent 2,7,8-trioxabicyclo[3.2.1] octanes 
(ABO-esters) of Wipf. 197 The advantage of such protecting groups (the assembly of 
which is exemplified in scheme 60) is that they are one of few carboxylic acid 
protecting groups that are resistant to !JUcleophiles and bases, the acidic hydroxyl group 
is removed as too is the electrophilic carbonyl function, greatly increasing the pKa of 
the a-hydrogens. Additionally, the facility of their preparation, from the oxetanyl esters 
294 with BF3-etherate in the case of the OBO-esters 295, and from the zirconocene 
catalyzed rearrangement of epoxy esters 296 in the case of ABO-esters 297, makes them 
particularly appealing as protecting groups. 
First to be examined were the OBO-esters, and the retrosynthetic route to the 
protected form of 209, OBO-triene 298 is shown in figure 25. 
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Figure 25. Retrosynthesis of the OBO ester 298. 
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In this strategy, it was envisaged that 300 would function as the non-Michael 
acceptor replacement for 214, with the elaboration to 298 occurring exactly as planned 
before. Two approaches were conceived to reach 300; a hydrometalation I 
stereoselective iodo-demetalation procedure on acetylenic ortho-ester 301 to install the 
requisite (Z)-alkenyl iodide functionality, or by triggering the rearTangement on the 
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approriate iodo-oxetanyl ester 302. Accordingly, 301 and 302 were prepared as shown 
in scheme 61. 
Scheme 61 
0 
JL + H0~0 ~"oH j'J 
303 
88% 
DCC, DMAP, DCM, 
1F)==o 
HO 
0°C, 2.5h I 0 
+ HO~O ~~0 f'J 82% 0 f'J 
302 304 303 
The rearrangment of 305 to 301 proved difficult; although 301 is a literature 
compound, the rearrangement failed every time under the prescribed conditions; 198 
instead, it was found that the conditions described by Corey for the rearrangement of 
similar oxetanyl esters were more suitable, and gave 301 as a white waxy solid that 
could be recrystallized from hexane (see figure 26), but the yields were consistently 
poor. Due to these low yields, efforts were focussed instead on oxetanyl ester 302. 
Commencing with the stereospecific hydroiodination of commercial propiolic 
acid to provide (Z)-3-iodo-2-propenoic acid 304,199 subsequent DCC-DMAP mediated 
coupling with 3-(hydoxymethyl)-3-methyloxetane 303 gave 302 in good yields after 
distillation. 
Attempts to trigger the rearr(lngement of 302 were unsuccessful however. A 
range of Lewis acids were tried (BF3-Et20, nitrophenylboronic acid, Cu(OTfh, 
Sn(OTfh, Ti(iOPr)4), but none gave satisfactory results and led to decomposition and 
multiple products on TLC; it is likely that the Lewis acids needed to trigger the 
rearrangment are incompatible with the iodide function of 302. 
Because this route directed towards the use of OBO-esters seemed problematic, 
the focus was switched to obtaining the corresponding ABO-esters, as a literature 
survey and information divulged had suggested that these may be more suitable, being 
generally more robust (ABO-esters are tolerant to acidic conditions whereas OBO-esters 
are rather acid sensitive, with the carboxylic .acid function beiQg r~tur:_n~d under even 
mildly acidic conditions), and it is also known that the rearrangement of their 
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epoxyester precursors (which occurs with mild Lewis acids such as zirconocenes) is 
tolerant of halides?00 
Figure 26. Crystal structure of OBO-ester 301. 
This intimated that the ABO-esters might be a superior alternative anyway, and 
synthetic efforts were directed towards 310, the ABO-protected analogue of 214, as 
indicated in scheme 62. 
Scheme 62 
i) 55% HI/ H20 ~OH 
0 
ii) oxalyl chloride 
;-OH 94% 1~0 
306 
307 ~0 0 
0 ~ mCPBA, DCM, 0 C~o o 1 
Et)N. DCM, 0 c 0 I ~ 309 
70% 85% 0 
308 I t Cp2ZrCI2/ 
AgCI04 
CyJ 
0 
310 
Accordingly, hydroiodination of propiolic acid and treatment of the (Z)-iodoacid 
with oxalyl chloride gave 306 in excellent yield. This was then coupled with alcohol 
307 to provide the ester 308, which was itself converted into epoxy-ester 309 by 
standard methodology. Sadly, again the rearrangment to give the orthoester could not 
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be realised; use of the advocated Lewis acid Cp2(Cl)Zr+ (generated in situ upon mixing 
Cp2(Cb)Zr with the sequestrate AgCl04) failed to induce the rearrangement, and a 
similar selection of Lewis acids as used before to attempt the rearrangement of 302 to 
301 gave poor results, mostly giving complex mixtures of products, or returning starting 
material. Having arrived at what seemed like a synthetic impasse, little choice was left 
but to return to the original strategy, and attempt to perform the Heck reaction between 
214 and 122 using bases that would not undergo the Michael addition-elimination 
sequence. 
2.4.2.3 Further palladium reaction screens. 
A Heck reaction involves a greater number of variables compared to many 
synthetic processes; even when coupling partners are kept constant, varying the base, 
palladium source, ligand, catalyst loading, solvent, additives (i.e. halide scavengers or 
phase-transfer catalysts) and reaction temperature and pressure will generate a vast 
number of conditions for screening. Nevertheless, it was realised that because of the 
limited freedom with regards choice of base imposed by the side-reaction described 
above, it would be necessary to perform as comprehensive a screen as possible, and 
investigate many of the conditions implemented in the chase for the highest activity, 
such as use of bidentate ligands, direct sources of palladium(O), and perhaps even 
phosphine-free systems. 
From the previous study, it had been discovered that N,N-diethylaniline 289j 
was reluctant to undergo this addition-elimination reaction, no doubt due to its steric 
bulk. 
This base, together with a number of others, was incorporated into a comprehensive 
screen in which all manner of ligands, solvents and palladium sources were employed. 
The conditions that were varied in the 150 or so screens performed in attempting to 
obtain conditions that would give a successful Heck reaction between 214 and 122 are 
listed in table 14, but only as a matter of reference, because disappointingly, and 
perhaps surprisingly, not a single combination of variables gave rise to a successful 
Heck product. 
The palladium sources tested varied from the standard palladium acetate to the 
more complex pilllacia.cycle I::Iermann' s catalyst,201 _d~ved fro~ ~ris(o-tolyl) phosphine 
and palladium acetate; similarly, ligands employed ranged from the standard 
107 
Resu/rs and Discussion 
monodentate phosphines such as triphenyl- and tris-(furyl) phosphine, to ligands such as 
tri-t-butyl phosphine and a selection of bidentate phosphines of varying bite angle.202 
Additionally, more esoteric catalytic species such as [bis(diphenylphosphino)ferrocene] 
dichloropalladium(Il) and tris( dibenzy lideneacetone) dipalladium(O)-chloroform203 
adduct were used. Neither the latter, nor tetrakis(triphenylphosphine) palladium(O), 
both sources of nucleophilic palladium(O) and therefore often found to offer higher 
reactivity, proved to have any bearing on the reaction. 
Table 14: conditions tried in the Heck coupling between 214 and 122 
Palladium sources (at loadings 
from 2.5-10 mol %) 
Ligands 
Additives 
Bases 
Solvents 
Temperatures 
PdCb, Pd(OAc)l, Pd(PPh3)4, Pd2(dba)3.CHCl3, Pd(dppfhCl2, 
Pd(MeCN)2Cl2, Pd(Bn)(PPh3)zCl, Hermanns catalyst 
PPh3, P(o-Tol)J, P(tBuh, P(nBuh, P(Cyh, dppb, dppp, dppe 
Ag2C03, K2C03, benzylidene benzylamine, tetramethylurea, 
DBU, N,N-diethylaniline. NaOAc. 
THF, MeCN, PhMe, DMF 
ambient to sealed tube conditions. 
It was observed that when particularly forcing conditions were used (sealed tube 
conditions at >l10°C for up to 4 days), the iodo.acrylate underwent de-hydroiodination, 
presumably through the action of the base. It was abundantly clear when this happened; 
TLC was used as the principal means of assessing the progress I success of these 
screens, specifically, disappearance of 214 was used to identify a potential succesful 
reaction. Frequently in such cases it transpired that upon work-up, the crude 1H NMR 
spectrum would show no alkene resonances. It was also observed that even N,N-
diethylaniline would start to undergo Michael addition under such harsh conditions. 
The only time coupled products were obtained was under phosphine-free 
conditions, and only then when the base silver carbonate was used. In this instance, the 
Suzuki product 311 was obtained as the exclusive product as represented in equation 18. 
Equation 18 
0 Pd(0Ac)2• Ag2C03 MoO~ =to, MeCN, RT. !6h ~OMe + OB~ 0 
I 6Ho/o 
214 122 311 
This result is not particularly surprising; the only examples of couplings of 
haloacrylates with organoboron partners in the literature show conversion to Suzuki 
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products in every instance and under similar conditions to those employed in this 
l ?04 examp e.-
Indeed, it is known that halide scavengers can accelerate Suzuki reactions by 
facilitating the exchange of halide for base at palladium in the species obtained from 
oxidative addition leading to intermediates with enhanced reactivity, and conventional 
wisdom also upholds that inorganic bases such as carbonates will nearly always favour 
a Suzuki pathway by activation of the organoboron reactant towards transmetalation. 
To check whether 214 was indeed capable of undergoing Heck coupling with 
any alkene, a separate series of experiments was carried out with hex-1-ene and the 
archetypal Heck alkene, styrene. These experiments were all done under conditions that 
most commonly give rise to Heck products (Pd(0Ac)2, DBU or N,N-diethylaniline, 
toluene reflux), yet no evidence of coupling was seen in any of these reactions. 
A further observation is that when forcing conditions were employed in these reactions 
in conjunction with triphenylphosphine, oftentimes styrylboronate 31298 was produced 
(figure 27) 
Figure 27 
~r;c: 
312 
In light of the reagents used, only one possible explanation exists for the 
production of this compound, and it does not bode well for the utility of 214 as a Heck 
iodide. Such compounds as 312 are the result of oxidative insertion by Pd(O) into the C-
p bonds of the ligand, and thus are usually taken as a sign of poor substrate 
reactivity; 187a exactly as was found to be the case here, where the only coupling evident 
was one where the conditions both cultivated a highly reactive catalytic engine and 
favoured the following of a thermodynamic pathway towards 311. 
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2.4.3 Routes towards the core cyclopentenol211. 
2.1.1.1 Existing syntheses in the literature. 
It should first be acknowledged that viridenomycin's core cyclopentenol has 
been the subject of recent attention, with two reported syntheses in the last three years. 
The first, reported by Meyers and co-workers,205 details the construction of 313 and 
involves at least eighteen stages giving an overall yield of 40%, with the key step 
exploiting the templating ability of a chiral bicyclic lactam to install the quaternary 
stereocenter at C10. 
Figure 28 
MeO~OTBDMS 
~ C02Me 
TBDMSO'''' i Me 
OBn 
313 
MeO~OPiv 
TBscf' i~ C02Me 
Me 
OAc 
314 
The second reported synthesis206 uses a markedly different strategy involving a 
highly functionalised tetrahydrofuran derived from D-glucose. Using this strategy, the 
authors accessed compound 314 in twenty three individual operations (yield was not 
reported), which they then converted to Meyers' product 313 for comparison. 
Although there are consequently two successful syntheses of the core already in 
the literature, it was felt that both strategies are rather long and unnecessarily elaborate, 
and it would be more satisfying to devise a new route utilizing different chemistry. 
2.1.1.2 Our approach based on the enantioselective 
Mukaiyama aldol reaction. 
The route that was developed, which hinged upon a stereoselective aldol 
reaction to install the crucial stereochemistry of 211, is outlined by way of the 
retrosynthetic scheme shown in figure 29. In this approach, a stereoselective aldol 
addition of a dienolate equivalent 318 to methacrolein would provide aldol 317; ensuant 
oxidative cleavage of th~ doul:Jle bond of 317 would yield ketone 316: It wasimagined 
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this ketone would be ideally poised to cyclize to gtve the desired enone 211 in a 
Knoevanagel condensation, via spontaneous dehydration of 315. 
Figure 29 
R~O OH···•OMe~ROv ... ,OMe [ O~ .. ,,OMel 
Me)--( ==~ Rrf~OP 
(R0)2B M OH e OP Me OH 
315 
208 211 
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YyH 
0 
Stereoselecti ve 
aldol 
0 0 
RO~··''OMe 
_,,:r('-oP 
316 0 
li ~Me _ /yyyoR 
OP 0 0 
317 
As eluded to above, the pivotal reaction in this sequence in terms of securing the 
correct diastereomer of 211 was to be the stereoselective aldol, and choice of reaction 
type here was not difficult to make in light of literature precedent. 
The Mukaiyama aldol reaction,207 the. preeminent example of a C-C bond 
forming process between a latent enolate equivalent and an activated acceptor, is a 
much-used and well-studied reaction?08 It is attractive since its procedural requirements 
entail the separation of the enolization process from the actual C-C bond addition 
reaction. Moreover, use of silyloxyalkenes (silyl enol ethers) in the reaction requires 
the intervention of a suitable Lewis acid catalyst to coordinate to and activate the 
acceptor towards nucleophilic attack, and this catalyst can also serve as a vehicle by 
which to achieve stereoselection. 
Having chosen the type of aldol reaction, it was necessary to select which of the 
many catalytic variants of it to employ, and the degree of freedom in making this choice 
was slightly limited by the nature of the electrophile. Use of copper complexes as chiral 
catalysts (for instance, the well-studied Cu-BOX and Cu-PyBOX systems) was 
precluded since it is known that an a-substituent capable of chelating copper is required 
on the acceptor. Of the other commonly employed systems, the chiral 
oxazaborolidinones derived from N-sulfonlyamino acids and borane seemed attractive 
due to the relative simplicity of their preparation and stability compared to other more 
elaborate systems based on titanium(IV), tin(II), gold(I) or silver(!); in addition, there 
was a wealth of literature detailing the successful deployment of the oxazolidinone-
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mediated Mukaiyama aldol reaction, sometimes giving aldol products with near-perfect 
enantioselection. 209 
The operation of the Mukaiyama reaction, exemplified by a typical case shown 
in scheme 63, revolves around the five-membered boron heterocycle 321 generated by 
the combination of 1 equivalent ofN-Ts-D-valine 324 and borane. 
Scheme 63 
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Unlike certain other metal catalyzed aldol reactions, the use of an 
oxazaborolidinone complex is purported to effect operation of an active mechanism to 
ensure efficient scavenging of electrophilic silicon species generated from the catalytic 
cycle. Such intramolecular silicon transfer is known to be crucial in order to achieve 
efficient transfer of chirality and catalyst regeneration, and proceeds in the following 
manner: the silyl oxocarbenium ion 322 produced via the nucleophilic addition of 319 
to RCHO places the boron carboxylate in a position to effect intramolecular silicon 
transfer, generating boron aldolate 323. Rearrangement of this aldolate, with 
cdncomitanCregeneration of the fivc-meiilberec.l catalytic boron heh~rocycle 321 and 
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silicon transfer to generate silyl aldol adduct 320, effectively precludes the incidence of 
enantioselectivity-reducing achiral silicon catalysis. 210 
Having opted to use a Mukaiyama aldol to install the requisite stereochemistry 
of the core 208, it was necessary to prepare a suitable enolate equivalent 318, but first, a 
prescient achiral pathway was explored, both to generally test the methodology and 
stability of the aldol 317, and also to test the stability of 317 towards ozonolysis. This 
required the synthesis of P-keto esters 327 and 329 from which to generate the requisite 
dienolates 318, since despite their utility, there were relatively few P-ketoesters 
commercially available (scheme 64). For simplicity and ease of preparation, the t-Bu P-
ketoester was generally preferred throughout the studies towards the core cyclopentenol 
211; additionally, using a t-Bu ester seemed sensible given that the core was to be 
tethered to the southern hemisphere tetraene by a macrolactonization, requiring removal 
of this ester. 
Scheme 64 
0 
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Having obtained 327 and 329 using rather straightforward chemistry, aldol reactions 
were carried out by generation of the lithium dienolates of both P-ketoesters, and the 
subsequent reaction of these with the chosen electrophile methacrolein (equation 19). 
Equation 19 
i) 2 eq. LOA, THF, -78°C 
3270
r 
329 
ii) methacrolein '--- _;: ~ J(OR 
IT 6Me -
R = t-Bu 330 (77%) 
R ==Me 331 (72%) 
113 
Resu/1s and Discussion 
Happily, both aldol adducts 330 and 331 appeared stable, and an ozonolysis was 
then attempted on the favoured t-Bu adduct 330 (equation 20). 
Equation 20 
OH 0 0 ~ ~0 
330 
i) ozone, DCM, -78°C 
ii) dimethyl sulfide 
98% rfrUo~ 0 OMe 
332 
Gratifyingly, the ozonolysis produced dione 332 virtually quantitatively after 
reductive work-up with DMS, and encouraged by these results, it was elected to attempt 
the preparation of suitable latent enolates equivalents of 327 and 329, which called for 
the synthesis of 1,4-dimethoxymethoxy-bis(TMS)-1,3-butadienes 335 and 336 
according to a procedure described by Brassard et al., who had made and prepared 336 
for use as a reactive diene in cycloaddition reactions aimed at purpurin synthesis 
(scheme 65).2ll 
In this method, the P-ketoester is activa~ed with a Lewis acid and then treated 
with base and TMS-Cl under thermodynamic conditions, producing the intermediate 
silyl enol ethers 333 and 334 as a 50:50 mixture of geometric isomers. These are then 
isolated and treated with LDA and TMS-Cl under kinetic conditions, affording the 1,4-
dimethoxy-bis(TMS)-1,3-butadienes 335 and 336 in good yields following direct 
distillation from the reaction, after first filtering to remove the amine hydrochloride salt. 
Scheme 65 
X 
OTMiJ H 0 Meo~0X 11 H>=M 327 - OTMS 87% 83% M eO OTMS 
333 335 
OTMS H OMe 
M eO~ ii H>=M 329 -, OTMS OMe M eO OTMS 
81% 72% 
334 336 
i) ZnC12. Et3N,TMS-CI, PhMc, 45°C 
ii) LDA, -78°C, THF, then TMS-Cl 
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The utility of these novel dienes in the Mukaiyama aldol reaction was confirmed 
by their successful reaction with methacrolein, mediated by oxazaborolidinone 321, 
generated in situ from borane-THF and N-Ts-D-valine. 
However, it was noted that after aqueous work-up, silylated products were being 
obtained, and as stirring with NaHC03212 failed to effect efficient desilylation, the 
Carreira procedure,213 which entails treating the crude silylated aldols with TFA-water 
at -78 °C, proved to be effective and provided 330 and 331 in good yields (76 % and 66 
%respectively). 
This desilylation procedure proved to be troublesome if it was not performed at low 
temperature; treatment at just 0 oc gave rise to retro-aldol products, thus ~-ketoester 327 
would be produced from the reaction between 335 and methacrolein, presumably as a 
result of retro-aldol from the 0-silylated aldolates. 
Having obtained good results with the reaction of methacrolein and 335, a range 
of electrophiles were examined to determine the scope and utility of this transformation, 
since aldol reactions of 1,4-dimethoxy-bis(TMS)-1,3-butadienes are unreported. 
Table 15 presents the results of this study, and the data suggests that these dienes are 
powerful nucleophiles in the Mukaiyama aldol reaction, affording good results with 
both sterically hindered aldehydes, and also those having electron-donating R groups. 
Obviously it was necessary to now probe the selectivity of these reactions, given that 
the requirement for the synthesis of the core was a syn selective aldol. However, and 
most disappointingly, discerning the ratio of diastereomers proved an impossible task, 
although not for want of trying! 
The first thing to note is that the 1H and 13C NMR data suggests a single major 
diastereomer. However, it was note~ that all of the carbon environments on the 13C 
NMR spectrum exhibited 4 resonances clustered around a particular value of 8, each of 
varying intensity, although there was in each case 1 dominant signal more intense than 
the others. Additionally, there appeared to be unclassifiable extra resonances not 
ascribable to the aldol adducts, that were still visible even after careful purification. 
Given the nature of the catalytic system employed in this reaction, 4 resonances 
close together for each carbon environment (implying 4 unique stereoisomers) seems an 
unusual observation. Unlike many other catalytic systems where the Lewis acidic 
metal gives rise to a tight 6-membered closed transition state, it is known that the 
Mukaiyama aldol reaction proceeds via an open anti-periplaoar .tra_ns_i_tjQn_state? 14 
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Table 15: aldol reactions between diene 335 and a range of electrophiles. 
Electrophile 
methacrolein 
trans-cinnamaldehyde 
trans-2-pentenal 
propionaldehyde 
para-anisaldehyde 
isobutyraldehyde 
3,5-dibromosalicylaldehyde 
2, 4-di ni tro benzaldehyde 
1-naphthaldehyde 
3 ,5-diiodosalicy !aldehyde 
Aldol adduct 
OH 0 0 ~ 
yt{o 330 
~oX V . 6Me 337 
~0~ 
OMe 338 
OH 0 0 
~0~339 
OH 0 0 O~ MoO~ 340 
OH 0 0 
~0~341 
OH OH 0 0 \..-Br~('\ y OMe 0 
Br 342 
N02 OH 0 0 O~ O,N~ 343 
344 
OH OH 0 0 \..-!~0"'\ y OMe 
I 345 
Results and Discussion 
Isolated yield 
76% 
90% 
77% 
72% 
78% 
67% 
80% 
88% 
72% 
83% 
Conditions: l mole electrophile per mole of diene, 25 mol % 321, DCM, -78 °C, 2-6h. Desilylation 
achieved with 10% TFA-water at -78 oc. 
Due to the nature of this transition state, m which it is imagined that the 
nucleophile and electrophile approach in such as way as to minimize torsional 
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interactions, the geometry of the silyl enol ether is not nearly so influential as it is in, for 
example, a Sn(II) mediated process; instead, the syn : anti ratio is heavily influenced by 
nucleophile structure. Thus, it is eminently possible to get a syn aldol adduct from both 
(E) and (Z) silyl enol ethers. In any case, it is difficult to predict which double bond 
geometry of 335 was installed during the enolization procedure under kinetic conditions 
(scheme 65); even if the application of the Ireland-Claisen model215 to this particular 
case was appropriate, scheme 66 reveals that there is not a great bias towards either enol 
geometry, and LDA is known to have intermediate influence in determining enol 
geometry anyway. 
Scheme 66 
)(' 
0 0 
)(' 
0 0 
h 
H 
H ><0 
MeQ '>=( >=< OTMS 
H OTMS 
E,Z 
H ><o 
H. >=< M OTMS 
MeO OTMS 
Z,E 
The rationalization of the stereochemical outcome in the reaction of either (E,Z)-
335 or (Z,E)-335 is shown in scheme 67, where, considering only the reactive double 
bond, it can be seen that only two aldol products are possible, since the catalytic species 
321 binds the aldehyde in such a way as to permit the nucleophile to approach via the Si 
face only. It then becomes a question of examining the 4 possible transition states that 
arise from the reaction of each face of either the (E) or (Z) silyl enol ethers, and since 
the configuration at one of the new stereocentres is completely controlled by steric 
effects due to the catalyst-electrophile complex 346, only two outcomes are possible: 
syn and_ anti diastereomers _(it should be noted that the transition state models in scheme 
67 do not consider the possible influence of any chelation effects.) 
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Scheme 67 
R OTMS 
unfavourable E 
E 
Resuils and Discussion 
H OMe 
TMSOlR 
MeO H 
VS. Rl.OTMS E 
H OMe MeO H 
)[ VS. )[ Z 
R OTMS TMSO R 
il lMe -/):ggoX 
anti 
z 
Ho-:tt c__~;;~, 0 
unfavourable 
z 
syn 
This makes the observation of 4 umque NMR environments for each carbon 
atom seem puzzling, however, a possible explanation for this can be found by 
examining the 13C shifts carefully. 
The 13C NMR spectra of adduct 330 is shown in figure 30, together with the 
expansions of the region around 8 170-175 and 8 88-92. Both regions shows resonances 
not readily attributable to compound 330, but instead, strongly suggest enol 
tautomerization of this aldol product. 
~ ~ 
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Figure 30 13C NMR spectrum of 330 
t 
.11. J I t ~ 
' 2/KJ ' ' ds ' ' t.!O ' ' ds ' 
· ulO ' ' 7~ ' ' 56 2~ 
DEPT analysis assisted the assignment of these extraneous resonances as 
illustrated in table 16, and the assumption of (E) I (Z) enol tautomers is validated by 
comparison alongside literature values for a typical enol tautomer of a ~-keto ester 347 
(figure 31)?16 
Figure 31 
OH 0 
I 11 
c c / 1.:::::- / J'"'"' / c2 o 
I 
H 
330 347 
Table 16: comparision between certain 13C NMR shifts for 330 and that of a standard enol 
tau to mer 
Carbon number DEPT analysis b I ppm in 330 b I ppm in 347 
1 quaternary 171.80; 171.60 177.5 
2 methine 91.14; 91.69 90.5 
3 quaternary 170.19; 171.24 174.7 
The explanation for the 4 resonances becomes apparent in light of this 
supporting information; the aldol adducts are produced as a mixture of syn and anti 
diastereomers, with a low equilibrium concentration of enol tautomer also being 
observed for both these diastereomers, giving rise to what at first glance look like minor 
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impurities in the spectrum (scheme 68). The groups of 4 resonances clustered together 
are due to conformational differences in the species present, which give rise to minor 
changes in the carbon environments, whilst those at 8 -90 and 8 -170 are clearly in 
different environments, as would be expected since the carbon atoms responsible for 
these signals have undergone configurational changes upon tautomerization. 
Scheme 68 
OH 0 0 \--nYO OH OH 0 \._ Yr.Yo/\ OMe H ~H + 11 ~M~ X 0 0 
syn-330 
~H 
11 dM~x 
0 0 
anti-330 
It is the problem of enol tautomerization that made it very difficult to measure 
the de for the aldol reaction. The first line of approach was to use chiral HPLC to 
determine the ratio of diastereomers, and separation conditions were employed based on 
functional group correlation between the aldol products and known compounds whose 
separation methods had been reported in the literature? 17 
Chiral HPLC proved unsuccessful; pure samples of 330 gave rise to peaks that 
were either too broad, that overlapped completely, or with some solvent systems, gave 
rise to numerous poorly defined peaks. (conditions are shown in table 17). 
A number of other strategies were tried in order to determine the diastereomeric 
ratio, as summarized in figure 32. In first approach, it was attempted to try to prepare a 
"heavy" derivative of 330 that would hopefully be crystalline, hence enabling the 
configuration of the major diastereomer to be identified by XRD. To this effect, the 
bromobenzoate ester 348 and pipsylate 349 were prepared by functionalization of the 
aldol hydroxyl group with 3,5-dibromobenzoyl chloride and 4-iodobenzenesulfonyl 
chloride respectively. It was noted that using amine bases (e.g., pyridine or TEA) in 
attempting to form 348 led to formation of the acid anhydride rather than esterification. 
Unfortunately neither of these compounds were cryst<1lli1te, instead being isolated a~ 
viscous oils. 
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Table 17: HPLC conditions tried in order to determine the stereoselectivity of the aldol reactions 
Solvent system Flow rate I ml min-1 Column 
95:5 hexane I EtOH + 0.01% 
TFA 
95:5 hexane I EtOH + 0.01% 
TFA 
95:5 hexane I EtOH + 0.01% 
TFA 
1, 3,5 and 10% IPA I Hexane 
1, 3,5 and 10% IPA I Hexane 
1, 3,5 and 10% IPA I Hexane 
1, 3,5 and 10% IPA I Hexane 
1, 3,5 and 10% IPA I Hexane 
1, 3,5 and 10% IPA I Hexane 
Figure 32 
1.0 Chiralpak AD 
0.5 Chiralpak AD 
0.25 Chiralpak AD 
1.0 Chiralpak AD 
0.5 Chiralpak AD 
0.25 Chiralpak AD 
1.0 Chiralpak OD 
0.5 Chiralpak OD 
0.25 Chiralpak OD 
02N~ 
~ 
··x·· 
0 0 0 0 ~ ~0 
BrYJBr 
t 0:/"'-.Cl 
NaH, THF, 0°C 
68% 
348 
OH OH 0 \._..-
,AAJl0,\ 
IT bMe ~-
OH 0 0 ~ ~0 
330 
NaBH4 / EtOH 
. OH OH 0 ~ ~0 
350 
TFA, 0°C, DCM ~0 
3h. MeO 
330 
<10% 0 0 
352 
330 
i. TsNHNH2, pTsOH, lh 
ii. NaCNBH3, 3h 
DMF, 70°C 
yield <10% 
OH 0 k ~0 
353 
121 
B(OH)z 
DCM reflux, 24h 
MgS04 
pyridine, pipsyl 
chloride, DCM. 
56% 
no reaction observed 
~ 
o=s=o 
I 
0 0 0 ~ ~0 
349 
R R(H) 
Oxo 0 R2(0Me)2 \._.-
X • ~o"\ 
OMe 351 
2,2-dimethoxypropane 
and benzaldehyde dimethyl 
acetal gave incomplete reaction 
. ;, 
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Attempts were also made to 'lock' the conformation of the aldol adducts by 
preparing a 6-membered boronate ester derivative through reaction of 330 with 4-
nitrophenylboronic acid, hoping that the thermodynamic stability of such a boronate 
ester would ensure complete reaction and that it would be possible to determine the 
configuration at the new stereocentres by either measuring the 3J coupling constants for 
the ring protons, or performing NOE studies. However, no reaction was observed even 
after forcing conditions were employed, i.e. prolonged reflux. 
Continuing the theme of preparing a cyclic derivative of 330, it was reported 
that treatment of similar adducts with TFA effects de-t-butylation and triggers their 
subsequent lactonization, and this procedure was carried out as described.218 Although 
this furnished lactone 352, the reaction was incomplete and led to a mixture of products 
and gave 352 in miniscule yield. Similarly, reduction of 330 with NaBH4 / EtOH gave 
the dial 350 that could be converted into the acetals 351, but again, the reactions never 
went to completion. It was observed that the intermediate dial 350 proved to be rather 
unstable, decomposing rapidly at room temperature and on silica, so for this reason the 
transformation 330-351 was attempted in a one-pot process. 
It was suspected that these difficulties were due to the fact that what was 
ostensibly a pure compound by TLC was actually a mixture of several isomers, and 
since this problem arose because of enol tautomerization, it was elected to try to remove 
the ketone by a modified Wolf-Kischner procedure, using p-tosylhydrazide to give the 
intermediate hydrazone followed by in situ reduction with sodium cyanoborohydride.219 
Unfortunately, this also gave very poor yields of 353 and the crude 1H NMR spectrum 
showed mixtures of products, including the intermediate hydrazone and even starting 
material 330. 
Attempts were also made to functionalize the ketone by converting it to a 
hydrazone that would hopefully be crystalline, and in order to add molecular weight, the 
aldol 330 was converted to the dione 332 with a view to obtaining the dihydrazone. It 
was found that simply stirring 332 with a solution of 2,4-dinitrophenylhydrazine in 
ethanol at ambient temperature gave the dihydrazone 354, albeit as a minor fraction, but 
regrettably (and rather astonishingly!) even this high molecular mass compound was 
isolated as a bright yellow oil that defied attempts to recrystallize it. Despite removing 
the ketone and hence the capacity for enol tautomerization, the 1H NMR spectra of 354 
was stilLoverly complicated and it was impossible to determine any information 
concerning the configurations at the chiral centres since the resonances were rather 
broad. 
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Equation 21 
' J llov 2,4-dinitrophenylhydrazine 
I( 'f "" _ '\_ EtOH, RT. 
0 OMe 36% 
332 
ReSIIlts and Discussion 
Having encountered considerable difficulties in trying to determine the 
diastereomeric ratio for the aldol reaction by derivatising the aldol adduct, it was 
decided to attempt the cyclization to the core 211, and hence determine the de from this, 
either through functionalization or by comparison to the reported data for 314. 
There were no exact pertinent procedures in the literature to assist in selecting 
conditions for the Knoevanagel condensation of 332, so instead a host of generic 
processes were tested. It was discovered that acid-base catalysts such as pyridinium 
acetate and triethylamine hydrochloride were ineffective; on the other hand, treatment 
with bases such as pyridine or piperidine, even in catalytic amounts and at lower 
temperatures, led to rapid decomposition of 332, evident on TLC by the appearance of 
numerous components. The only reactions that appeared clean were those using 
inorganic bases, such as K2C03 or MgC03 in MeOH (essentially a source of MeO-), or 
dilute sodium hydroxide in diethyl ether. However, upon working these reactions up 
and isolating the major component, it became apparent that 332 was over-eliminating, 
since the NMR, IR and MS evidence· strongly pointed towards cyclopentadienone 355 
as being the major product (equation 22). 
Equation 22 
~0~ 
0 OMe 
332 
K2C03 or MgC03 
in MeOHor 
I M NaOH in Et20 rlo MoO~+ 
355 
It was unfortunate that this difficulty coult.l not be overcorne- during the time of this 
study, since it means that what appeared to be a reliable and expedient method for 
preparing the core of viridenomycin fails at the final hurdle. 
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2.5 Concluding remarks 
As anticipated, viridenomycin 11 proved to be a formidable synthetic challenge 
and there is much work still to be done in order to complete the total synthesis. Despite 
the fact that viridenomycin was chosen as a candidate with which to further test the 
palladium coupling methodology developed in these laboratories, it actually transpired 
that very little palladium coupling chemistry was performed, such were the problems 
encountered both in attempting to acquire the requisite halide coupling partners in the 
case of the southern tetraene 210, and with one of the partners itself in the case of the 
northern triene 209. This highlights the need to perhaps adopt an alternative strategy 
with respect to the latter fragment. 
Nevertheless, considerable in-roads were made towards achieving the synthesis 
of 11 and these studies called for the development of new chemistry, and the need to 
improve on existing chemistry. Most notable was the development of new aldol 
chemistry used in the approach to the core cyclopentenone 211, and the greatly 
improved procedures developed en route to the southern hemisphere 210 which were 
based around phenylglycine, but which should be readily applicable to any amino acid. 
2.6 Further work 
As alluded to above, the preparation of the northern triene 209 may require a 
rethink; it might be necessary to reduce iodoacrylate 214 to the iodoalcohol, couple this 
alcohol with a vinylboronate and then perform the iodo-deboronation procedure. 
Carrying out a mild oxidation later op. to return to the required acid oxidation level at 
this stage should allow this triene to be assembled free from the problems associated 
with using a Michael acceptor in the Heck reaction. 
Two problems came to light in attempting to synthesize the core 211. The first 
of these concerns the determination of the de from the Mukaiyama aldol reaction. The 
NMR evidence suggests tautomers of a major diastereomer, in which case it may be 
necessary to pursue the idea of removing the ketone function that gives rise to 
tautomerization. More attractive perhaps is employing one of the chiral silylation 
reagents recently reported by Meinwald and co-workers,220 which should enable the de 
to~be~determined after the aldol reactions-by functionalization of-the aldol hydroxyl with 
a suitable chiral silyl derivative. Alternately, it may be possible to use MTPA ester 
methodology.221 
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Yet another approach may be to further investigate chiral HPLC as a means of 
determining this de; although a range of conditions was examined, this was by no means 
comprehensive and a recent paper has come to light which describes the preparation of 
similar aldol adducts from Chan' s diene222 that may offer a potential solution, and at 
least affirms the belief that it should be possible to separate aldol diastereomers such as 
330 using HPLC. 223 
Concerning the southern tetraene 210 and the problems encountered with trying 
to progress beyond dienylboronate 268, if indeed the problem was the labile nature of 
the Boc protecting group in the presence of ICl, a simple solution may be to try a more 
robust protecting group, or else use a milder source of I+. Given the sensitivity and 
capricious nature of some of the amino acid functional group transformations that went 
into building 268, the former suggestion may not be easy. 
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3.0 Experimental Section 
3.1 General Experimental Details 
1H NMR spectra were recorded on Bruker AC200, AC300 and AC400 
instruments and on Varian 200, 300 and 500 model spectrometers at frequencies of 200-
500MHz in d-chloroform unless otherwise stated. 13C NMR spectra were recorded on 
the same instruments at 75.5, 100 or 125.5MHz. Chemical shifts are expressed as parts 
per million downfield from the internal standard TMS. El (70 eV) and Cl mass spectra 
were performed on Kratos MS25, Micromass Autospec or Finnigan MAT XP 95 
spectrometers. ES mass spectra were recorded on Finnigan MAT 900 XLT and 
Micromass Autospec spectrometers. FAB spectra were recorded on a Kratos MS50 
using meta nitrobenzyl alcohol matrix; high resolution spectra were obtained from 
either Kratos Concept IS, Finnigan MAT 900 XLT or Micromass Autospec 
spectrometers. IR-spectra were recorded on a Perkin-Elmer 298 spectrometer. Melting 
points were determined using an Electrothermal melting point apparatus. Column 
chromatography was achieved under medium pressure using Acros silica gel, 60 mesh. 
TLC was carried out on Fluka Kieselgel 60F254 aluminium backed plates, visualization 
was achieved using either phosphomolybdic acid, ethanolic vanillin, or alkaline 
KMn04. [a] 0 values are given in deg cm2 g- 1 and were recorded at the D line of sodium 
(589 nm) in a 1 dm cell unless otherwise stated. 
All glassware was dried in an oven and cooled under a stream of argon when an 
inert atmosphere was required. Exhaustive deoxygenation was achieved by the freeze-
pump-thaw method (3 cycles); standard degassing was achieved by sparging with argon 
for 2 hours. Chemicals were obtained from commercial suppliers and were used without 
further purification unless otherwise stated. Carbonylchlorobis(triphenylphosphine) 
rhodium(!) and tri-t-butylphosphine were supplied by Alfa. Hermann's catalyst was 
supplied by Lancaster Synthesis. Polystyryl diphenylphosphine was obtained from 
Aldrich. Tetrakis(triphenylphosphine) palladium(O) was prepared according to a 
published procedure.Z24 Benzaldehyde was pre-dried over anhydrous calcium chloride 
and distilled prior to use. p-toluenesulfonyl chloride was purified by dissolving in the 
minimum quanitity of diethyl ether, wa~hing ~ith _5_% _NaOI:I unti! the organic phase 
was colourless, drying the ether layer over MgS04 and finally recrystallizing at -78 °C. 
Methanesulfonyl chloride was distilled from P20s and stored under argon. 
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Diisopropylamine and triethylamine were distilled from CaH2 onto KOH pellets. Dry 
solvents were obtained by distillation from CaH2 (dichloromethane, hydrocarbons), 
magnesium and iodine (methanol and ethanol) and sodiurn!benzophenone (THF and 
Et20). Anhydrous DMSO and DMF were purchased from Aldrich. Pet. ether refers to 
the fraction boiling in the range 40-60 oc. 
3.2 Specific Experimental Details 
Preparation of pinacolborane ( 4,4,5,5-tetramethyl-1,3,2-dioxaborolane )117 
To a solution of anhydrous pinacol (2.36 g, 20 mmol) in dry DCM (2 mL) stirred at ooc 
under argon was added BH3.SMe2 (1.89 mL, 20 mmol) dropwise. The reaction mixture 
was stirred at 0 oc for 1 hour, and then stirred at room temperature until no further 
evolution of hydrogen was observed. Kugelrohr distillation (20 mmHg) gave 
pinacolborane as a colourless clear liquid; analytical data was consistent with that 
reported in the literature. 
4,4,5,5-Tetramethyl-2-vinyl-1,3,2-dioxaborolane 122see 185 
Vinylmagnesium bromide (100 mL of a l.OM solution in THF, 100.0 mmol) was added 
dropwise to a stirred solution of anhydrous trimethylborate (10.2 mL, 90 mmol) in dry 
THF (170 mL) at -78 °C under argon,. The solution was stirred for a further hour, then 
allowed to warm to room temperature. 20 % HCl (44 mL) was added, and the mixture 
was stirred for 10 minutes. A solution of pinacol (10.6 g, 90 mmol) in diethyl ether was 
added, and the reaction was stirred for a further hour. The aqueous layer was extracted 
with diethyl ether (100 mL) and the organic layers washed with saturated Na2C03 
(2x100 mL) and water. Double distillation of the organic layer gave pure 122 (8.22 g, 
53%) as a clear colourless liquid; b.p.l15-l20°C (760 mmHg); Vmax (neat)/cm-1 3100 
(medium, olefinic C-H str.), 3000 (strong, aliphatic C-H str.), 1625 (strong, C=C str.), 
1450 (strong, aliphatic C-H def.), 1380 (strong, doublet, -C(CH3)z), 1330 (very strong, 
B-0 str.), 1250 (very strong, C-B str.), 1150 (strong, C-0 str.), 1030 (medium, C-Q 
str.); SH (300 MHz) 1.29 (12H, s, 4xCH3), 5.86 (1H, dd, J 19.2, 13.8Hz, -CH:B), 6.03 
(lH, bdd, J 13.3, 4.36Hz, :CH), 6.16 (lH, dd, J 19.2, 4.36Hz, :CH); Se (75.5 MHz) 25.1 
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(-CH3), 83.7 (Cq, -CO-), 135.3 (b, :CHB), 137.4 (H2C:); mlz (FAB+) 136 (100%); (Cl+) 
172.0525 (100%, M+NH/, C8H19BNOt requires 172.0522) 
1-Phenyl-3-butyn-1-ol219135' 124 
Method A 
Propargyl bromide (8.8 mL of an 80% solution in toluene, 84.0 mmol), benzaldehyde 
(5.69mL, 56.0mmol), tetra-n-butyl ammonium bromide (18.1 g, 56.0 mmol) and tin(II) 
chloride (20.9 g, 92.0 mmol) were added to 170 mL of distilled water, and the resulting 
mixture stirred at 50 °C for 8 hours. The mixture was cooled and extracted with diethyl 
ether, and the aqueous phase washed with diethyl ether (3 x 20 mL). The combined 
organic phases were washed with distilled water, dried (MgS04) and concentrated to 
give mostly 219 as a pale yellow oil; purification by Kugelrohr distillation gave pure 
219 (9.41 g, 67%) Vmax(film)/cm-1 3420 (b, alcohol 0-H str), 3300 (medium, alkyne C-
H str.), 3030 (weak, aryl C-H str.), 2920 (weak, aliphatic C-H str.), 2140 (weak, C=C 
str.), 1600, 1510 (medium, C=C aromatic str.), 1450 (medium, aliphatic C-H def.), 1050 
(b, medium, C-0 str.); OH (300 MHz) 2.10 (IH, s, J 2.7, =CH), 2.69 (2H, dd, J 6.5, 2.7, 
-CH2-), 4.80 (IH, t, J 6.5, -CH-); 7.32-7.65 (5H, m, ArH); 8c (75.5 MHz) 29.8 (-CH2-), 
71.4 (-CH(OH)), 72.7 (=CH), 81.2 (-C=CH), 127.4 (Ar-C), 128.4 (Ar-C), 129.5 (Ar-
C), 143.0 (Ar-C) m/z (Cl+) 164.2233 (100%, M+NH4 +, C10H14NO+ requires 164.2237) 
Method B 
Aluminium powder (1.95 g, 73.0 mmol) and mercuric chloride (259 mg, 1.0 mmol) 
were added in one portion to a solution of propargyl bromide (7.18 mL of an 80% 
solution in toluene, 66.0 mmol) in anhydrous diethyl ether stirred under argon at room 
temperature. The mixture was warmed to inititiate the reaction (signified by 
effervecsence and the solution becoming almost black). The solution was refluxed for 1 
hour, then cooled to -78 °C. Benzaldehyde (7.38 mL, 73.0 mmol) was added dropwise 
over an hour. The solution was maintained at -78 °C for a further 2 hours, before being 
refluxed for a further 1 hour. After this time, the reaction was quenched with saturated 
NH4Cl and diluted with Et20. The organic phase was separated and washed with brine 
and distilled water; concentration of the combined organic layers after drying (MgS04) 
gave crude 219 as a dark red oil (60%); analytical data was consistent with product 
obtained by method A. 
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Method C 
A mixture of benzaldehyde (9.58 mL, 94.0 mmol), propargyl bromide (8.97 mL of an 
80% solution in toluene, 85.0 mmol) in anhydrous diethyl ether was added to a mixture 
containing activated zinc dust (7.00 g, 100.0 mmol) and mercuric chloride (50 mg) in 
dry toluene. The mixture was maintained at gentle reflux for 3 hours; after this time, 
the reaction was cooled and extracted into diethyl ether (100 mL) and washed with 
water (3 x 200 mL). The combined organic layers were dried (MgS04) and 
concentrated to give a yellow oil containing 219 (55%); analytical data was consistent 
with product obtained by method A. 
1-JPhenyl-3-butyn-1-one 221a129 
To a solution of 221a (2.5 g, 17.0 mmol) in acetone ( 14 ml) cooled to -10 oc was added 
a solution containing sodium dichromate dihydrate ( 1.3 g, 4.0 mmol) and concentrated 
H2S04 (1.2 mL) in water (1.2 mL) dropwise with stirring. The reaction temperature was 
maintained below -5 °C during the addition. The reaction was then allowed to warm to 
room temperature, and was stirred for a further 10 minutes. After this time the mixture 
was diluted with diethyl ether, and filtered. The filtrate was washed with saturated 
sodium carbonate solution, and the organic phase separated and washed with distilled 
water. Drying (MgS04) and concentration gave a dark red oil containing 221a (less 
than 10%) data for crude product Vmax (film)/cm- 1 3340 (weak, alkyne C-H str.), 3240 
(weak, aryl C-H str.), 2105 (weak, C=C str.), 1690 (strong, C=O str.), 1600, 1550 
(medium, Ar-H str.); 8H (300 MHz) 2.33 (lH, t, J 2.6Hz, -CH2- ), 3.89 (2H, d, J 2.6Hz, 
-CH-), 7.25-7.65 (3H, m, ArH), 7.85-8.20 (2H, m, ArH); 8c (75.5 MHz) 30.9 (-CH2-), 
74.1 (-C=CH), 83.3 (-C=CH), 127.7 (Ar-C), 129.1 (Ar-C), 130.6 (Ar-C), 134.1 (Ar-C), 
193.1 (Cq, C=O) m/z (Cl+) 162 (M+NH/, 60%). 
N -[(E)-l?heny lmethylidene 1-N -( trimethy lsilyl)amine 222133 
I N ·u~ "'TMS 
-& 
To HMDS (10.8 mL, 51.8 mmol) cooled to 0 °C and stirred under argon was added n-
BuLi 18.8 mL of a 2.5 M solution, 47.0 mmol) dropwise. The solution was stirred for 
30mins, and the solvent removed until a white ppte was formed. The ppte was cooled 
-- - -
to 0°C, and benzaldehyde (4.8 mL, 47.0 mmol) added over 10 mins. The reaction was 
stirred for 30 mins, and allowed to warm to room temperature. Product was purified by 
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vacuum distillation (Kugelrohr, 110-115 °C, 0.8 mmHg), affording 222 as a pale yellow 
oil (5.58 g, 69%); analytical data matched that reported in the literature; 8c (75.5 MHz) 
0.4 (-SiMe3), 127.6 (Ar-C), 128.3 (Ar-C), 131.7 (Ar-C), 140.0 (Ar-C), 169.4 (-C=N) 
m/z (ES+) 178.1048 (MH+, 100%, C10Ht6NSi requires 178.1052). 
2-[(E)-3-Bromo-1-propenyl]-1,3,2-benzodioxaborole 223a225 
Propargyl bromide (0.88rnL of an 80% solution in toluene, 8.3mmol) was cooled to 0°C 
under argon, and catecholborane (0.88rnL, 8.3mmol) carefully added with stirring. The 
reaction mixture was heated to 50°C for 1h. The resulting mixture containing mostly 
223a (90%) was used without further purification. ()H (300 MHz) 4.15 (2H, d, J 8.3Hz,-
CH2-), 6.07 (lH, d, J 17.7Hz, :CH-B), 7.15 (2H, m, ArH), 7.27 (lH, m, ArH), 7.40 
(lH, m, H2C-CH:); 8c (75.5 MHz) 33.5 (-CH2-), 113.1 (Ar-C), 123.4 (Ar-C), 129.5 
(C:CH-B), 138.3 (CH2C:), 149.8 (ArC-0). 
2-[(E)-3-Bromo-1-propenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 223b226 
Pinacolborane (0.158 rnL, 1.1 mmol) was added to a stirred solution of Rh(PPh3)3Cl 
(9.25 mg, 0.01 mmol) in dry DCM (1 rnL) at 25 °C under argon. The solution was 
stirred for 2 minutes, and propargyl bromide (0.104 rnL of 80% solution in toluene, 1 
mmol) added. After stirring for 3 hours, the reaction was quenched with water (1 rnL) 
and extracted into diethyl ether (1 rnL). Drying (MgS04) and concentration of the 
organic phase gave a yellow oil containing 223b (58%, 62% internal isomer 223c); 
analytical data was consistent with reported literature values. 
N -(Diphenylmethvlene )(phenyl)methanamine 247159 
A solution of benzophenone imine (5rnL, 25.5 mmol) and benzylamine hydrochloride 
(3.7 g, 25.5 mmol) in dry DCM (25 rnL) were stirred for 24h under argon at room 
temperature. The crude mixture was filtered, and the filtrate concentrated in vacuo to 
give the crude product as a pale yellow solid (6.81 g, 98%). Recrystallization from 
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pentane gave pure 247 as a white crystalline solid (6.57 g, 95%); m.p. 57-59°C, lit. 
value 54-56°C;227 Ymax(film)/cm- 1 1630 (strong, C=N str.); OH (300 MHz) 4.68 (2H, s, -
CH2-), 7.30-7.85 (15H, m, ArH); Oc (75.5 MHz) 57.9 (-CH2-), 127.0 (ArC), 128.2 
(ArC), 128.5 (ArC), 128.8 (ArC), 130.7 (ArC), 137.1 (Cq, ArC), 140.2 (Cq, ArC), 
141.1 (Cq, ArC), 169.2 (Cq, C=N); m/z (ES+) 272.1436 (100%, MH+, C20H18N+ 
requires 272.1439). 
Diphenyl-N-[(E)-phenylmethylidene]methanamine 248159 
To a stirred solution of diphenylmethanamine (3.1 g, 16.9 mmol) in dry DCM (25 mL) 
under argon at room temperature was added anhydrous MgS04 (4 g) and benzaldehyde 
(1.74 g, 16.4 mmol) portionwise. The reaction was stirred until TLC indicated 
consumption of benzaldehyde (5h), after which the crude mixture was concentrated in 
vacuo to give 248 as a pale yellow solid (4.25 g: 93%). Recrystallization from pentane 
gave pure 248 (4.19 g, 91 %) as a pale yellow crystalline solid; m.p. 100-103°C, lit. 
value 98-100°C; 159 Ymax(film)/cm- 1 1638 (strong, C=N str.); OH (300 MHz) 5.65 (lH, s,-
CH), 7.22-7.63 (13H, m, ArH), 7.9 (2H, m, ArH), 8.45 (lH, s, :NH); Oc (75.5 MHz) 
77.9 (Ph2CH-), 127.3 (ArC), 127.7 (ArC), 128.9 (ArC), 129.0 (ArC), 130.5 (ArC), 
131.2 (ArC), 136.8 (Cq, ArC), 144.4 (Cq, ArC), 161.2 (-C=N); m/z (ES+) 272.3651 
(100%, MH+, C2oH 1sN+ requires 272.3652). 
N -(Diphenylmethylene )-1-phenyl-3-butyn-1-amine 249 
To diphenyl-N-[(E)-phenylmethylidene]methanamine (2.00 g, 7.4 mmol) in anhydrous 
THF (20mL) was added potassium t-butoxide (1.00 g in 10 mL of THF, 1.2 eq). 
Propargyl bromide ( 1.00 g, 1.1 eq) was then added to the purple solution, and the 
reaction stirred under argon at room temperature. After 2h, the reaction was quenched 
with cold water and extracted with DCM (2 x 20 mL). Drying over MgS04 and 
concentration in vacuo of the combined organic layers gave an -orange liquid; 
purification by flash chromatography (2: 1 pet. ether/DCM as eluant) gave 
propargylimine 249 as the minor fraction; colourless solid (0.19 g, 17%) Ymax(film)/cm- 1 
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3295 (strong, C-H str. alkyne), 2123 (weak, C=C str.), 1637 (medium, C=N str.); oH 
(300 MHz) 1.97 (lH, t, J 3.1Hz, C=CH), 2.71-2.77 (lH, m, -CH2-), 2.83-2.89 (lH, m,-
CH2-), 4.63-4.66 (lH, m, -CH), 7.15-7.75 (15H, m, ArH); Oc (75.5 MHz) 27.6 (-
CH2C=CH), 63.9 (PhCH-), 75.1 (=CH), 84.1 (q, HC=C-), 127.4 (ArC), 127.6 (ArC), 
128.5 (ArC), 128.8 (ArC), 129.3 (ArC), 129.9 (ArC), 137.2 (Cq, ArC), 137.3 (Cq, 
ArC), 141.9 (Cq, ArC), 170.1 (Cq, C=N); m/z (FAB+) 309.4146 (100%, MH+, 
C23H2oN+ requires 309.4149). major fraction was found to be N-(diphenylmethylene)-N-
{2-[(diphenylmethylene)amino]-1,2-diphenylethyl}amine 255 (2.71g, 68%), structure 
determined by XRD. 
tert-Butyl (lS)-2-hydroxy-1-phenylethylcarbamate 257161 
To a suspension of NaBH4 (15.0 g, 0.396 mol) in dry THF (350 mL) cooled to 0 °C and 
stirred under argon was added h (42.0 g, 0.165 mol) as a solution in dry THF (75 mL) 
dropwise over 1h. When evolution of gas ceased, (S)-phenylglycine 256 (25.0 g, 0.165 
mol) was added portionwise over 1h, the reaction was then refluxed for 18h. After this 
time, the reaction was cooled to 0 °C and MeOH (30· mL) added cautiously and the 
mixture stirred. After evolution of gas ceased (20 minutes), THF (200 mL) was added 
to the clear solution, and the reaction was cooled to 0 °C. Et3N (24.2 mL, 0.165 mol) 
was added, followed by di-tert butyl dicarbonate (38.0 g, 0.167 mol) portionwise with 
vigorous stirring; the reaction was then warmed to room temperature and stirred for 3h. 
Solvent was removed in vacuo, and the white residue was stirred with EtOAc (200mL) 
and water (150 mL). The white residues were destroyed by the additon of 1:1 brine I 
10% HCl (200 mL). After stirring for 10 minutes, the mixture was then poured into a 
separating funnel containing EtOAc (150 mL), and the phases separated. The aqueous 
phase was washed with EtOAc (2 x 100 mL), and the combined organic phase then 
washed with a) 1:1 solution of brine I 5% HCl (2 x 100 mL) b) 1:1 solution of sat. 
NaHC03 solution and brine (2 x 100 mL), and finally with H20 to pH 7. After drying 
over MgS04, solvents were partially removed in vacuo to leave approximately 50mL of 
mother liquor; to this was added hexane (150 mL). After chilling at -10 °C for 12h, the 
white crystals were collected to afford a crude white solid that was recrystallized (3 
crops) from cold DCM-cyclohexane; reconcentration and flash chromatography (Si gel, 
1:1 Et20-hexane) gave a further 2 g of pure material; total recovery of pure 257 (37.6 g, 
96%) as white needles; m.p. 136-138°C (from cyclohexane/DCM), lit. value 137-
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138°C; 161 [a] 21 o= +39.8 (c 1.6, CHCb) lit. [a]22o= +39.4 (c 1.67, CHCh); 161 C13H190 3N 
requires C 65.8 H 8.07 N 5.90%; found C 66.1 H 8.78 N 6.01 %; Vmax (film)/cm·' 3525 
(broad, 0-H str.), (003430-2980 (several bands, broad, strong, N-H amide and Ar-H 
str.), 1680 (strong, C=O str, amide), 1551 (medium, N-H bend), 1366 ((strong, -
C(CH3)3 C-H str. ), 1060 (medium, C-0 str.); 8H (300 MHz) 1.39 (9H, s, 3xCH3), 3.50 
(1H, bs, -CH20H, exchanges with D20), 3.90 (2H, d, 1 4.5Hz, -CH2-), 4.75 (lH, bs), 
5.26 (1H, bs), 7.25-7.41 (5H, m, ArH); 8c (75.5 MHz) 28.6 (-CH3), 57.9 (-COH), 66.2 
(CHPh), 78.5 (Cq, C(CH3)3), 127.0 (ArC), 128.3 (ArC), 128.7 (ArC), 142.2 (Cq, ArC), 
155.5 (Cq, -C=O); m/z (ES+) 238.3018 (100%, MH+, C13H200 3N+ requires 238.3020), 
220,206, 199, 182, 168, 150, 138, 124, 106, 91, 57. 
(2S)-2-[(tett-Butoxycarbonyl)aminol~2-phenylethyl 4-methylbenzenesulfonate 
To a solution of amino alcohol 257 (10.0 g, 0.0421 mol) dissolved in freshly distilled 
DCM (150 mL), stirred under Ar and cooled to 0 °C, was added freshly distilled Et3N 
(8.85 mL, 1.5 eq) followed by, over lh, tosyl chloride (8.03 g, 1eq) as a solution in 
DCM (50 mL). The solution was allowed to stir at < 20 oc for 16h, before a sat. 
solution of NaHC03 (75 mL) was added. After stirring for 5 minutes, the phases were 
separated and the aqueous phase washed with DCM (50 mL). The combined organic 
phases were washed with brine (2 x 50 mL) and dried over MgS04. Removal of 
solvents in vacuo (Et3N and DCM) gave a cream solid (14.3 g, 87%) that was 
recrystallized from DCM-hexane to afford tosylate 258 as a cream voluminous powder 
(13.8 g, 82%); m.p. 164-166°C, lit value 160°C; 169 [a]200 = +2.5 (c 3, CHCb) lit. value 
for (R) enantiomer [af5o= -2 (c 3, CHCb); 169 Vmax (KBr disc)/cm·' 3495-2975 (several 
bands, strong, N-H amide and Ar-H str.), 1675 (strong, C=O str, amide), 1555 (medium, 
N-H bend), 1395 (weak, 502-0 str.), 1365 ((strong, -C(CH3)3 C-H str. ), 1060 (C-0 
str.); 8H (400 MHz) 1.45 (s, 9H, 3xCH3); 2.44 (s, 3H, ArCH3), 4.22 (m, 2H, -CH2-), 
4.91 (bs, lH, PhCH), 5.23 (bs, 1H, -NH, exchanges with D20), 7.20 (d, 2H, 18Hz, 
ArH), 7.30 (m, 5H, ArH), 7.65 (d, 2H, 18Hz, ArFI); 8c (100 MHz) 22.1 (PhCH3), 28.7 
(C(CH3)3), ss:o (-CH2-), 71.9 (PhCH), 80.5 (Cq, C(CH3)3), 127.0 (ArC), 129.1 (ArC), 
128.4 (ArC), 130.3 (ArC), 132.8 (Cq, ArC), 138.2 (Cq, ArC), 145.4 (Cq, ArC), 155.3 
(Cq, C=O), m/z (ES+) 392.4966 (100%, MH+, C20H21NOsS+ requires 392.4970). 
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tert-Butyl (2R)-2-phenyl-1-aziridinecarboxylate 259180 
To a solution of 257 (1.0 g, 4.20 rnmol) and p-toluenesulfonyl chloride (0.96 g, 5.00 
mmol) in dry Et20 (100 mL) stirred at room temperature under argon was added freshly 
powdered anhydrous KOH (0.95g, 16.9mmol). After refluxing for 4h, the mixture was 
poured into a separating funnel containing crushed ice, and the organic phase separated, 
washed with brine (50 mL) and dried over MgS04. After removing the solvent in 
vacuo, the pale yellow liquid was purified by column chromatography (silica gel, 1:1 
hexane I Et20 as eluant) to give 259 as a white waxy solid (0.81 g, 87%) that was best 
stored at -20°C under argon. [a] 21 0 = -165.2 (c 1, DCM) lit. [a]200 = -163.5 (c 1, 
DCM); 180 Ymax (film)lcm-1 3555-2997 (several bands, strong, N-H amide and Ar-H str), 
1678 (strong, C=O str, amide), 1368 (strong, -C(CH3)3 C-H str. ); 8H (400 MHz) 1.48 
(9H, s, 3x-CH3), 2.31 (lH, d, J 5Hz, -CHz-), 2.64 (lH, d, J 5Hz, -CHz-), 3.42 (lH, t, J 
5Hz, -CH-), 7.15-7.48 (5H, m, ArH); 8c (75.5 MHz) 28.1 (-C(CH3)3), 32.8 (-CHz-), 
46.4 (-CHPh), 79.8 (Cq, -C(CH3)3), 122.4 (ArC), 127.5 (ArC), 128.9 (ArC), 144.4 (Cq, 
ArC), 154.1 (Cq, C=O); m/z (ES+) 219.2788 (100%, C13H 18N02 +requires 219.2789). 
tert-Butyl (lS)-2-iodo-1-phenylethylcarbamate 260161 
To a stirred solution of tosylate 258 (1.00 g, 2.6 rnmol) in anhydrous propionitrile 
(15mL) was added sodium iodide (0.80 g, 5.1 mmol). The mixture was stirred at room 
temperature for 2 days, then diluted with diethyl ether. The reaction was filtered 
through Celite, evaporated, and the residue redissolved in DCM. After washing with 
saturated Na2S20 3 solution (30 mL) and water (50 mL), the organic phase was dried 
(MgS04) and concentrated to give a cream solid that was recrystallized from acetone-
water to give crude 260 as a white solid; purification by column chromatography (silica 
gel, 1:1 hexane I Et20 as eluant) afforded an analytically pure sample (0.76 g, 88%) as 
fine white crystals; m.p. 97-99°C, lit. value 97-98°C; 161 b [a]200 = +50.9 (c 0.9, CHCh) 
lit.[a]250 = +51.6 (c 0.88, CHCh); 161 C13H1sN02I requires C 44.97 H 5.22 N 4.03%; 
found C 45.11 H 5.01 N 3:89%; Vmax(KBr disc)lcm-1 3347~2920 (several bands, strong, 
N-H amide and Ar-H str.), 1689 (strong, C=O str. amide), 1556 (medium, N-H bend.), 
1370 (strong, -C(CH3)3 C-H str.), 515 (medium, C-I str.); 8H (400 MHz) 1.45 (9H, s, 
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3x(CHJ)), 3.42-3.60 (2H, m, -CH2-), 4.7 (IH, m, -CH-), 5.10 (IH, bs, -NH), 7.25-7.42 
(5H, m, ArH); 8c (100 MHz) 28.7 (-C(CH3)3), 55.3 (-Cl), 72.9 (CHPh), 80.5 (Cq, -
C(CH3)3), 126.5 (ArC), 128.5 (ArC), 129.3 (ArC), 140.5 (Cq, ArC), 155.3 (Cq, C=O) 
m/z (ES+) 348.0463 (100%, MH+, C13Ht9N02I+ requires 348.0460). 
tert-Butyl (lS)-2-iodo-1-phenylethylcarbamate 260 from 257 method A: 
To a stirred solution of polystyryl diphenylphosphine (1.18 g, 3.16 mmol) in dry DCM 
(15 mL) at RT under Ar was added h (0.40 g, 3.16 mmol). After stirring for 15 mins., 
imidazole (0.24 g, 3.59 mmol) was added, and the mixture was stirred for a further 15 
mins. 257 (0.34 g, 1.44 mmol) was added as a solution in DCM (5 mL), and the 
resulting mixture refluxed for 2h. After this time, the reaction was filtered through 
Celite (washing with DCM), and the organic phase washed with Na2S20 3, and then with 
water to pH 7. Concentration in vacuo gave 0.45 g of pure 260 as a white solid (91% ). 
tert-Butyl (lS)-2-iodo-1-phenylethylcarbamate 260 from 257 method B: 
To a stirred solution of PPh3 (2.42 g, 2.2 eq.) in dry DCM (15 mL) at RT under Ar was 
added 12 (1.17 g, 2.2 eq). After 35 mins., imidazole (0.71 g, 2.5 eq.) was added, and the 
solution stirred for a further 15 mins. 257 (1.00 g, 4.20 mmol) in DCM (5 mL) was 
added in one portion, and the resulting solution refluxed for 6h. The reaction was 
cooled, and the organic phase washed with Na2S20 3 (2 x 10 mL), water (2 x 20 mL), 
and dried over MgS04. Silica gel chromatography of the concentrated material (gradient 
elution from pet ether 60-80 to 8:1 pet. ether I EtOAc) afforded 0.98 g of 260 (67%). 
(2S)-2-[(tert-Butoxycarbonyl)amino]-2-phenylethyl methanesulfonate 262171e 
To a solution of 257 (10.0 g, 42.0 mmol) in freshly distilled DCM (150 rnL), cooled to 0 
oc and stirred under argon, was added freshly distilled Et3N (8.90mL, 1.5 eq.), followed 
by, over 1h, a solution of freshly distilled methanesulfonyl chloride (3.43 mL, 1.05 eq.) 
in dry DCM (50 rnL) .. The solution was stirred at RT for 12h, then sat. NaHC03 (75 
mL) was added and the phases were separated after stirring for 10 min. The aqueous 
phase was washed with DCM (2 x 25mL), and the combined organic phases were 
washed with sat. NaCJ (2 x 50mL) and dried over MgS04. Concentration in vacuo (to 
remove Et3N and DCM) gave an off-white solid (13.9 g) that was recrystallized from 
DCM I hexane to give crearri cryStals of 262 (11.5 g, 87%); m.p. 115-fl7°C, lit. value 
112-114°C; 171e[a]220 = +23.1 (c 0.9, CHC13) lit. val for (R) enantiomer [a]25o= -21 (c 1, 
CHCi}); 171 r C 14H21 N05S requires C 53.32 H 6.71 N 4.44%; found C 53.11 H 6.67 N 
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4.34%; VmaxCKBr disc)/cm-1 3445-2979 (several bands, strong, N-H amide, and Ar-H 
str.), 1668 (strong, C=O str, amide), 1558 (medium, N-H bend), 1389 (wea,k, S02-0 
str.), 1367 (strong, -C(CH3)3 C-H str. ), 1063 (medium, C-0 str.); OH (500 MHz) 1.4 
(9H, bs, 3xCH3), 2.84 (3H, s, -CH3), 4.39 (2H, s, -CH2-), 4.99 (lH, bs, -CHPh), 5.33 
(lH, bs, NH, exchanges with D20); oc (125.5 MHz) 28.3 (-C(CH3)3), 37.9 (-CH3), 53.3 
(CHPh), 71.4 (-CH20S02CH3), 81.1 (Cq , b, C(CH3)3,), 127.5 (ArC), 128.9 (ArC), 
129.9 (ArC), 139.8 (Cq, ArC), 155.8 (Cq, C=O); m/z (ES+) 338.1 (100%, (M+Nat). 
tert-Butyl (lR)-2-cyano-1-phenylethylcarbamate 263 from 261161b 
A solution of tosylate 258 (5.0 g, 12.8 mmol) in DMF (10 rnL) was slowly added to a 
stirred solution of NaCN (1.9 g, 39.0 mmol) in DMF (20 rnL) under argon. The 
reaction was stirred for 24h at room temperature, then diluted with H20 (50 rnL) and 
extracted into ethyl acetate (50 rnL). The organic phase was washed with H20 (3 x 
20rnL), 5% HCl (3 x 20mL) and finally H20 (50 mL), before being dried over MgS04 
and concentrated in vacuo to give crude 263 as a cream solid. Recrystallization from 
DCM-hexane gave pure 263 as a white solid (3.03 g, 96%); m.p. 110-l12°C, lit. value 
112-113°C;161b [af3o= +41.6 (c 0.5, EtOH) lit. [af5o= +42.2 (c 0.45, Et0H); 161b 
C14H1sN202 requires C 68.26, H 7.36, 11.37%; found C 68.07, H 7.29, N 11.49%; 
Vmax(KBr disc)/cm- 1 3440-2948 (several bands, strong, N-H str. and Ar-H str.), 2250 
(weak, C=N str.), 1688 (strong, C=O str.), 1555 (medium, N-H bend.), 1367 (strong, -
C(CH3)3 C-H str.); oH (500 MHz) 1.46 (9H, s, 3xC(CH3)3), 2.88 (1H, dd, J 16.4Hz, 
6.2Hz, -CH2-) 3.00 (lH, dd, J 16.4, 6.2Hz, -CH2-), 4.90-5.07 (1H, m, -CHPh-), 5.18 
(lH, bd, J 5.7Hz, -NH exchanges with D20), 7.33-7.44 (5H, m, ArH); Oc (100 MHz) 
25.6 (-CH2-), 28.7 (-C(CH3)3), 51.6 (-CHPh), 80.9 (Cq, -C(CH3)3), 117.53 (Cq, -C=N), 
126.6 (ArC), 128.9 (ArC), 129.5 (ArC), 139.1 (Cq, ArC), 155.3 (Cq, C=O); m/z (ES+) 
247.1446 (100%, MH+, C14H19N202+ requires 247.1446); 
tert-Butyl (lR)-2-cyano-1-phenylethylcarbamate 263 from 262 
To a solution of mesylate 262 (10 g, 31.7 mmol) in anhydrous DMSO (150 mL) stirred 
under argon, was added NaCN (4.7 g, 3 eq.) in one portion. The suspension was stirred 
vigorously at 45 oc for 18h, then cooled to 0 oc. Water (250 rnL) was added, and the 
DMSO I H20 phase was washed with Et20 (3 -x 100mL). The combined ether extracts 
were washed with sat. NaCl (3 x 100mL), and dried over MgS04. Concentration in 
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vacuo gave a white solid that was recrystallized from cold DCM I hexane to give white 
crystals of263 (5.84 g, 74%). 
tert-Butyl (lR)-2-cyano-1-phenylethylcarbamate 263 from 258: alternative 
procedure 
The conditions above were followed, substituting the N-Boc amino mesylate 262 for the 
corresponding tosylate 258. Yield is typically 70%. 
tert-Butyl OR)-3-oxo-1-phenylpropylcarbamate 264181 
To a partially solubilized solution of nitrile 263 (5.00 g, 20.3 mmol) in dry Et20 (100 
mL) cooled to -40°C and stirred vigorously under argon was added DIBAL-H (81.2 mL 
of a 1M solution in PhMe, 4 eq) over 15 minutes. The reaction was stirred for a further 
O.Sh, then quenched by the cautious addition of MeOH (5 mL). The mixture was 
immediately poured into a separatory funnel containing saturated NH4Cl solution (100 
mL). After warming to room temperature, the thick gel was progressively destroyed by 
the slow addition of O.lM HCl, then 1M HCl, and finally the pH was reduced to 2-3 by 
the addition of 3M HCl. After extracting with EtOAc (100 mL), the organic phase was 
washed with i) 2 x 50mL of a 1 M HCl I brine solution ( 1: 1) ii) 2 x 50mL of a saturated 
NaHC03 I brine solution (1: 1). The organic phase was dried (K2C03) and concentrated 
in vacuo. The resulting yellow residue was distilled (Kugelrohr, 0.05 mmHg) to give a 
white solid that was recrystallized from 1:4 diisopropyl ether I hexane; recovered 3.59 g 
(71 %); m.p. 92-93°C, lit. value 91-93°C; 181 [a]23 0 = +29.9 (c 1.5, CHCi]) lit. value for 
(S) enantiomer: [a]250 = -30.1 (c 1.5, CHCi]); 181 C14H 19N03 requires C 67.45 H 7.68 N 
5.62%; found C 67.41 H 7.61 N 5.46%; Ymax(KBr disc)lcm· 1 3440-2942 (several bands, 
strong, N-H str. and Ar-H str.), 2722 (weak, C-H str. aldehyde), 1742 (strong, C=O str. 
aldehyde), 1678 (strong, C=O str. amide), 1553 (medium, N-H bend.), 1374 (strong, -
C(CH3)3 C-H str.); ()H (300 MHz) 1.41 (9H, s, 3xC(CH3h), 2.90-3.11(2H, m, -CHz-), 
5.01-5.23 (2H, m, -CHPh+NH), 7.23-7.39 (5H, m, ArH), 9.73 (lH, s, CHO); 8c (100 
MHz) 28.2 (-C(CH3)3), 50.1 (-CHPh), 80.1 (Cq, b, (CH(CH3)3), 126.2 (ArC), 128.3 
(ArC). 129.4 (ArC). 141.5 (Cq, ArC), 154.5 (Cq, C=O), 200.4 (Cq, CHO); mlz (ES+) 
272.3 (100%, (M+Nat). 
(Iodomethyntriphcnylpnosphoniu:m ·iodide 265228 
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To a solution of triphenylphosphine (10.0 g, 38.1 mmol) in dry DCM (100 mL) was 
added diidomethane (12.3 mL, 4 eq). The solution was stirred at RT for 18h, and after 
this time the mixture was concentrated in vacuo (0.05 mmHg). Hexane was added to 
the resulting semi-sold material, and the solution was filtered. The solids were washed 
with hexane, and dried in vacuo. Obtained 265 as a cream solid that was best stored 
under argon (18.9 g, 94%); OH (500MHz) 5.01 (2H, d, J 13.8Hz, -CH2-), 7.72-7.94 
(15H, m, ArH); mlz (ES+ in 1% TFA I MeCN) 403.1 (100%, (M-It) 
tert-Butyl (1R,3Z)-4-iodo-1-phenyl-3-butenylcarbamate 266184 
To a slurry containing (iodomethyl)triphenylphosphonium iodide 265 (2.46 g, 1.1 eq) in 
dry THF (50 mL) was added KHMDS (18.0 mL of a 0.5M sol. in PhMe, 2.2 eq.) 
dropwise. The orange-black suspension was stirred for 10min, and cooled to -78°C 
before adding HMPA (2.80 mL, 4 eq.). After 15min, a solution of aldehyde 264 (1.00 
g, 4.0 mmol) in dry THF (15 mL) was added. After stirring for 15min, the reaction was 
quenched with sat. NH4Cl, and filtered in vacuo. The resulting solution was extracted 
with Et20 (2 x 25mL), and the organic phase was washed with brine, and dried over 
MgS04. Removal of solvents gave a dark brown oil that was subjected to column 
chromatography (Si gel, eluted with hexane, then 8:1 hexane I EtOAc). Obtained pure 
266 (0.695 g, 47%) as an off-white solid (>10:1 ZIE; isomers could not be separated); 
m.p. 105-107°C, lit. value 104-106°C; 184 [af5o= +27.9 (c 1.20, CHCI))lit. val for (S) 
enantiomer [a]o= -26.5 (c 1.19, CHC1)); 184 VmaxCKBr disk)/cm·1 3380-2977 (several 
bands, strong, N-H str. and Ar-H str:), 1688 (strong, C=O str.), 1610 (medium, C=C 
str.), 1560 (medium, N-H bend); OH (400 MHz) 1.42 (9H, bs, 3xC(CH3)3), 2.63 (2H, m, 
-CH2-), 4.86 (2H, m, CHPh + NH), 6.13-6.17 (lH, dd, J 16.4, 9.3Hz, :CH), 6.35 (lH, d, 
J 9.3Hz, :CH), 7.26-7.35 (5H, m, ArH); oc (100 MHz) 28.3 (-C(CH3)3), 40.9 (-CH2-), 
53.9 (-CHPh), 80.2 (Cq, b, -C(CH3)3), 85.8 (:CHI), 126.4 (ArC), 127.8 (ArC), 129.1 
(ArC), 137.8 (:CH), 142.0 (Cq, ArC), 156.8 (Cq, C=O); m/z (ES+) 374.2361 (100%, 
CtsH21IN02 +requires 374.2364) 
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tert-Butyl-(1R,3Z,SE)-1-phenyl-6-(4,4,6-trimethyl-1,3,2-dioxaborinan-2-yl)-3,5-
hexadienylcarbamate 268 
Palladium acetate (6 mg, 0.0267 mmol), triphenylphosphine (15 mg, 0.0572 mmol) and 
iodide 266 (100 mg, 0.268 mmol) were suspended in freshly distilled toluene (5 mL). 
Vinylboronate 272 (60 )lL, 0.348 mmol) and tri-n-butylamine (76 )lL, 0.322 mmmol) 
were added, and the mixture was degassed thoroughly (freeze-pump-thaw). The 
reaction was heated to 120 oc in a sealed tube for 20h. The mixture was filtered 
through Celite, extracted into Et20 (2 x 5mL) and washed with 5% HCl (2 x 5mL) and 
brine (5 mL). The combined organic phases were dried over MgS04 and solvents 
removed in vacuo. Purification by column chromatography (Si gel, 10:1 hexane I ethyl 
acetate as eluant) gave the desired compound 268 as a 19:1 mixture with the Suzuki 
product (75 mg, 70% ); yellow oil; Vmax(film)/cm- 1 3440-2960 (several bands, strong, N-
H str. and Ar-H str.), 1685 (strong, C=O str.), 1620 (medium, C=C str.), 1604 (medium, 
C=C str.), 1557 (medium, N-H bend); 8H (500 MHz) 1.21 (3H, s, -CH3), 1.23 (9H, s, -
C(CH3)3), 1.27 (6H, s, 2 x -CH3), 1.38 (lH, m, -CH), 1.69 (lH, m, -CH), 2.82 (2H, dd, 
J 14.6, 6.91Hz, -CH2), 4.12 (1H, m, -CH), 4.61 (1H, bs, NH, exchanges with D20), 
4.76 (lH, m, CHPh), 5.01 (lH, td, J 11.0, 6.90Hz, :CH), 5.47 (lH, d, J 18.5Hz, :CH), 
6.03 (lH, dd, J 11.0, 10.6Hz, :CH), 7.15-7.29 (6H, m, ArH +:CH); 8c (125.5 MHz) 
23.4 (-CH3-), 28.2 (3 X CH3), 31.9 (-CH)), 35.7 (-CH2-), 45.9 (-CH2-), 58.9 (-CH-), 
63.8 (-CH-), 70.4 (-C(CH3)2), Cq), 77.1 (:CH), 80.1 (-C(CH3)3, Cq), 120.6 (:CH), 122.7 
(ArC), 126.9 (ArC), 127.8 (ArC), 129.3 (:CH), 131.2 (:CH), 141.8 (ArC, Cq), 156.2 
(C=O, Cq); m/z (ES+) 400.2655 (100%, MH+, C23H35BNO/ requires 400.2659). 
4,4,5,5-Tetrabenzyl-2-vinyl-1,3,2-dioxaborolane 271 
Procedure followed as for 122 above, substituting benzopinacol (4.29 g, 11.7 mmol) Jor 
pinacol. Gave 271 as a grey powder (3.98 g, 77%) VmaxCKBr disc)/cm- 1 3097 (medium, 
olefinic C-H str.), 3039 (very strong, aromatic C-H str.), 2998 (strong, aliphatic C-H 
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str.), 1623 (strong, C=C str.), 1590, 1505 (very strong, aromatic C=C str.), 1449 (strong, 
aliphatic C-H def.), 1331 (very strong, B-0 str.), 1247 (very strong, C-B str.), 1151 
(strong, C-0 str.), 1028 (medium, C-0 str.); OH (300 MHz) 6.8-5.85 (m, 3H), 7.15 (m, 
4H), 7.30 (m, 8H); Oc (75.5 MHz) 83.4, 127.4, 127.7, 128.8, 130.5, 142.9, 144.6; m/z 
(Cl+) 403.1874(100%, MH+, C28H23B02 requires 403.1869). 
4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane 272229 
Procedure followed as for 122, substituting rac-2-methyl-2,4-pentanediol (6.28 mL, 
49.5 mmol) for pinacol. Gave 272 as a yellow oil that was purified by distillation 
(Kugelrohr, 50-55 oc at 0.3 mmHg). Recovered 5.45 g (71 %) of clear oil; 
Vmax(neat)/cm- 1 3095 (medium, olefinic C-H str.), 3007 (strong, aliphatic C-H str.), 1622 
(strong, C=C str.), 1451 (strong, aliphatic C-H def.), 1379 (strong, doublet, -C(CH3h), 
1329 (very strong, B-0 str.), 1247 (very strong, C-B str.), 1153 (strong, C-0 str.), 1028 
(medium, C-0 str.); OH (400 MHz) 1.23 (3H, s, CH3), 1.26 (3H, s, -CH3), 1.28 (3H, s, -
CH3), 1.48 (lH, m, -CH), 1.75 (lH, dd, 1 11.2, 2.7Hz, -CH), 4.10 (lH, m, -CH), 5.81 
(lH, dd, J 19.2, 13.5, :CH), 5.97 (1H, dd, J 13.5, 4.26, :CH), 6.11 (IH, dd, J 19.2, 4.26, 
:CH); Oc (100.0 MHz) 23.3 (-CH3-), 28.3 (-CH3-), 31.4 (-CH3-), 46.1 (-CH2-), 64.9 (-
CH-), 70.92 (C(CH3)2, Cq) 129.6 (B:CH), 133.96 (:CH2); m/z (Cl+) 172.1511 (100%, 
M+NH/, C8H 19BN02+ requires 172.1509) 
General Procedure for Heck couplings of Aryl iodides 
lodobenzene (102 mg, 0.5 mmol), palladium acetate (6 mg, 5 mol %) and 
triphenylphosphine (16 mg, 12 mol %) were suspended in freshly distilled toluene (5 
ml), and vinylboronate 272 (105 flL, 1.2 eq.) and tri-n-butylamine (238 flL, 2 eq.) were 
added. The mixture was degassed thoroughly, and heated in a sealed tube at 110 oc for 
8h. After this time, the reaction was cooled and sat. NH4Cl solution (10 mL) added. The 
mixture was filtered through Celite, and the filtrate extracted into EtOAc (20 mL) and 
washed with a) 5% HCl (2 x lOmL) b) brine (2 x lOmL). The combined organic 
phases were dried over MgS04 , and concentrated in vacuo. The products were isolated 
by silica gel chromatography with 5:1 hexane I EtOAc as eluant. 
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4,4,6-Trimethyl-2-[(E)-2-phenylethenyl]-1,3,2-dioxaborinane 27 6a230 
pale yellow oil; recovered 119 mg (97%) from 0.5mmol iodide; Ymax(film)/cm-1 3030-
3015 (weak, various C-H aromatic str.), 1625 (strong, C=C str.), 1511 (strong, aromatic 
C=C str.), 1328 (strong, B-0 str.), 1250 (strong, C-B str.), 1150 (strong, C-0 str.), 1030 
(medium, C-0 str.); 8H (300 MHz) 1.22 (3H, s, -CH3), 1.27 (6H, s, 2 x -CH3), 1.41 (lH, 
m, -CH), 1.68 (lH, m, -CH), 4_13 (lH, m, -CH), 6_09 (lH, d, J 18_1Hz, :BCH), 7_11-
7.18 (4H, m, ArH), 7_22 (lH, dd, J 6_9, 12Hz, ArH), 7.57 (lH, d, J 18JHz, :CH); 8c 
(75.5 MHz) 22.3 (-CH3), 24.8 (-CH3), 31.2 (-CH3), 46.2 (-CH2-), 64.9 (-CH), 71.1 (Cq, 
C(CH3)2), 117.1 (b, BCH), 126.9 (ArC), 129.1 (ArC), 130.1 (ArC), 135.4 (ArC), 149.9 
(:CH); mlz (Cl+) 248_1823 (70%, M+NH/. C14H23NOzB+ requires 248.1822) 
4,4,6-Trimethyl-2-[(E)-2-( 4-methylphenyl)ethenyl]-1,3,2-dioxaborinane 27 6b 
yellow solid; recovered 94 mg (77%) from 0.5mmol iodide; YmaxCKBr disc)/cm-1 3027-
3012 (weak, various C-H aromatic str.), 1623 (strong, C=C str.), 1510 (strong, aromatic 
C=C str.), 1330 (strong, B-0 str.), 1253 (strong, C-B str_), 1152 (strong, C-0 str.), 1035 
(medium, C-0 str.); 8H (400MHz) 1.20 (3H, s, -CH3), 1.24 (6H, s, 2 x -CH3), 1.41 (lH, 
m, -CH), 1.65 (lH, m, -CH), 4.18 (1H, m, -CH), 2.24 (3H, s, -CH3), 5.98 (lH, d, J 
18.5Hz, :BCH), 7J9 (2H, d, J 8.1Hz, ArH), 7.36 (lH, d, J 18.5Hz, :CH), 7.39 (2H, d, J 
8.1Hz, ArH); 8c (75.5 MHz) 2L4 (ArCH3), 22.4 (-CH3), 30.8 (-CH3), 46.1 (-CHz-), 
64.8 (-CH-), 70.9 (Cq, C(CH3h), 115.5 (b, :BCH), 126.9 (ArC), 128.9 (ArC), 131.5 
(Cq, ArC), 138.9 (Cq, ArC), 151.5 (:CH); m/z (ES+) 267.1536 (100%, M+Na+, 
C,sH21B02Na+ requires 267.1533) 
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2-[(E)-2-( 4-Methoxyphenyl)ethenyl]-4,4,6-trimethyl-1 ,3,2-dioxaborinane 276c 
pale yellow solid; recovered 62 mg (48%) from 0.5mmol iodide; YmaxCKBr disc)lcm- 1 
3020-3010 (weak, various C-H aromatic str.), 1625 (strong, C=C str.), 1508 (strong, 
aromatic C=C str.), 1327 (strong, B-0 str.), 1251 (strong, C-B str.), 1151 (strong, C-0 
str.), 1030 (medium, C-0 str.); 8H (400 MHz) 1.21 (3H, s, -CH3), 1.23 (3H, s, -CH3), 
1.25 (3H, s, -CH3), 1.43 ( 1 H, m, -CH), 1.68 ( 1 H, dd, 1 11.1, 2.6Hz, -CH), 3.68 (3H, s, -
OCH3), 4.18 (lH, m, -CH), 5.87 (lH, d, 1 18.2Hz, :BCH), 6.98 (2H, dd, 6.8, 2.1Hz, 
ArH), 7.33 (lH, d, 18.2Hz, :CH), 7.46 (2H, dd, 1 6.8, 2.1Hz, ArH); 8c (75.5 MHz) 23.4 
(-CH3), 25.6 (-CH3), 30.4 (-CH3), 45.9 (-CH2-), 55.5 (-OCH3), 62.1 (-CH), 71.2 (Cq, 
C(CH3)2), 112.6 (ArC), 115.9 (b, BCH), 129.5 (ArC), 130.4 (Cq, ArC), 149.9 (:CH), 
160.8 (Cq, ArC); m/z (Cl+) 278.1927 (100%, M+NH/, C15H25BN03+ requires 
278.1928) 
General Procedure for Heck coupling of bromides 
p-bromotoluene (0.1 g, 5.84 mmol), palladium acetate (13 mg, 10 mol %) and 
triphenylphosphine (34 mg, 22 mol %) were suspended in freshly distilled toluene (5 
mL). Vinylboronate 272 (122 flL, 1.2 eq) and tri-n-butylamine (278 flL, 2 eq) were 
added and the mixture was degassed thoroughly. The reaction was heated at ll0°C in a 
sealed tube for 4 days, after which time it was cooled and quenched with sat. NH4Cl 
solution (5 mL), filtered through Celite, and the filtrate extracted into EtOAc (20 mL). 
The organic phase was washed with a) 5% HCl (2 x 25mL) b) brine (2 x 25mL), and the 
combined organic phases dried over MgS04 and concentrated in vacuo. Products were 
isolated via silica gel chromatography with 6: 1 hexane I EtOAc or 4:1 hexane I EtOAc 
as eluant. 
4,4,6-Trimethyl-2-[(E)-2-( 4-methylphenyl)ethenyl]-1.3,2-dioxaborinane 27 6a 
isolated 0.1 g (77%) from 0.1 g of p-bromotoluene; analytical data as quoted above. 
2-[(E)-2-( 4-Methoxypheny l)etheny I] -4,4,6-trimethy 1-1 ,3,2-dioxaborinane 27 6b 
isolated 60 mg ( 40%) from 72 flL of p-bromoanisole; analytical-data as-quoted above. 
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2-[(E)-2-( 4,4,6-Trimethyl-1,3,2-dioxaborinan-2-yl)ethenyl]phenylamine 27 6d 
brown oil; isolated 47 mg (33%) from 0.1 g of o-bromoaniline Vmax(film)/cm-1 3350 
(strong, N-H str.) 3035-3016 (weak, various C-H aromatic str.), 1620 (strong, C=C str.), 
1510 (strong, aromatic C=C str.), 1325 (strong, B-0 str.), 1249 (strong, C-B str.), 1150 
(strong, C-0 str.), 1032 (medium, C-0 str.); oH (300 MHz) 1.22 (3H, s, -CH3), L26 
(3H, s, -CH3), 1.32 (3H, s, -CH3), 1.40 (lH, m, -CH), 1.59 (lH, dd, J 11.1, 3.0Hz,-
CH), 3.58 (2H, bs, -NH2), 4.17 (lH, m, -CH), 6.22 (lH, d, J 18.2Hz, BCH), 6.77 (lH, 
dd, J 7.9, 1.6Hz, ArH), 7.26 (1H, t, J 7.9Hz, ArH), 7.35 (lH, t, J 7.9Hz, ArH), 7.47 
(lH, d, J 18.2Hz, :CH); 8c (75.5 MHz) 22.4 (-CH3), 24.5 (-CH3), 31.2 (=CH3), 46.1 (-
CH2-), 62.3 (-CH), 70.8 (Cq, -C(CH3) 2), 115.7 (b, BCH), 119.8 (ArC), 121.9 (ArC), 
123.7 (Cq, ArC), 126.8 (ArC), 130.1 (ArC), 148.2 (Cq, ArC), 148.6 (:CH); m/z (Cl+) 
263.1931 (80%, M+NH/, C14H24BNz02+ requires 263.1927) 
4,4,6-Trimethyl-2-[(E)-2-(1-naphthyl)ethenyl]-1,3,2-dioxaborinane 27 6e 
colourless oil; isolated 67 mg (50%) from 0.1g 1-bromonaphthalene; Vmax(film)/cm-1 
1610 (strong, C=C str.), 1507 (strong,-aromatic C=C str.), 1321 (strong, B-0 str.), 1251 
(strong, C-B str.), 1150 (strong, C-0 str.), 1030 (medium, C-0 str.); OH (400 MHz) 1.23 
(3H, s, -CH3), 1.27 (3H, s, -CH3), 1.30 (3H, s, -CH3), 1.43 (1H, m, -CH), 1.62 (lH, m,-
CH), 4.1 (lH, m, -CH), 6.21 (1H, d, J 18.3Hz, BCH), 7.41-7.55 (3H, m, ArH), 7.79-
7.91 (3H, m, ArH), 8.25 (lH, d, J 18.3Hz, :CH), 8.29 (lH, d, J 8.0Hz, ArH); 8c (75.5 
MHz) 24.4 ( -CH3), 25.6 ( -CH3), 31.5 ( -CH3), 46.9 ( -CHz), 63.3 (-CH), 71.5 (Cq, 
C(CH3)z), 118.8 (b, BCH), 122.9 (ArC), 123.5 (ArC), 126.9 (ArC), 127.0 (ArC), 127.1 
(ArC), 127.3 (ArC), 128.1 (ArC), 128.8 (ArC), 133.3 (Cq, ArC), 136.9 (Cq, ArC), 
151.4 (:CH); m/z (Cl+) 298.1977 (100%, M+NH/, C1sHzsBN02+ requires 298.1979) 
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4,4,6-Trimethyi-2-[(E)-2-( 4-nitrophenyl)ethenyl]-1,3,2-dioxaborinane 27 6f 
pale yellow oil; isolated 267 mg (51%) from O.lg p-bromonitrobenzene; Vmax(film)/cm-1 
3040-3022 (weak, various C-H aromatic str.), 1628 (strong, C=C str.), 1512 (strong, 
aromatic C=C str.), 1320 (strong, B-0 str.), 1254 (strong, C-B str.), 1153 (strong, C-0 
str.), 1030 (medium, C-0 str.); 8H (300 MHz) 1.21 (3H, s, -CH3), 1.26 (3H, s, -CH3), 
1.31 (3H, s, -CH3), 1.42 (lH, m, -CH), 1.66 (lH, m, -CH), 4.15 (lH, m, -CH), 6.35 
(lH, d, J 18.5Hz, BCH), 7.47 (lH, d, J 18.5Hz, :CH), 7.67 (2H, d, J 8.5Hz, ArH), 8.22 
(2H, d, J 8.5Hz, ArH); 8c (75.5 MHz) 23.4 (-CH3), 25.5 (-CH3), 30.9 (-CH3), 46.1 (-
CH2-), 62.8 (-CH), 71.1 (Cq, C(CH3h), 116.3 (b, BCH), 125.4 (ArC), 128.1 (ArC), 
140.4 (Cq, ArC), 148.9 (Cq, ArC), 150.1 (:CH); m/z (Cl+) 293.1671 (75%, M+NH/, 
C14H22BN20/ requires 293.1673) 
4,4,6-Trimethyl-2-[(E)-2-(2-thienyl)ethenyl]-1,3,2-dioxaborinane 27 6g 
light brown oil; isolated 106 mg (77%) from 56JlL 2-bromothiophene; Vmax(film)/cm-1 
1618 (strong, C=C str.), 1510 (strong, aromatic C=C str.), 1328 (strong, B-0 str.), 1250 
(strong, C-B str.), 1150 (strong, C-0 str.), 1031 (medium, C-0 str.); 8H (400 MHz) 1.22 
(3H, s, -CH3), 1.25 (3H, s, -CH3), 1.29 (3H, s, -CH3), 1.42 (lH, m, -CH), 1.66 (1H, m,-
CH), 4.19 (lH, m, -CH), 5.80 (lH, d, J 18.1Hz, BCH), 6.89 (lH, dd, J 5.1, 3.4Hz, 
ArH), 7.09 (lH, d, J 3.4Hz, ArH), 7.34 (lH, d, J 5.1Hz, ArH), 7.59 (lH, d, J 18.1Hz, 
:CH); 8c (125.5MHz) 23.4 (-CH3), 25.7 (-CH3), 30.4 (-CH3), 45.1 (-CH2-), 62.7 (-CH), 
70.5 (Cq, C(CH3h), 113.9 (b, BCH), 127.1 (ArC), 128.9 (ArC), 130.5 (ArC), 142.2 
(Cq, ArC), 147.8 (:CH); mlz (Cl+) 237.1121 (100%, MH+, C12H1sB02S+ requires 
237.1121). 
Methyl (Z)-3-iodo-2-propenoate 214190 
()=o 
M eO 
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Methyl propiolate (2.50 g, 30 mmol), sodium iodide (7.13 g, 48 mmol) and glacial 
acetic acid (10.9 mL, 102 mmol) were stirred at 115 oc under argon for 1 hour. The hot 
reaction was poured into 100 mL of water, and extracted with diethyl ether (50 mL). 
The phases were separated and the aqueous phase extracted with diethyl ether (2 x 
25mL). The combined organic phases were washed with a) saturated Na2C03, b) 
saturated NazSz03 and brine, before drying (MgS04). Concentration gave 214 as a 
colourless oil (4.77 g, 75%) Vmax (neat)/cm- 1 2950 (medium, alpihatic C-H str.), 1730 
(strong, C=O str.), 1600 (strong, C=C str., conj.), 1440 (strong, aliphatic C-H def.), 
1340 (strong, -CH3 sym. def.), 1200 (2 bands, strong, C-0 str.); 8H (300 MHz) 3.8 (3H, 
s, -OCH3), 6.91 (1H, d, J 9Hz, :CHI), 7.55 (lH, d, J 9Hz, Me02C-CH:); 8c (75.5 MHz) 
52.0 (-OCH3), 95.5 (:CHI), 129.9 (MeOzC-CH:), 165.2 (Me02C-); m/z (Cl+) 212.0038 
(100%, MH+, C4H6IO/ requires 212.0036). 
Representative procedure for the formation of amino acrylates 290 
Iodoacrylate (0.7 g, 0.0033 mol) and amine (2 eq.) were refluxed in dry toluene or 
acetonitrile (3 mL) until TLC indicated consumption of iodoacrylate. After this time, 
the cooled reaction was filtered to remove the salts 291, and the filtrate washed with 5% 
HCl and distilled water. The organic phase was dried over MgS04 and concentrated in 
vacuo. Purification by column chromatography (typically 4:1 hexane I ethyl acetate) 
gave the pure amino acrylates; 
Methyl (E)-3-(diethylamino)-2-propenoate 290a191 
0~ 
brown oil; Ymax(film)/cm- 1 1689 (strong, C=O str.), 1607 (strong, C=C str., conj.); 8H 
(300 MHz) 1.15 (6H, t, J 7, 2xCH3); 3.15 (4H, q, J 7, 2xCHz); 3.63 (3H, s, -OCH3); 
4.57 (lH, d, J 13.3, :CH); 7.45 (1H, d, J 13.3, :CH) 8c (75.5 MHz) 15.0 (-CH3); 42.7 (-
CHz-); 50.7 (-OCH3); 83.3 (:CH); 151.4 (:CH); 170.7 (Cq, C=O) mlz (ES+) 158.1178 
(100%, MH+, CsH 16NOz+ requires 158.1181) 
Methyl (E)-3-(dibutylamino)-2-propenoate 290b 
OMe 
o=(_ 
~ 
light yellow oil; Vmax(film)/cm- 1 1689 (strong, C=O str.), 1611 (C=C str., conj.); 8H (300 
Mfiz)0.90 (t, 6H, J 7.5Hz; 2xCH3); 1.2'7 (4H, m, 2xCH2); 1.50 (4H, m, 2xCHz); 3.10 
(4H, bm, 2xCH2); 3.62 (3H, s, -OCH3); 4.50 (lH, d, J 13.2, :CH); 7.41 (lH, d, J 13.2, 
:CH) 8c (75.5 MHz) 14.3 (-CH3-); 20.3 (-CHz-); 29.3 (-CH2-);50.6 (-OCH3-); 55.5 (-
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CHz-); 83.6 (:CH); 152.1 (:CH); 170.5 (Cq, C=O) m/z (ES+) 214.1808 (100%, MH+, 
C12H24N02+ requires 214.1807). 
Methyl (E)-3-[ ethyl(isopropyl)amino]-2-propenoate 290c195 
0~ 
NEt{'Pr) 
yellow oil, Vmax(film)/cm·1 1685 (strong, C=O str.), 1600 (C=C str., conj.); ()H (300 
MHz) 1.10-1.25 (9H, m,); 3.12 (2H, q, 17.5, -CH2); 3.5 (lH, m, 17.5, -CH); 3.65 (3H, 
s, -OCH3); 4.55 (lH, d, 1 13.7, :CH); 7.50 (lH, d, 1 13.7, :CH); 8c (75.5 MHz) 11.7 (-
CHJ); 21.3 (-CH(CH3)2); 40.0 (-NCH2CH3); 47.0 (-CH(CH3)z); 49.3 (-OCH3); 82.1 
(:CH); 148.4 (:CH); 169.4 (Cq, C=O) m/z (ES+) 172.1335 (100%, MH+, C9H1sN02+ 
requires 172.1337). 
Methyl (E)-3-{1-pyrrolidinyl)-2-propenoate 290d191 
0~ 
0 
yellow crystalline solid; Vmax(film)/cm·1 1689 (C=O. str.), 1615 (C=C str., conj.); ()H 
(300 MHz) 1.90 (bm, 4H, 2xCH2); 3.1 (bm, 4H, 2xCH2); 3.60 (3H, s, -OCH3); 4.45 
(1H, d, 1 13.1, :CH); 7.60 (1H, d, 1 13.1, :CH); 8c (75.5 MHz) 24.2 (-CHz-); 49.3 (-
CH2-); 83.2 (:CH); 147.7 (:CH); 168.9 (Cq, C=O); mlz (ES+) 156.1025 (100%, MH+, 
CsH14N02+requires 156.1024). 
Methyl (E)-3-( 4-morpholinyl)-2-propenoate 290e191 
light yellow crystalline solid; Vmax(film)/cm·1 1689 (C=O str.), 1607 (C=C str., conj.); 8H 
(300 MHz) 3.17 (4H, t, 1 7, 2xCH2); 3.65 (7H, m, -OCH3 and 2xCHz); 4.67 (lH, d, 1 
13.4, :CH); 7.33 (lH, d, 1 13.4, :CH) 8c (75.5 MHz) 47.6 (-CH2-); 50.3 (-OCH3); 65.1 
(-CH2-); 84.9 (:CH); 150.8 (:CH); 168.8 (Cq, C=O); m/z (ES+) 172.0969 (100%, MH+, 
CsH14N03 +requires 172.0973). 
Methyl (E)-3-(diisopropylamino )-2-propenoate 290f191 
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light yellow oil; Vmax(film)/cm-1 1689 (C=O str.), 1600 (C=C str., conj.); 8H (300 MHz) 
1.15 (12H, s, 2x-(CH3)2); 3.60 (5H, bs, -OCH3 and 2xCH); 4.65 (lH, d, J 13.5, :CH); 
7.55 (lH, d, 1 13.5, :CH) 8c (75.5 MHz) 20.5 (b, -CH3); 47.0 (-CH-); 49.3 (-OCH3-); 
82.1 (:CH); 146.2 (:CH); 169.4 (Cq, C=O) m/z (ES+) 186.1492 (100%, MH+, 
C10H2oN02 +requires 186.1494). 
Methyl (E)-3-(dibenzylamino)-2-propenoate 290g191 
0~ 
yellow oil; Vmax(film)/cm-1 1693 (C=O str.,), 1607 (C=C str., conj.); 8H (300 MHz) 3.68 
(3H, s, -OCH3); 4.30 (4H, bs, 2xCH2); 4.83 (lH, d, J 13.1, :CH); 7.41-7.13 (10H, m, 
ArH); 7.83 (lH, d, J 13.1, :CH) 8c (75.5 MHz) 37.6 (-CH2-); 51.7 (-OCH3); 85.9 
(:CH); 126.9 (ArC); 128.8 (ArC); 130.1 (ArC); 138.2 (ArCq); 153.2 (:CH); 170.6 (Cq, 
C=O) m/z (ES+) 282.1493 (100%, MH+, C1sH16~02+ requires 282.1494) 
Methyl (E)-3-{1-piperidinyl)-2-propenoate 290h191 
0~ 
0 
yellow powder; Vmax(KBr disc)/cm-1 1705 (C=O str.), 1610 (C=C str., conj.); 8H (300 
MHz) 1.60 (6H, bs, 3xCH2), 3.19 (4H, bs, 2xCH2), 3.65 (3H, s, -OCH3), 4.61 (lH, d, J 
13.1, :CH), 7.40 (lH, d, J 13.1, :CH) 8c (75.5 MHz) 24.5 (-CH2), 25.8 (-CH2), 50.8 (-
OCH3), 52.0 (-CH2), 83.6 (=CH), 152.5 (=CH), 170.9 (Cq, C=O); m/z (ES+) 170.1180 
(100%, MH+, C9H16N02+ requires 170.1181) 
N-Ethyi-N ,N-diisopropyl-2-propanaminium iodide 291c195 
white crystalline solid (70% ); 8H (D20, 300 MHz) 1.28 (t, 3H, J 6.9Hz, CH3CH2-), 1.57 
(18H, m, 3x(-CH3)2), 3.06 (2H, bm, CH3CH2-), 4.52 (3H, bm, 3xCH-); 8c (D20, 75.5 
MHz) 10.1 (-CH3CH2-), 18.7 (-CH3), 49.5 (-CH2-), 57.3 (-CH-); mlz (ES+) 
172.2065(100%, (M-I/, C11 H26N+ requires 172.2059) 
1,1-Dimethylpyrrolidinium iodide 291d231 
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off-white crystalline solid (74%); 8H (DzO, 300 MHz) 2.24 (4H, m, 2x-CH2), 3.38 (6H, 
s, 2xCH3), 3.69 (4H, m, 2xCHz); 8c (DzO, 75.5 MHz) 21.9 (-CH2-), 52.6 (-CH3), 68.7 
(-CH2-); m/z (ES+) 116.1077 (100%, (M-I/, C6H14NO+ requires 116.1075) 
4,4-Dimethylmorpholin-4-ium iodide 291e232 
] 
off-white crystalline solid (86%); 8H (DzO, 300 MHz) 3.16 (6H, s, 2 x CH3), 3.41 (4H, 
t, J 6.28Hz, 2 x CH2-), 3.95 (4H, bm, 2 x -CH2-); 8c (D20, 75.5 MHz) 54.7 (-CH3), 
64.8 (-CH2-), 64.9 (-CHz-); mlz (ES+) 116.1077 (100%, (M-I/, C6H14NO+ requires 
116.1075). 
N-Ethyl-1-ethanaminium iodide 291f195 
Et 
\ + 
H-N-Et l 
I 
H 
white crystalline solid (83%); 8H (D20, 300 MHz) 1.18 (6H, t, J 8.15, 2 x -CH3), 2.98 
(4H, q, J 7.16Hz, 2x -CH2); 8c (D20, 75.5 MHz) 12.1 (-CH3), 44.5 (-CHz-); m/z (ES+) 
74.0966 (100%, (M-I/, C4H12N+ requires 74.0969). 
N-Isopropyl-2-propanaminium iodide 291g195 
white crystalline solid (77%); 8H (D20, 300 MHz) 1.17 (6H, s, 2 x -CH3), 1.19 (6H, s, 2 
x -CH3), 3.40 (2H, m, 2x -CH-); 8c (DzO, 75.5 MHz) 19.8 (-CH3), 48.8 (-CH-); mlz 
(ES+) 102.1281 (100%, (M-I/, C6Hl6~+ requires 102.1283). 
1,1-Dimethylpyrrolidinium iodide 291h195 
off-white solid (72%); 8H (D20, 300 MHz) 1.89 (4H, m, -CHz-), 3.18 (4H, m, -CH2-); 
8c (D20, 75.5 MHz) 24.1 (-CH2-), 46.1 (-CH2-); mlz (ES+) 72.0813 (100%, (M-I/, 
C4H10N+ requires 72.0813). 
Morpholin-4-ium iodide 291i195 
148 
Experimental 
beige solid (72%); 8H (D20, 300 MHz) 2.99 (4H, bs, -CH2-), 3.74 (4H, bs, -CH2-); 8c 
(D20, 75.5 MHz) 44.2 (-CH2-), 65.6 (-CH2-); m/z (ES+) 88.0760 (100%, (M-It, 
C4HwNO+ requires 88.0762). 
N-Benzyl(phenyl)methanaminium iodide 291j 195 
Q\~ 
~ 
yellow solid; 8H (D20, 300 MHz) 4.20 (4H, bs, 2 x -CH2-), 7.43-7.49 (lOH, m, ArH); 
8c (D20, 75.5 MHz) 51.4 (-CH2-), 128.6 (ArC), 129.5 (ArC), 129.9 (ArC), 130.8 (ArC, 
Cq); m/z (ES+) 198.1283 (100%, (M-It, C14H16N+ requires 198.1282) 
Piperidinium iodide 291k195 
off-white solid (91 %); 8H (D20, 300 MHz) 1.56 (2H, m, -CH2-), 1.66 (4H, m, -CH2-), 
3.05 (4H, t, J 6.75Hz, -CHr); 8c (D20, 75.5 MHz) 21.9 (-CH2-), 22.6 (-CH2-), 44.9 (-
CH2-); m/z (ES+) 86.0971 (100%, (M-I)+, C5H12N+ requires 86.0969). 
1-Methylpiperidinium iodide 2911195 
off-white solid (88%) 8H (D20, 300 MHz) 1.55 (2H, m, -CH2-), 1.78 (4H, bm, -CH2-), 
3.00 (3H, bs, -CH3), 3.24 (4H, t, J 6.38Hz, -CH2-); 8c (D20, 75.5 MHz) 21.9 (-CH2-), 
23.9 (-CH2-), 44.7 (-CH3), 57.4 (-CH2-); m/z (ES+) 100.1124 (100%, (M-It, C6H14N+ 
requires 100.1126). 
1-[(Z)-3-Methoxy-3-oxo-1-propenyll-1-methylpyrrolidinium iodide 293d195 
white solid; 8H (400MHz, D20) 2.18 (4H, bm, -CH2-), 3.44 (3H, s, -NCH3), 3.78 (3H, s, 
-OCH3), 3.89 (4H, bm, -CH2-), 6.19 (lH, d, J 9.70 Hz, :CH), 6.65 (lH, d, J 9.70 Hz, 
:CH); 8c (75.5MHz, D20) 21.8 (-CH2-), 50.9 (-NCH3), 53.7 (-OCH3), 68.9 (-CH2-), 
" - - - - - - - -
120.3 (:CH), 147.4 (:CH), 164.6 (Cq, C=O); mlz (ES+) 170.1178 (100%, (M-It, 
C9H16N02+ requires 170.1181) 
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4-[(Z)-3-Methoxy-3-oxo-1-propenyll-4-methylmorpholin-4-ium iodide 293e195 
white solid; ()H (400 MHz, D20) 3.53 (3H, s, NCH3), 3.73 (3H, s, -OCH3), 3.89-4.12 
(8H, bm, 4x-CH2), 6.32 (1H, d, J 10.4Hz, :CH), 6.58 (IH, d, J 10.4Hz, :CH); 8c (75.5 
MHz, 020) 53.7 (-NCH3), 54.2 (-OCH3), 62.1 (-CH2-), 64.1 (-CH2-) 122.0 (:CH), 
140.5 (:CH), 164.3 (Cq, C=O); m/z (ES+) 186.1129 (100%, (M-It, CgHt6N03+ requires 
186.1130). 
1-[(Z)-3-Methoxy-3-oxo-]_-propenyl J-1-methylpiperidinium iodide 2931195 
white solid; ()H (400 MHz, 020) 1.48 (2H, bm, -CH2-) 1.66-1.82 (4H, bm, -CH2-), 3.40 
(3H, s, -NCH3), 3.37-3.46 (4H, bm, -CH2-), 3.74 (3H, s, -OCH3), 6.24 (IH, d, J 10.4Hz, 
:CH), 6.43 (IH, -d, 1 10.4Hz, :CH); 8c (75.5 MHz, 0 20) 20.2 (-CH2-), 21.3 (-CH2-), 
53.8 (-NCH3), 54.1 (-OCH3), 65.7 (-CH2-), 121.0 (:CH), 140.6 (:CH), 164.8 (Cq, 
C=O); mlz (ES+) 184.1337 (100%, (M-It, CwH1sN02+ requires 184.1337) 
1-Ethynyl-4-methyl-2,6,7-trioxabicyclo[2.2.2]octane 301198 
To a solution of oxetane ester 305 (2.00 g, 12.9 mmol) in anhydrous OCM (lOmL) 
stirred at -15 °C under argon was added BF3.Et20 (0.37 mL, 2.9 mmol). The mixture 
was stirred at -15 °C for 18h, then quenched by the addition of Et3N (1.6 mL). After 
diluting with Et20 and filtering, the filtrate was concentrated and filtered through silica 
gel pretreated with Et3N to afford 301 as a white waxy solid; 0,76 g(38%); Ymax(KBr 
disc)/cm- 1 3290 (strong, C-H str. alkyne), 2115 (weak, C=C str.); ()H (300MHz) 0.82 
(3H, s, -CH3), 2.56 (IH, s, -C=CH), 3.98 (6H, s, 3xCHz); 8c (75.5MHz) 14.7 ( -CH3), 
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30.6 (Cq, C(CH20)3, 70.9 (=CH), 73.4 (-CH2-), 77.9 (Cq, C=CH), 101.7 (Cq, 
C(OCH2)3); m/z (ES+) 155.0709 (100%, MH+, CsH1103+ requires 155.0708) 
(3-Methyl-3-oxetanyl)methyl (Z)-3-iodo-2-propenoate 302233 
To a solution of 3-(hydoxymethyl)-3-methyloxetane 303 (2.50 mL, 25.0 mrnol), DCC 
(7.30 g, 35.0 mmol) and DMAP (200 mg) in anhydrous DCM (80 mL) stirred at 0 oc 
under argon was added 304 (5.00 g, 25.0 mmol) over 2.5h. The mixture was diluted 
with DCM (100 mL), filtered to remove the urea by-product, and the filtrate washed 
with a) 1% NH4Cl (30 mL) b) NaHC03 (30 mL) and finally H20 (30 mL). The organic 
phase was dried over MgS04 and concentrated to give a dark brown oil (7.82 g) that 
was double distilled (Kugelrohr, 110 °C, 0.5 rnmHg) to give pure 302 as a yellow oil 
(5.85 g, 82%) Vmax(film)/cm-1 1730 (strong, C=O str.), 1620 (strong, C=C str.); 8H (400 
MHz) 1.37 (3H, s, -CH3), 4.29 (2H, s, -CH2), 4.4 (2H, d, J 6.1Hz, -CH2), 4.54 (2H, d, 1 
6.1Hz, -CH2), 6.91 (1H, d, J 9.9Hz, :CH), 7.49 (1H, d, J 9.9Hz, :CHI); 8c (100 MHz) 
21.2 (-CH3), 39.4 (Cq, -C(CH3)), 69.4 (-CH20), 79.9 (-CH2-), 96.0 (:CHI), 130.0 
(:CH), 164.9 (Cq, C=O); m/z (Cl+) 300.0097 (100%, M+NH/, CsH15IN03+ requires 
300.0097). 
(Z)-3-Iodo-2-propenoic acid 304199 
/)=o 
HO 
To a solution of 55% aqueous HI (20. mL) and H20 (30 mL) was added propiolic acid 
(7.00 g, 100.0 mmol). The mixture was heated at 50 °C for 17h, then cooled and diluted 
with Et20. The layers were separated, and the aqueous layer extracted with Et20. The 
combined organic phases were washed with H20 and dried over MgS04. After 
removing the solvent in vacuo, the residue was washed with cold hexane affording pure 
304 as a pale yellow solid (17.4 g, 88%); m.p. 66-68°C, lit. value 66-67°C; 199 Vmax(KBr 
disc)/cm-1 3120-2560 (several strong bands, 0-H str. H-bonding), 1727 (C=O str.), 1612 
(C=C str.); 8H (300 MHz) 6.98 (lH, d, J 9.8Hz, :CH), 7.71 (lH, d, J 9.8Hz, :CHI), 11.9 
(lH, s, -OH); 8c (75.5 MHz) 99.0 (:CHI), 129.9 (:CH), 170.6 (Cq, C=O); mlz (Cl+) 
215.9520 (100%, M+NH4+, C3I-hiN02+ require-s 215.9522) 
(3-Methyl-3-oxetanyl) methyl propiolate 305198 
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To a solution of 3-(hydoxymethyl)-3-methyloxetane (20.0 g, 196.0 mmol), DCC (57.0 
g, 276.0 mmol) and DMAP (1.2 g) in anhydrous DCM (80 mL) stirred at 0 °C under 
argon was added propiolic acid (13.8 g, 196.0 mmol) over 2.5h. The mixture was 
diluted with DCM (100 mL), filtered to remove the urea by-product, and the filtrate 
washed with a) 1% NH4Cl (250 mL) b) NaHC03 (250 mL) and finally H20 (250 mL). 
The organic phase was dried over MgS04 and concentrated to give a dark red oil (26.3 
g) that was distilled (75 °C, 0.5 mmHg) to give pure 305 as a colourless oil (15.9 g, 
53%) Vmax(film)/cm-1 3297 (strong, C-H alkyne str.), 2120 (weak, C=C str.), 1715 (C=O 
str.); 8H (300 MHz) 1.37 (3H, s, -CH3), 2.96 (lH, s, =CH), 4.29 (2H, s, -CH2-), 4.43 
(2H, d, J 6Hz, -CH2), 4.52 (2H, d, J 6Hz, -CH2); 8c (75.5 MHz) 21.1 (-CH3), 39.4 (Cq, 
-C(CH3)), 68.4 (-CH2), 74.7 (=CH), 75.9 (Cq, =C-), 79.7 (-CH2-), 153.1 (Cq, C=O); 
m/z (ES+) 155.0707 (100%, MH+, CsH1103 +requires 155.0708) 
(Z)-3-Iodo-2-propenoyl chloride 306234 
Cl~ 
I 
Oxalyl chloride (6.00 mL, 0.067 mol) was added dropwise with stirring to a solution of 
304 (5.00 g, 0.025 mol) in anhydrous DCM (60mL). After stirring at room temperature 
for 12h, the solvent was removed in vacuo, giving a noxious and lachrymatory light 
brown liquid (5.13 g, 94%) that was used without further purification. An analytically 
pure sample was obtained by distillation (75 °C, 0.5 mmHg); Vmax(film)/cm-1 1734 
(strong, C=O str.), 1605 (C=C str.); 8H (300 MHz) 7.13 (lH, d, J 8.9Hz, :CH), 8.45 
(lH, d, J 8.9Hz, :CHI); 8c (75.5 MHz) 108.8 (:CHI), 140.7 (:CH). 164.3 (Cq, C=O); 
m/z (CI+).233.9180 (100%, M+NH/, C3H6NOICl+ requires 233.9183) 
3-Methyl-3-butenyl (Z)-3-iodo-2-propenoate 308 
~0~ 
I 
To a solution of 304 (5.00 g, 0.023 mol) in anhydrous DCM (20 mL) cooled to 0 °C was 
added 3-methyl-3-buten-1-ol 307 (2.33 mL, 0.023 mol) followed by Et3N (3.11 mL, 
0.023 mol) dropwise. The reaction was stirred at RT for lh, after which time 1H NMR 
indicated the reaction was complete. The reaction was diluted with DCM, washed with 
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5% HCl (50mL) and brine, before being dried over MgS04. Removal of solvents in 
vacuo gave a brown oil that was doubly-distilled (Kugelrohr, 75-85 °C, 0.5 mmHg) to 
give the title compound as a yellow liquid 2.56 g ( 42% ); Ymax(film)lcm· 1 1725 (strong, 
C=O str.), 1630 (strong, C=C str.), 1611 (medium, C=C str.); 8H (300 MHz) 1.76 (3H, s, 
-CH3), 2.39 (2H, t, J 6.9Hz, -CH2-), 4.31 (2H, t, J 6.9Hz, -CH20-), 4.78 (lH, s, :CH), 
4.84 (1H, s, :CH), 6.91 (lH, d, J 8.9Hz, :CH), 7.46 (lH, d, J 8.9Hz, :CHI); 8c (75.5 
MHz) 22.9 ( -CH3), 37.0 ( -CH2-), 63.4 (-CH20-), 95.4 (:CHI), 113.4 (:CH2), 141.8 (Cq, 
C:CH2), 164.9 (Cq, C=O); mlz (Cl+) 284.0146 (100%, M+NH4+, C8H15IN02 +requires 
284.0148) 
2-(2-Methyl-2-oxiranyl)ethyl (Z)-3-iodo-2-propenoate 309 
A solution of iodo-ester 308 (250 mg, 0.94 mmol) in dry DCM (5mL) was treated 
portionwise with m-CPBA (284 mg, 1.5eq of a 57% wlw peroxide mixture) at 0 °C. 
The mixture was at RT for 5h, then cooled to 0 oc and filtered. The filtrate was washed 
with 5% KOH solution, and brine. The organic phase was dried and concentrated in 
vacuo to give a crude oil that was purified by column chromatography (Si02, 1:1 Et20 I 
hexane) to yield pure epoxyester 309 as a light yellow oil: 143 mg (53%), 
Ymax(film)lcm· 1 1728 (strong, C=O str.), 1627 (strong, C=C str.); 8H (400 MHz) 1.36 
(3H, s, -CH3), 2.04 (2H, m, -CH2-), 2.60 (1H, d, J 4.7Hz, -CH), 2.69 (lH, d, J 4.7Hz, -
CH), 4.31 (2H, t, J 6.6Hz, -CH20-), 6.91 (lH, d, J 8.8Hz, :CH), 7.47 (1H, d, J 8.8Hz, 
:CHI); 8c (75.5 MHz) 20.9 (-CH3), 38.8 (-CH2-), 54.8 (Cq, C(CH3)), 55.9 (-CH2-), 63.1 
(-CH20-), 95.8 (:CHI), 131.1 (:CH), 164.7 (Cq, C=O); m/z (Cr+) 300.0093 (100%, 
M+NH4 +, CsHtslN03 +requires 300.00,97) 
Methyl (2Z)-2,4-pentadienoate 311235 
=.F);-oMe 
0 
Iodoacrylate 214 (0.33 mL, 2.95 mmol) and palladium acetate (66 mg, 10 mol%) were 
dissolved in dry MeCN (5mL). Silver carbonate (1.2 g, 1.5 eq.) and vinylboronate 122 
(1.4 mL of a 60% solution in THF, 2 eq.) were added and the mixture degassed 
thoroughly, before being allowed to stir under Ar at ambient temperature overnighl. 
The reaction was diluted with MeCN (10 mL), filtered through a cotton wool plug, 
washed with 5% HCl (2 x 25 mL) and brine (2 x 20 mL), and the organic layer was 
dried over MgS04. Concentration gave a dark yellow oil that was purified by 
chromatography following adsorption onto silica gel (6: 1 hexane I ethyl acetate as 
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eluant). Gave the Suzuki product 311 exclusively as a pale yellow oil; 224 mg (68% ); 
Vmax(film)/cm-1 1710 (strong, C=O stc), 1625 (medium, C=C str.); OH (400 MHz) 3.41 
(3H, s, -OMe), 5.47 (lH, d, J 11.2Hz, :CH), 5.55 (lH, dd, J 10.5, 1.8Hz, :CH), 5.66 
(1H, dd, J 16.8, 1.8Hz, :CH), 6.63 (lH, dd, J 16.8, 10.5Hz, :CH); 6.89 (1H, d, J 11.2Hz, 
:CH); 8c (75.5 MHz) 50.3 ( -OMe), 116.50 (:CH2), 117.9 (:CH), 132.6 (:CH). 137.6 
(:CH), 170.2 (Cq, C=O); m/z (Cl+) 113.0602 (90%, MH+, C6H90 2+ requires 113.0602). 
(2R)-3-Methyl-2-{[( 4-methylphenyl)sulfonyl]amino }butanoic acid (N-Ts-D-Val) 324 
HO y ~NHTs 
0 
To a stirred suspension of D-valine (10.0 g, 85.0 mmol) in H20 (100 mL) cooled 0 oc 
was added solid NaOH (3.50 g, 85.0 mmol) portionwise. p-toluenesulfonyl chloride 
(16.3 g, 85 mmol) was added, and the solution stirred at room temperature for 3h 
(during the course of the reaction, a pH of 9 was maintained by the addition of 10% 
NaOH solution). The reaction was then filtered and the filtrate acidified with 10% HCl 
solution to pH 5. Filtration gave 324 as white powder after drying (98%) analytical data 
was consistent with that reported.236 
Butyl 2-methoxyacetate 325237 
0 
~~OMe 0 
To a solution of pyridine (7.5 mL, 95.0 mmol), n-butanol (8.3 mL, 90.0 mmol) and dry 
DCM (100 mL) stirred at 0 °C under argon was added methoxyacetyl chloride (10.0 g, 
90 mmol) dropwise. The mixture was refluxed for 1 hour then cooled to room 
temperature and filtered. The filtrate was washed with 5% HCl, brine, and finally water. 
After drying (MgS04) and concentration of the combined organic phases, pure 325 was 
obtained (11.3 g, 84 %) Dmax (neat)/cm-1 3000 (strong, aliphatic C-H str.), 1760 (strong, 
C=O str.), 1480 (strong, C-H def.), 1190 (strong, 2 bands, C-0 str.); OH (300 MHz) 0.90 
(3H, t, J 6.9Hz, -CH3), 1.35 (2H, m, -CH2-), 1.65 (2H, m, -CH2-), 3.45 (2H, s, -CH2-), 
3.97 (3H, s, -OCH3), 4.15 (2H, t, J 6.9Hz, -CH2-) ; 8c (75.5 MHz) 13.7 (-CH2CH3), 
19.2 (-CH2CH3), 31.2 (CH3CH2CH2-), 59.3 (-OCH3), 64.7 (CH3CH2CH2CH2-0), 69.7 
(-CH20CH3), 170.4 (Cq, C=O) m/z (Cl+) 164.2218 (M+NH4, 100%, CnH1sN03+ 
requires 164.2230) 
tert-Butyl 4-methoxy-3-oxobutanoate 327 
0 0 
MeoJJ0X 
!54 
Experimental 
To a solution of dry diisopropylamine (6.5 mL, 47.3 mmol) in anhydrous THF (15 mL) 
stirred at 0 °C under argon was added n-BuLi (19.0 mL of a 2.5 mL solution in hexanes, 
47.5 mmol) dropwise. The mixture was stirred for 0.5h, and the temperature reduced to 
-78 °C. Distilled tert-butyl acetate was added (5.8 mL, 43.0 mmol) dropwise and the 
reaction stirred for 10 minutes. Distilled methyl methoxyacetate (4.26 mL, 43.0 mmol) 
was added dropwise and the reaction stirred at -78 °C for 2h. The reaction was warmed 
to room temperature before quenching by the addition of 5% HCl (10 mL). After 
extracting into Et20 and washing with 5% HCl (50 mL) and H20 (50 mL), separation 
and concentration of the organic phase gave crude 327 that was distilled (95-100 °C, 0.5 
mmHg) to yield pure 327 (6.21 g, 77%) Vmax (neat)/cm- 1 2979-2825 (several bands, 
medium, C-H. str.), 1748 (strong, C=O str. ester), 1726 (medium, C=O str. ketone), 
1656 (weak, C=C str. enol), 1367 (strong, -C(CH3h C-H str. ), 1152 (medium, C-0 
str.); OH (300 MHz) 1.42 (9H, s, 3x(CH3h), 3.47 (2H, s, -CH2-), 3.48 (3H, s, -OCH3), 
4.11 (2H, s, -CH2-); oc (100 MHz) 28.3 ((CH3)3), 47.5 (-CH2-), 59.7 (-OCH3), 81.5 
(Cq, -C(CH3)3), 75.7 (-CH2-), 166.5 (Cq, C=O ester), 202.3 (Cq, C=O ketone); m/z 
(FAB) 377 (10%, 2M+H+), (ES+) 189.1127 (100%, MH+, C9H170/requires 189.1127). 
Methyl 4-bromo-3-oxobutanoate 328238 
0 0 
Br 11 11 ~OMe 
To a solution of methyl acetoacetate (18.6 mL, 170.0 mmol) in CHCh (lOO.OmL), 
cooled to 0 °C and stirred under argon, was added Br2 (8.8 mL, 160.0 mmol) as a 
solution in CHCh (50.0 mL) dropwise. The reaction was stirred overnight at room 
temperature, and after this time air was passed through the solution for 2h. The 
remaining solvent was removed in vqcuo, and the resulting liquid distilled (Kugelrohr 
80 °C, 0.6 mmHg) to give 328 as a colourless oil (33.2 g, 98%) Vmax(neat)/cm-1 1748 
(strong, C=O str. ester), 1724 (medium, C=O str. ketone), 1633 (weak, C=C str. enol); 
OH (400 MHz) keto form 3.72 (2H, s, -CH2-), 3.79 (3H, s, -OCH3), 4.08 (2H, s, -CH2Br) 
enol form 3.81 (3H, s, -OCH3), 3.90 (2H, s, -CH2Br), 5.30 (lH, s, :CH); oc (100 MHz) 
keto form 34.4 (-CH2Br), 46.5 (-CH2-), 52.8 (-OCH3), 167.9 (Cq, C=O ester), 195.0 
(Cq, C=O ketone) enol form 42.3 (-CH2Br), 52.1 (-OCH3), 92.2 (:CH), 167.0 (:COH), 
172.8 (Cq, C=O ester); m/z (Cl+) 211.9922 (M+NH/, 100%, CsHt1Br03N+ requires 
211.9922) 
Methyl 4umethoxyu3uoxobutanmllte 329211 
0 0 
M eO~ 
OMe 
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To a boiling suspension of sodium methoxide (8.5 g, 160 mmol) in anhydrous THF 
(200 mL) was added bromoketoester 328 (10.0 g, 50 mmol) dropwise. After refluxing 
for 10 minutes, the reaction was cooled, neutralized with 20% HCl, filtered, and 
concentrated in vacuo. The residue was poured into water (150 mL) and extracted with 
DCM (100 mL). The organic layer was separated, dried over MgS04 and concentrated 
to give a yellow oil that was purified by double distillation (85 cc, 0.3 mmHg) to give 
pure 329 as a pale yellow oil (5.04 g, 67%) Vmax(film)/cm-1 1747 (strong, C=O str. 
ester), 1729 (medium, C=O str. ketone), 1657 (weak, C=O str. H-bonded enol chelate), 
1633 (weak, C=C str. enol); 8H (300 MHz) keto form 3.35 (3H, s, -OCH3), 3.46 (2H, s, -
CHz-), 3.68 (3H, s, -OCH3 ester), 4.05 (2H, s, -CH2-) enol form 2.20 (lH, s, -OH, 
exchanges with D20), 3.41 (3H, s, -OCH3), 3.70 (-OCH3 ester), 3.91 (2H, s, -CH2-), 
5.19 (lH, s, :CH); 8c (100 MHz) keto form 46.2 (-CH2-), 52.7 (-OCH3 ester), 59.5 (-
OCHJ), 77.8 (-CH2-), 167.8 (Cq, C=O), 202.0 (Cq, C=O ketone) enol form 51.7 (-
OCH3 ester), 61.8 (-OCH3), 71.5 (-CH2-) 103.9 (:CH), 174.3 (Cq, C=O ester) 184.27 
(Cq, =COH); m/z (Cl+) 164.0925 (100%, M+NH/, C6H 14NO/ requires 164.0923) 
tert-Butyl 5-hydroxy-4-methoxy-6-methyl-3-oxo-6-heptenoate 330 via dienolate 
To a stirred solution of dry diisopropylamine (1.45 mL, 10.5 mmol) in anhydrous THF 
(20.0 mL) stirred at 0 cc under argon was added n-BuLi (4.3 mL of a 2.5M solution in 
hexanes, 10.8 mmol) dropwise. The reaction was stirred for 0.5h, and the temperature 
lowered to -78 cc. Tert-butyl 4-methoxy-3-oxobutanoate 327 (1.00 g, 5.28 mmol) was 
added dropwise and the reaction was stirred for 30 minutes. Methacrolein (0.46 mL, 
5.28 mmol) was added dropwise and the reaction stirred at -78 cc for a further 2h. The 
reaction was warmed to room temperature, quenched by the addition of saturated 
NaHC03 (2 mL), diluted with Et20, and the organic layer separated. After washing 
with saturated NaHC03 (15 mL) and brine (15 mL), the combined organic phases were 
dried over MgS04 and concentrated to give a crude mixture of 330. Purification by 
column chromatography (silica gel, 4:1 petroleum ether I ethyl acetate as eluant) gave 
pure 330 as the major product; pale yellow oil (1.05 g, 77%) Vmax (film)/cm-1 3456 (b., 
0-H str.), 2979-2925 (several strong bands, C-H. str.), 1716 (strong, C=O str. ketone), 
1649 (weak, C=C str. enol), 1367 (strong, -C(CH3)3 C-H str.), 1159 (2 bands, medium, 
C-0 str.); 8H (400 MHz) 1.45 (9H, s, 3x(CH3h), 1.79 (3H, d, J 4.5Hz, :CH(CH3)), 2.60 
(lH, bs, -OH, exchanges with D20), 3.45 (2H, s, -CH2-), 3.50 (3H, s, -OCH3), 3.80 (lH, 
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d, J 4.5Hz, -CH(OMe)), 4.31 (lH, d, J 4.5Hz, -CH(OH)), 5.05 (1H, d, J 8.1Hz, :CH), 
5.09 (lH, d, J 8.1Hz, :CH); 8c (100 MHz) 17.9 (:CH(CH3), 26.9 (-C(CH3)3), 46.4 (-
CH2-), 58.9 (-OCH3), 74.3 (-CH(OH)), 79.6 (Cq, -C(CH3)3), 86.8 (-HC(OCH3), 112.0 ( 
:CHz), 142.4 (Cq, -C:CH2), 165.7 (Cq, C=O ester), 204.0 (Cq, C=O ketone); m/z 
(FAB+) 297 (MK+, 100%), 259 (MH+, 60%); (ES+) 259.1544 (100%, MH+, C13H230 5+ 
requires 259.1545). 
Methyl 5-hydroxy-4-methoxy-6-methyl-3-oxo-6-heptenoate 331 via lithium 
dienolate 
~OMo 
OMe 
Prepared and purified by the procedure described above for 330; pale yellow oil (72%) 
Ymax(neat)/cm- 1 3459 (b., 0-H str.), 2790 (several strong bands, C-H str.), 1725 (strong, 
C=O str. ketone), 1650 (weak, C=C str. enol), 1188 (2 bands, medium, C-0 str.); 8H 
(300 MHz) 1.78 (3H, t, J 4.55Hz, :C(CH3)), 2.85 (lH, bs, -OH exchanges with D20), 
3.42 (2H, s, -CH2-), 3.51 (3H, s, -OCH3), 3.75 (3H, s, -OCH3), 3.82 (lH, m, -
CH(OCH3)), 4.30 (1H, m, -CH(OH)-), 5.09 (lH,d, J 8.5Hz, :CH), 5.13 (1H, d, J 8.5Hz, 
:CH); 8c (75.5 MHz) 17.9 (:CH(CH3)), 45.4 (-CH2-), 51.3 (-C02CH3), 59.0 (-OCH3), 
73.1 (-CH(OH)), 86.7 (-CH(OCH3)), 112.8 (:CH2), 142.2 (:Cq), 166.8 (C=O ester, Cq), 
203.7 (C=O ketone, Cq); m/z (ES+) 217.1076 (100%, MH+, CwHn05+ requires 
217.1076). 
tert-Butyl 5-hydroxy-4-methoxy -3,6-dioxoheptanoate 332 
r!)Lto~ 
0 OMe 
A solution of aldol adduct 330 (2.00 g) in dry DCM ( 15 mL) was cooled to -78 oc and 
saturated with 0 3 (until the blue-purple colour persisted). Oxygen was then passed 
through the solution for a further 5 minutes, after which time anhydrous methyl sulfide 
(2mL) was added dropwise with stirring. The solution was then allowed to warm to 
room temperature, and was concentrated in vacuo. The residue was purified by column 
chromatography (silica gel, 3:1 hexane I EtOAc as eluant) affording pure 332 (1.98 g, 
98%); Ymax(neat)/cm- 1 3467 (b, strong, 0-H str.), 2990-2919 (several strong bands, C-H 
str.), 1721 (strong, C=O str. ester), 1716 (strong, C=O str. ketone), 1651 (weak, C=C 
str. enol), 1365 (strong, -C(CH3)3, C-H str.), 1160 (2 bands, medium, C-0 str.); 8H (300 
MHz) 1.49 (9H, s, 3 x -CH3), 2.27 (3H, s, -CH3), 2.72 (lH, bs, -OH, exchanges with 
D20), 3.335 (2H, s, -CH2-), 3.54 (3H, s, -OCH3), 4.18 (lH, m, -CH(OMe)), 4.52 (lH, 
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m, -CH(OH)); 8c (75.5 MHz) 26.7 ( -CH3), 28.6 ( -C(CH3)3), 48.0 ( -CH2-), 60.8 (-
OCH3), 77.4 (CH(OH)), 82.5 (C(CH3)3), 87.7 (CH(OCH3)), 166.8 (C=O ester, Cq), 
203.8 (C=O ketone, Cq), 206.2 (C=O ketone, Cq); m/z (ES+) 278.1605 (100%, 
(M+NH4t· C12H24N06+ requires 278.1604. 
4-(tert-Butoxy)-1-methoxy-4-[( trimethylsilyl)oxy]-3-buten-2-one 333 
OTMS 
Me0~0X 
procedure followed as for 334; distillation (Kugelrohr, 95-100 °C, 0.6 mmHg) gave 333 
as a colourless oil (87% ); Vmax (film)/cm· 1 1719 (strong, C=O str.), 1638 (medium, C=C 
str.), 1245 (medium, C-0 str.), 846 (strong, SiMe3); 8H (300 MHz) E isomer: 0.014 
(9H, s, -SiCH3), 1.20 (9H, s, 2 X -CH3), 3.10 (3H, s, -OCH3), 4.18 (2H, s, -CH2), 4.92 
(lH, s, :CH) Z isomer: 0.02 (9H, s, -Si(CH3)3), 1.21 (9H, s, 3 x C(CH3)3), 3.11 (3H, s,-
OCH3), 3.49 (2H, s, -CH2), 5.02 (IH, s, :CH); 8c (75.5 MHz) 0.70 (-Si(CH3)3), 27.7 (3 
X -CH3), 58.7 (-OCH3), 68.8 (-CH2-), 78.5 (-C(CH3)3, Cq), 127.6 (:CH), 161.0 (:C, 
Cq), 166.0 (C=O, Cq). 
1,4-Dimethoxy-4-[(trimethylsilyl)oxy]-3-buten-2-one 334211 
OTMS
0
. 
M eO~ 
OMe 
To a fine suspension of anhydrous zinc chloride (135.0 mg) in anhydrous Et3N (10.3 
mL, 74.0 mmol) was added methyl4-methoxy-3-oxobutanoate 329 (5.00 g, 34.0 mmol) 
as a solution in anhydrous toluene (25 mL). The mixture was cooled to 0 °C, and TMS 
chloride (8.57 mL, 68.0 mmol) added slowly (2h). The reaction was stirred for 16h at 
45 °C, and was then filtered, concentrated, and diluted with pet. ether (100 mL). After 
repeating this operation twice, the r.esidue was distilled (Kugelrohr, 80-90 °C, 0.5 
mmHg) to yield 334 as a pale yellow liquid (6.03 g, 81% ); analytical data was 
consistent with that reported; 8c (100 MHz) 0.4 (-Si(CH3)3), 50.3 (-OCH3 ester), 58.1 (-
CH3), 73.1 (-CH2-), 128.5 (:CH), 162.7 (:CH, Cq), 167.1 (C=O ester, Cq). 
4-(tert-Butoxy)-2,4-bis[(trimethylsilyl)oxy]-1,3-butadienyl methyl ether 335 
Procedure was carried out as for 336 above; yield typically 83%; pale yellow oil 
. ·-
(Kugelrohr, 115-125 °C, 0.5 mmHg); Vmax (film)/cm· 1 1677 (strong, C=C str. enol 
ether), 1617 (strong, C=C str: conj), 1367 (strong, -C(CH3)3 C-H str.), 1248 (strong, 
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SiMe3), 1215 (medium, C-0 str.), 844 (strong, SiMe3); major isomer: bH (300 MHz) 
0.27 (9H, s, -Si(CH3)3), 0.33 (9H, s, -Si(CH3)J), 1.41 (9H, s, -C(CH3)3), 3.48 (3H, s,-
OCH3), 4.83 (lH, s, :CH),5.70 (IH, s, :CH); be (75.5 MHz) -0.60 (-Si(CH3)3), 0.3 (-
Si(CH3h), 27.8 (C(CH3)3), 59.3 (-CH3), 78.5 (C(CH3)3), 84.2 (:CH), 100.5 (:CH), 
132.9 (:CH, Cq), 150.8 (:CH, Cq). NB: Due to the instablility of 335 and 336, a 
thorough analysis could not be obtained. 
1,4-Dimethoxy-3-[( trimethylsilyl)oxy]-1,3-butadienyl trimethylsilyl ether 336211 
To a solution of diisopropylamine (2.23 mL, 11.0 mmol) in dry THF (20 mL) cooled to 
0 oc and stirred under argon was added n-BuLi (4.8 mL of a 2.6M solution in hexanes, 
11.5 mmol) dropwise. After stirring for 0.5h, the temperature was reduced to -78 °C. A 
solution of 334 (2.5 g, 11.0 mmol) in dry THF (5 mL) was added over 2h, followed by 
TMS-Cl (1.45 mL, 11 mmol) over 2h. After stirring for O.Sh, the solution was allowed 
to warm to room temperature and was concentrated in vacuo. The residue was treated 
with pet. ether (30 mL) and filtered. After repeating this operation, the residue was 
distilled (Kugelrohr, 75-85 °C, 0.6 mmHg) to give 336 as a pale yellow liquid (72%). 
Analytical data obtained was in accord with that published; be (75.5MHz) -0.6 (-
Si(CH3h), 0.3 (-Si(CH3)3), 27.8 (C(CH3)3), 59.3 (-CH3), 78.5 (C(CH3)3), Cq), 84.2 
(:CH), 100.5 (:CH), 132.9 (:CH, Cq), 150.8 (:CH, Cq). 
Typical procedure for the oxazaborolidine promoted asymmetric aldol reaction 
To a solution of N-Ts-D-valine 324 (0.20 g, 25 mol%, 0.75 mmol) in dry DCM (lOmL) 
was added BH3 (0.75 mL of a l.OM solution in THF, 25 mol %, 0.75 mmol) dropwise 
over 0.5h. The mixture was stirred for a further 0.5h, and the temperature lowered to -78 
°C. Methacrolein (0.26 mL, 3.00 mmol) was added dropwise, followed by a solution of 
335 (1.00 g, 3.00 mmol) in dry DCM (5 mL). The reaction was stirred for 6h at -78 °C 
then warmed to room temperature and stirred for a further 16h. After this time, 
saturated NaHC03 (3 mL) was added and the reaction stirred for a further 0.5h. The 
reaction mixture was diluted with DCM (20 mL), and the organic layer was washed 
with brine (20 mL), dried over MgS04 and concentrated in vacuo. The residue was 
treated with cold hexane and filtered to recover the N-Ts-0-valine (with typically 90% 
recovery).-Tlfe- solution w-as ·re-concentrated in vacuo, and the residue diluted with THF 
(25 mL), cooled to 0 °C, and treated dropwise with a 10% aqueous solution of TFA (5 
mL). After stirring for 2h, the solution was warmed to room temperature and 
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partitioned between Et20 and H20. The organic layer was washed with saturated 
NaHC03 solution (20 mL) and finally brine (20 mL), before being dried over MgS04 
and concentrated in vacuo. Purification by column chromatography (silica gel, 4:1 
hexane I EtOAc as eluant) gave the aldol product as the major component (0.59 g, 
76% ); analytical data was consistent with that obtained for 330. Yield from 1,4-
dimethoxy-3-[(trimethylsilyl)oxy]-1,3-butadienyl trimethylsilyl ether 336 0.49 g (66%); 
analytical data consistent with that obtained for 331. 
tert-Butyl (E)-5-hydroxy-4-methoxy-3-oxo-7-phenyl-6-heptenoate 337 
obtained from 0.75 mmol of diene 335: bright yellow oil (215 mg, 90% ); Vmax(film)/cm· 
1 3450 (b, 0-H str.), 3025-3009 (medium, several bands, C-H str.), 1715 (strong, C=O 
str.), 1600 and 1515 (strong, C=C str.), 1365 (strong, -C(CH3)3 C-H str. ), 1160 (strong, 
C-0 str.); 8H (400MHz) 1.39 (9H, s, -C(CH3)3), 2.82 (lH, bs, -OH, exchanges with 
D20), 3.42 (2H, s, -CH2-), 3.51 (3H, s, -OMe), 3.72 (lH, m, -CH(OMe), 4.65 (1H, m,-
CH(OH)), 6.18 (lH, m, :CH), 6.62 (lH, d, J 14.7Hz, :CH), 7.23-7.31 (5H, m, ArH); 8c 
(100 MHz) 28.4 (-C(CH3)3), 47.8 (-CH2-), 59.8 (-OCH3), 73.3(-CH(OH)), 82.3 (-
C(CH3)3), 89.6 (-CH(OCH3)), 126.6 (ArC), 126.9 (ArC), 127.6 (ArC), 128.9 (ArC), 
129.4 (ArC), 136.5 (Cq, ArC), 166.3 (Cq, C=O ester), 204.2 (Cq, C=O ketone); m/z 
(ES+) 343.1519 (100%, M+Na+, C18H240sNa+ requires 343.1522) 
tert-Butyl (E)-5-hydroxy-4-methoxy-3-oxo-6-nonenoate 338 
~0-~-
0Me 
obtained from 0.75 mmol of diene 335: light yellow oil (151 mg, 77%); Vmax(film)/cm·' 
3466 (b., 0-H str.), 2787 (several strong bands, C-H str.), 1720 (strong, C=O str. 
ketone), 1646 and 1620 (weak, C=C str.), 1362 (strong, -C(CH3)3 C-H str.), 1185 (2 
bands, medium, C-0 str.); 8H (300 MHz) 0.96 (3H, t, J 7.1Hz, -CH3), 1.45 (9H, bs, -
C(CH3)3), 1.99 (2H, m, -CH2CH3), 2.83 (lH, bs, -OH), 3.45 (2H, s, -CHz-), 3.51 (3H, s, 
-OCH3), 3.81 (lH, m, -CH(OMe)), 4.46 (lH, m, -CH(OH)), 5.45 (lH, dd, J 16.9, 
7.1Hz, :CH), 6.03 (lH, td, J 6.6, 16.9Hz, :CH); 8c (75.5 MHz) 14.5 (-CH3), 24.6 (-
CH2CH3), 26.8 ( -C(CH3)3), 46.5 ( -CHz-), 59.7 ( -OCH3), 73.4 (-CH( OH)), 80.6 (-
C(CH3)3), 86.7 (-C(OMe)), 131.6 f:CH), 136.1 ~:CH), 166.5 (Cq, C::_O ester), 203.8_ 
(Cq, C=O ketone); mlz (ES+) 273.1705 (100%, MH+, C,4Hzs0s+ requires 273.1702). 
tert-Butyl 5-hydroxv-4-methoxy-3-oxoheptanoate 339 
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obtained from 0.75 mmol of diene 335: light yellow oil (127 mg, 72%); Vmax(film)/cm- 1 
3457 (b_, 0-H str.), 2790 (several strong bands, C-H str.), 1725 (strong, C=O str. 
ketone), 1650 (weak, C=C str. enol), 1365 (strong, -C(CH3)3 C-H str.), 1188 (2 bands, 
medium, C-0 str.); OH (400 MHz) 0.97 (3H, t, J 6.9Hz, -CH3), 1.47 (9H, bs, -C(CH3)3), 
1.55 (2H, m, -CH2CH3), 2.87 (lH, bs, -OH exchanges with D20), 3.48 (2H, s, -CH2-), 
3.52 (3H, s, -CH3), 3.77 (lH, m, -CH(OMe)), 4.33 (lH, m, -CH(OH)); Oc (100 MHz) 
10.8 (-CH3), 26.8 (-CH2CH3), 27.8 (-C(CH3)3), 47.1 (-CH2-), 59.9 (-OCH3), 74.7 (-
CH(OH)), 80.1 (-C(CH3)3), 86.9 (-CH(OMe)), 166.6 (Cq, C=O ester), 203.9 (Cq, C=O 
ketone); m/z (Cr+) 264.1810 (100%, M+NH/, C12H26N05+ requires 264.1811) 
tert-Butyl 5-hydroxy-4-methoxy-5-( 4-methoxyphenyl)-3-oxopentanoate 340 
OH 0 0 
~0~ 
M eO 
obtained from 0.75 mmol of diene 335: light yellow oil (183 mg, 78%); Vmax(film)/cm- 1 
3450 (b., 0-H str.), 3040-3025 (medium, Ar-H str.aromatic), 1733 (strong, C=O str. 
ketone), 1656 (weak, C=C str. enol), 1369 (strong, -C(CH3)3 C-H str.), 1168 (2 bands, 
medium, C-0 str.); OH (500MHz) 1.48 (9H, s, -C(CH3)3), 2.77 (lH, bs, -OH exchanges 
with D20), 3.49 (2H, s, -CH2-), 3.52 (3H, s, -OCH3), 3.80 (3H, s, Ar0CH3), 3.91 (lH, 
m, -CH(OMe)), 4.66 (CH(OH)), 6.88 (2H, d, J 8.1Hz, ArH), 7.08 (2H, d, J 8.1Hz, 
ArH); Oc (75.5 MHz) 27.1 (-C(CH3)3), 46.9 (-CH2-), 56.1 (Ar-OCH3), 77.3 (-CH(OH)), 
80.8 (Cq, -C(CH3)3), 89.1 ( -CH(OMe)), 114.6 (ArC), 129.6 (ArC), 139.3 (Cq, ArC), 
158.7 (Cq, ArC), 165.0 (Cq, C=O est~r), 205.0 (Cq, C=O ketone); m/z (ES+) 347.1469 
(100%, M+Na+, C17H2406Na+ requires 347.1471) 
tert-Butyl 5-hydroxy-4-methoxy-6-methyl-3-oxoheptanoate 341 
obtained from 0.75 mmol of diene 335: pale yellow oil (126 mg, 67%); Vmax(film)/cm- 1 
3459 (br., 0-H str.), 2790 (several strong bands, C-H str.). 1725 (strong, C=O str. 
ketone), 1654 (weak, C=C str. enol), 1365 (strong, -C(CH3)3 C-H str.), 1188 (2 bands, 
medium, C-0 str.); OH (300 MHz) 0.89 (3H, s, -CH3), 0.92 (3H, s, -CH3), 1.39 (9H, bs, 
C(CH3)3), 2.19 (lH, m, -CH), 2.58 (lH, bs, -OH, exchanges with D20), 3.39 (2H, s,-
CH2-), 3.41 (3H, s, -OCH3), 3.83 (lH, m, -CH(OMe)), 4.21 (lH, m, -CH(OH)); Oc 
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(75.5 MHz) 18.4 (-CH3), 20.7 (-CH3), 27.8 (C(CH3)3), 30.2 (CH), 46.6 (-CH2-), 60.1 (-
OCH3). 71.2 (CH(OH)), 82.2 (Cq, -C(CH3)2), 85.9 (CH(OMe)), 165.6 (Cq, C=O ester), 
202.2 (Cq, C=O ketone); m/z (ES+) 283.1520 (100%, M+Na+, C13H240 5Na+ requires 
283.1522) 
tert-Butyl 5-(3,5-dibromo-2-hydroxyphenyl)-5-hydroxy-4-methoxy-3-
oxopentanoate 342 
OH OH 0 o o\-Br 
OMe 
Br 
obtained from 0.75 mmol of diene 335: yellow oil (270 mg, 80%); Vmax(film)/cm-1 3459 
(b., 0-H str.), 3035 (weak, Ar-H str.), 2790 (several strong bands, C-H str.), 1725 
(strong, C=O str. ketone), 1652 (weak, C=C str. enol), 1365 (strong, -C(CH3)3,C-H str.), 
1175 (2 bands, medium, C-0 str.); OH (300Hz) 1.42 (9H, bs, -C(CH3)3), 2.61 (1H, bs, -
OH exchanges with D20), 3.40 (2H, s, -CH2-), 3.54 (3H, s, -OCH3), 4.00 (lH, m, 
CH(OCH3)), 4.92 (IH, s, Ar-OH, exchanges with D20), 5.79 (lH, m, CH(OH)), 7.59 
(1H, d, J 2.4Hz, ArH), 7.82 (IH, d, J 2.4Hz, ArH); 8c (75.5 Hz) 28.6 (-C(CH3)3), 46.2 
( -CHz-), 58.3 ( -OCH3), 63.8 (-CH( OH)), 79.7 (Cq, C(CH3)3), 89.3 (CH(OCH3), 111.4 
(Cq, ArC), 120.8 (Cq, ArC), 128.6 (Cq, ArC), 132.1 (Cq, ArC), 133.64 (ArC), 156.2 
(Cq, ArC), 165.2 (Cq, C=O ester), 200.9 (Cq, C=O ketone); m/z (ES+) 490.9509 (100%, 
M+Na+, C16HzoBrz06Na+ requires 490.9504) 
tert-Butyl 5-(2,4-dinitrophenyl)-5-hydroxy-4-methoxy-3-oxopentanoate 343 
obtained from 0.75 mmol of diene 335: yellow oil (244 mg, 88%); Vmax(film)/cm-1 3459 
(b., 0-H str.), 3034-3015 (several bands, medium, Ar-H str.aromatic), 2790 (several 
strong bands, C-H str.), 1725 (strong, C=O str. ketone), 1635 (weak, C=C str. enol), 
1525 (strong, N-0 str.), 1365 (strong, -C(CH3)3 C-H str. ), 1355 (2 bands, strong, N-0 
asymm. and symm. str.), 1177 (2 bands, medium, C-0 str.); oH (300 Hz) 1.44 (9H, s, -
C(CH3)3), 2.89 (lH, bs, -OH exchanges with D20), 3.49 (2H, s, -CHz-), 3.54 (3H, s, -
OCH3), 4.10 (lH, m, -CH(OCH3)), 5.90 (lH, m, -CH(OH)), 8.09 (lH, d, J 8.1Hz, 
ArH), 8.4 (lH, dd, J 8.1, 2.0Hz, ArH), 8.77 (lH, d, J 2.0Hz, ArH); Oc (75.5 Hz) 28.2 (-
C(CH3)3), 47.4 (-CH2-), 59.4 (-OCH3), 68.9 (-CH(OH)). 82.9 (Cq, C(CH3)3), 87.9 
(CH(OCH3)), 120.1 (ArC), 127.4 (ArC), 131.1 (ArC), 147.4 (Cq, ArC), 143.3 (Cq, 
162 
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ArC), 147.5 (Cq, ArC), 167.3 (Cq, C=O ester), 204.2 (Cq, C=O ketone); m/z (ES+) 
385.1168 (100%, MH+, C,6H21N209+ requires 385.1169). 
tert-Butyl 5-hydroxy-4-methoxy-5-(1-naphthyl)-3-oxopentanoate 344 
OH 0 o a'\.-
obtained from 0.75 mol of diene 335: pale yellow oil (179 g, 72%); Vmax(film)/cm·' 
3459 (br., 0-H str_), 3055-3035 (several bands, medium, Ar-H str.aromatic), 2790 
(several strong bands, C-H str.), 1725 (strong, C=O str_ ketone), 1650 (weak, C=C str_ 
eno1), 1365 (strong, -C(CH3)3 C-H str_ ), 1180 (2 bands, medium, C-0 str.); bH (300Hz) 
1.39 (9H, s, -C(CH3)3), 2.78 (lH, bs, -OH exchanges with D20), 339 (2H, s, -CH2-), 
3.49 (3H, s, -OCH3), 3.92 (1H, m, -CH(OCH3)), 5.86 (1H, m, -CH(OH)), 6.91-8.16 
(7H, m, ArH); be (75.5 Hz) 27.7 (-CH3), 46.7 (-CH2-), 58.3 (-OCH3), 72.3 (CH(OH)), 
80.8 (Cq, C(CH3)3), 87.8 (CH(OMe)), 122.8 (ArC), 125.2 (ArC), 125.4 (ArC), 126_2 
(ArC), 126.7 (ArC), 129.3 (ArC), 129.9 (Cq, ArC), 130.3 (ArC), 133.1 (Cq, ArC), 
145.7 (Cq, ArC), 167.3 (Cq, C=O ester), 202.9 (Cq, C=O ketone); m/z (Cl+) 338.2342 
(100%, M+NH/, C20H28N05+ requires 338.2345) 
tert-Butyi 5-hydroxy-5-(2-hydroxy-3,5-diiodophenyl)-4-methoxy-3-oxopentanoate 
345 
OH OH 0 
obtained from 0.75 mol of diene 335: light yellow oil (337 g, 83%); Vmax(film)/cm·' 
3469 (b., 0-H str_), 3038-3012 (several bands, medium, Ar-H str.), 2790 (several strong 
bands, C-H str.), 1725 (strong, C=O str. ketone), 1647 (weak, C=C str_ enol), 1365 
(strong, -C(CH3)3 C-H str_ ), 1175 (2 bands, medium, C-0 str.); bH (500Hz) 1.45 (9H, s, 
-C(CH3)3), 2.58 (lH, bs, -OH exchanges with D20), 3.44 (2H, s, -CH2-), 3.52 (3H, s,-
OCH3), 3.97 (lH, m, -CH(OMe)), 4.79 (lH, bs, Ar-OH exchanges with D20), 5.81 (IH, 
m, -CH(OH)), 7.48 (lH, d, 1 2.0Hz, ArH), 7.80 (lH, d, 1 2.0Hz, ArH); be (125.5MHz) 
- ~--
29.1 (-C(CH3)3), 47.2 (-CH2-), 58.8 (-OCH3), 64.5 (-CH(OH)), 80.1 (Cq, -C(CH3)3), 
88.7 (CH(OCH3)), 113.5 (Cq, ArC), 131.6 (Cq, ArC), 137.8 (ArC), 147.9 (ArC), 157.3 
163 
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(Cq, ArC), 166.6 (Cq, C=O ester), 201.0 (Cq, C=O ketone); m/z (ES+) 585.9454 (100%, 
M+Na+, C 17H22h05Na+ requires 585.9455) 
1-[ 4-(tert-Butoxy)~ 1 ~methoxy-2,4-dioxobutyll-2-methyl-2-propenyl-3,5-
dibromobenzoate 348 
srUB' ~~( 
0 0 0 0 ~ ~0 
To a stirred suspension of sodium hydride (10.0 mg, 1.08 eq) in anhydrous THF (10 
mL) cooled to 0 oc and stirred under Ar was added solution of aldol 330 (100.0 mg, 
0.387 mmol) in anhydrous THF (2 mL) dropwise. A solution of 3,4-dibrombenzoyl 
chloride (116.9 mg, 1.0 eq) in anhydrous THF (2 mL) was added dropwise, and the 
reaction stirred at 0 oc and monitored by TLC. After 2h the reaction was quenched by 
the addition of 1% HCl and extracted into Et20. The organic phase was washed with 
1% HCl (2 x 10mL) and brine (20mL), and dried over MgS04. Concentration in vacuo 
gave a yellow oil that was purified by silica gel chromatography (eluting with 4:1 
hexane I EtOAc) to give 348 (78 mg, 68%); Vmax(film)/cm- 1 3040-3020 (several bands, 
weak, Ar-H str.), 2790 (several strong bands, C-H str.), 1720 (strong, C=O str. ketone), 
1642 (weak, C=C str. enol), 1366 (strong, -C(CH3)3 C-H str. ), 1169 (2 bands, medium, 
C-0 str.); 8H (400 MHz) 1.44 (9H, s, C(CH3)3), 1.71 (3H, d, J 4.5Hz, -CH3), 3.38 (2H, 
s, -CH2-), 3.53 (3H, s, -OCH3), 4.24 (IH, m, CH(OCH3)), 5.01 (lH, d, J 8.1Hz, :CH), 
5.05 (lH, d, J 8.1Hz, :CH), 5.82 (lH, 'm, CH(C02Ar), 7.38 (IH, d, J 2.2Hz, ArH), 8.11 
(2H, d, J 2.2Hz, ArH); 8c (100 MHz) 17.8 (-CH3), 26.9 (-C(CH3)3), 46.6 (-CHz-), 59.8 
(-OCH3), 77.1 (CH(02C)), 81.2 (Cq, C(CH3)3), 85.5 (CH(OCH3)), 114.4 (:CHz), 124.8 
(ArC), 129.1 (Cq, ArC), 131.2 (ArC), 133.1 (Cq, ArC), 140.9 (Cq, C:CHz), 163.8 (Cq, 
C=O ester), 166.5 (Cq, C=O ester), 203.4 (Cq, C=O ketone); m/z (ES+) 520.9994 
(100%, MH+, CzoHzsBrz06+ requires 520.9998) 
tert-Butyl 5-{ [( 4-iodophenyl)sulfonyll oxy }-4~ methoxy -6-me thy 1-3-oxo-6-heptenoate 
349 
164 
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To a solution of aldol 330 (50.0 mg, 0.192 mmol) in dry DCM (2 mL) cooled to 0 oc 
and stirred under Ar was added pyridine (22 11L, 1.1 eq) followed by a solution of 4-
iodobenzenesulfonyl chloride (59.0 mg, 1 eq) in dry DCM (1 mL) dropwise. The 
reaction was warmed to RT and stirred overnight. After this time the reaction was 
diluted with DCM (5 mL) and the organic phase washed with 5% HCl (10 mL) and 
brine (2 x 10 mL). The combined organic phase was dried over MgS04 and 
concentrated in vacuo to give a brown oil; purification by silica gel chromatography 
(1: 1 hexane I Et20 as eluant) gave 349 as a light yellow oil (57 mg, 56%); 
Vmax(film)lcm-1 3045-3027 (several bands, medium, Ar-H str.aromatic), 2790 (several 
strong bands, C-H str.), 1725 (strong, C=O str. ketone), 1645 (weak, C=C str. enol), 
1365 (strong, -C(CH3) 3 C-H str. )1188 (2 bands, medium, C-0 str.); OH (400 MHz) 1.44 
(9H, s, -C(CH3)3), 1.80 (3H, d, J 4.4Hz, :CH(CH3)), 3.48 (2H, s, -CH2-), 3.51 (3H, s, -
OCH3), 4.02 (lH, m, -CH(OCH3)), 4.64 (lH, m, -CH(OS02Ar)), 5.04 (lH, d, J 8.3Hz, 
:CH), 5.11 (lH, d, J 8.3Hz, :CH), 7.66 (2H, d, J 7.8Hz, ArH), 7.99 (2H, d, J 7.8Hz, 
ArH); Oc (100 MHz) 19.7 (-CH3), 27.0 (-(CH3)3), 46.5 (-CH2-), 58.9 (-OCH3), 81.1 
(Cq, C(CH3)3), 85.5 (CH(OH)), 86.8 (CH(OCH3)), 97.9 (Cq, ArC), 113.0 (:CH2), 128.3 
(ArC), 135.9 (ArC), 141.8 (Cq, :C(CH2), 148.2 (Cq, ArC), 167.7 (Cq, C=O ester), 
203.9 (Cq, C=O ketone); m/z (ES+) 547.3640 (100%, M+Na+, C19H2sl01SNa+ requires 
547.3643) 
6-Isopropenyl-5-methoxydihydro-2H-pyran-2,4(3H)-dione 352 
To a solution of aldol 330 (50.0 mg, 0.194 mrnol) in dry DCM (2 mL) cooled to 0 oc 
and stirred under Ar was added TFA (98 11L, 7 eq). The reaction was stirred at RT for 
3h, after which time solid NaHC03 was added to quench. The mixture was extracted 
into EtOAc and washed with water to pH 7. After drying over MgS04, concentration in 
vacuo gave a brown oil that was passed through a short silica column using 5:1 hexane I 
EtOAc as eluant. Gave 352 as a minor fraction; (11 mg, 33% ); Vmax(film)/cm-1 1754 
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(strong, C=O str.); oH (500 MHz) 1.81 (3H, d, J 4.6Hz, -CH3), 3.22 (2H, m, -CH2-), 
3.49 (3H, s, -OCH3), 3.89 (lH, m, -CH), 4.98 (lH, d, J 7.7Hz, :CH), 5.03 (lH, d, J 
7.7Hz, :CH), 5.11 (lH, m, CH); oc (125.5 MHz) 18.6 (:CH(CH3)), 45.1 (-CH2-), 59.1 (-
OCH3), 78.7 (CH), 85.6 (CH), 116.9 (:CH2), 140.8 (Cq, C(CH2)), 166.7 (Cq, C=O 
ester), 209.1 (Cq, C=O ketone); m/z (ES+) 207.0629 (100%, M+Na+, C9H120 4Na+ 
requires 207.06233) 
te rt-Butyl ( 4R ,SR) -6-[(E)-2-(2,4-dinitropheny I) hydrazono ]-3-[(Z)-2-(2,4-
dinitrophenyl)hydrazono]-5-hydroxy-4-methoxyheptanoate 354 
To a solution of 2,4-dinitrophenylhydrazine (140.0 mg, 2.2 eq of a 35% water-
moistened solid) in EtOH stirred at RT under Ar was added dione 332 (50.0 mg, 0.192 
mmol). After stirring overnight, the reaction was concentrated in vacuo to give a bright 
orange oil that was subjected to silica gel chromatography (3: 1 hexane I EtOAc as 
eluant). Minor (second) fraction: yellow oil (42.7 mg, 36%) that was best stored at -18 
oc under Ar; Vmax(film)/cm-1 3519 (b., 0-H str.), 3395 (medium, N-H imine), 3053-
3038 (several bands, medium, Ar-H str.aromatic), 2790 (several strong bands, C-H str.), 
1725 (strong, C=O str. ketone), 1525 (strong, N-0 str.), 1687 (strong, C=N str.), 1365 
(strong, -C(CH3)3 C-H str. ) 1355 (2 bands, strong, N-0 asymm. and symm. str.), 1188 
(2 bands, weak, C-0 str.); OH (400 MHz) 1.40 (9H, s, C(CH3)3), 1.92 (3H, s, -CH3), 2.91 
(lH, bs,-OH, exchanges with D20), 3.33 (3H, s, -OCH3), 3.49 (2H, s, -CH2), 4.91 (lH, 
m, -CH(OCH3)), 5.29 (1H, m, -CH(OH)), 7.81-7.97 (4H, d, J 8.9Hz, ArH), 8.78 (2H, d, 
J 2.3Hz, ArH), 8.91 (2H, bs, -NH); Oc (100 MHz) 15.1 (-CH3), 27.8 (b, C(CH3)3), 39.5 
( -CH2-), 56.9 ( -OCH3), 70.1 (CH( OH)), 74.2 (CH(OCH3)), 82.5 (Cq, C(CH3)3), 105.6 
(ArC), 12].9 CArCJ, 131.3 (ArC),_ 13_1.5 (A_rC), 138.1 (Cq, ArC), 138.8 (Cq, ArC), 
139.1 (Cq, ArC), 139.4 (Cq, ArC), 144.8 (Cq, C=N), 145.1 (Cq, C=N), 145.9 (Cq, 
ArC), 146.7 (Cq, ArC), 169.9 (Cq, C=O ester); m/z (Cl+) 638.56 (100%, M+NH/) 
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tert-Butyl 4-methoxy-2-methy&-5-oxo-1,3-cydopentadiene-1-carboxylate 355 
To a solution of dione 332 (50.0 mg, 19.2 mmol) in dry MeOH (2mL) cooled to 0 oc 
and stired under Ar was added K2C03 (53.0 mg, 2 eq). After stirring for 5h at 0 °C, the 
reaction was quenched by the addition of water (2 mL) and extracted with EtzO (1 0 
mL). The organic phases were washed with brine, concentrated in vacuo, and dried 
over MgS04 to give a dark brown solid (1 05 m g); mixture could not be separated by 
column chromatography. Analytical data for principal component: Vmax(film)/cm- 1 1685 
(strong, C=O str.), 1610 (strong, C=C str.); 8H (400 MHz) 1.48 (9H, s, 3 x CH3), 2.19 
(3H, s, -CH3), 3.68 (3H, s, OCH3), 7.36 (lH, s, :CH); 8c (100 MHz) 20.6 (-CH3), 28.8 
(3 X -CHJ), 56.1 (-OCHJ), 82.1 (C(CHJ)J), 130.9 (Cq, :CH(C02C(CH3)3), 145.5 (:CH), 
153.9 (Cq, C(OCH3)), 163.5 (Cq, C=O ester), 171.1 (Cq, C(CH3)), 180.5 (Cq, C=O 
ketone); m/z (Ct) 200.1 (100%, M+NH/). 
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Table 1. Crystal data and structure refinement for 255 
Empirical formula C20 H 16 N 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta= 24.97° 
Max. and min. transmission 
Refinement method 
Data I restraints I parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Largest diff. peak and hole 
270.34 
203(2) K 
0.71073 A 
Monoclinic 
P 211c 
a= 10.013(3) A 
b = 10.770(3) A 
c = 13.828(2) A 
1487.3(6) A3 
4 
1.207 Mglm3 
0.070 mm· 1 
572 
0.40 x 0.30 x 0.30 mm3 
2.04 to 24.97°. 
~= 94.151(16t. 
-11<=h<=2, 0<=k<=l2, -16<=1<=16 
3379 
2613 [R(int) = 0.0221] 
100.0% 
0.9794 and 0.9726 
Full-matrix least-squares on F2 
2613 I 0 I 254 
1.019 
R1 = 0.0456, wR2 = 0.0873 
R1 = 0.0921, wR2 = 0.1037 
0.125 and -0.156 e.A-3 
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A.2x 1Q3) 
for 255. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
X y z U(eq) 
N(8) 5802(2) 1403(1) 532(1) 33(1) 
C(l) 7468(2) 2598(2) 1397(1) 31(1) 
C(2) 8217(2) 2862(2) 2251(2) 42(1) 
C(3) 9140(2) 3817(2) 2295(2) 49(1) 
C(4) 9305(2) 4531 (2) 1491(2) 46( I) 
C(5) 8558(2) 4282(2) 643(2) 42(1) 
C(6) 7652(2) 3327(2) 589(2) 37(1) 
C(7) 6458(2) 1588(2) 1345(1) 29(1) 
C(9) 4805(2) 417(2) 418(1) 32(1) 
C(IO) 3442(2) 987(2) 202( I) 36(1) 
C( 11) 3231(3) 1837(2) -544(2) 45(1) 
C(l2) 1987(3) 2347(2) -759(2) 61(1) 
C(13) 942(3) 2030(3) -233(2) 69(1) 
C(l4) 1132(3) 1204(3) 513(2) 69(1) 
C(l5) 2380(2) 673(2) 736(2) 55(1) 
C(l6) 6248(2) 859(2) 2239(1) 30(1) 
C(l7) 5106(2) 1046(2) 2729(1) 39(1) 
C(18) 4854(3) 311 (2) 3506(2) 46(1) 
C(19) 5724(3) -607(2) 3808(2) 48(1) 
C(20) 6874(3) -793(2) 3342(2) 47(1) 
C(21) 7135(2) -60(2) 2560(2) 39(1) 
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Table 3. Bond lengths [A] and angles [0 ] for 255. 
N(8)-C(7) 1.276(2) 
N(8)-C(9) 1.458(2) 
C( 1)-C(2) 1.382(3) 
C(1)-C(6) 1.389(3) 
C(l)-C(7) 1.484(3) 
C(2)-C(3) 1.381(3) 
C(3)-C(4) 1.372(3) 
C(4)-C(5) 1.371(3) 
C(5)-C(6) 1.370(3) 
C(7)-C(l6) 1.492(3) 
C(9)-C(l0) 1.506(3) 
C(9)-C(9)# 1 1.537(4) 
C(l0)-C(15) 1.380(3) 
C( 10)-C(l1) 1.384(3) 
C(11)-C(12) 1.374(3) 
C(12)-C(13) 1.360(4) 
C(l3)-C(14) 1.365(4) 
C(14)-C(15) 1.388(4) 
C(l6)-C(21) 1.381 (3) 
C( 16)-C( 17) 1.385(3) 
C( 17)-C( 18) 1.372(3) 
C(18)-C(19) 1.364(3) 
C( 19)-C(20) 1.373(3) 
C(20)-C(21) 1.380(3) 
C(7)-N(8)-C(9) 120.88(16) 
C(2)-C(1)-C(6) 118.42(19) 
C(2)-C( 1 )-C(7) 121.23(18) 
C(6)-C( 1 )-C(7) 120.32(17) 
C(3)-C(2)-C(1) 120.7(2) 
C(4)-C(3)-C(2) 120.1(2) 
C( 5)-C( 4 )-C(3) 119.6(2) 
C(6)-C(5)-C(4) 120.7(2) 
C(5)-C(6)-C(l) 120.4(2) 
N(8)-C(7)-C( 1) 117.60(16) 
N(8)-C(7)-C(l6) 12:f59(17) 
C( 1 )-C(7)-C( 16) 118.80(16) 
N(8)-C(9)-C( 10) 109.15(16) 
170 
N(8)-C(9)-C(9)# l 107.3(2) 
C( l 0)-C(9)-C(9)# l 111.4(2) 
C(l 5)-C( 10)-C(ll) 118.6(2) 
C( l 5)-C( l 0)-C(9) 121.1(2) 
C(ll )-C( l0)-C(9) 120.3(2) 
C( 12)-C( ll )-C( l 0) 120.8(3) 
C(l3 )-C(l2)-C(ll) 120.3(3) 
C( 12)-C( l3)-C(l4) 119.8(3) 
C( 13)-C( 14)-C( 15) 120.7(3) 
C( l 0)-C( l 5)-C( 14) 119.8(3) 
C(2l )-C( 16)-C( 17) 118.76(19) 
C(2l )-C( l6)-C(7) 121.11(18) 
C( 17)-C( l6)-C(7) 120.01(18) 
C( 18)-C( 17)-C( 16) 120.3(2) 
C( 19)-C( 18)-C( 17) 120.6(2) 
C( 18 )-C( l9)-C(20) 120.0(2) 
C( l9)-C(20)-C(2l) 119.8(2) 
C(20)-C(2l )-C( 16) 120.5(2) 
Symmetry transformations used to generate equivalent atoms: 
#l -x+l,-y,-z 
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Table 4. Anisotropic displacement parameters CA2 x 103) for 255. The anisotropic 
displacement factor exponent takes the form: -2n2[ h2a* 2U11 + ... + 2 h k a* b* U12 ) 
UII U22 U33 uz3 Ul3 u12 
N(8) 34(1) 31(1) 33(1) 0(1) 1(1) -4( 1) 
C(1) 27(1) 32(1) 34(1) -2(1) 4(1) 1 (l) 
C(2) 41(1) 45(1) 39(1) 3(1) -4(1) -6(1) 
C(3) 40( 1) 50(1) 54(2) -5(1) -11(1) -1 0(1) 
C(4) 32(1) 42(1) 64(2) 0(1) 1 (l) -8(1) 
C(5) 35(1) 42(1) 48(1) 6(1) 7(1) -4(1) 
C(6) 31(1) 41(1) 39(1) -1(1) 4(1) -4( 1) 
C(7) 28(1) 31(1) 29(1) -1(1) 2(1) 4(1) 
C(9) 37(1) 31(1) 29(1) 4(1) 1(1) -8(1) 
C(lO) 37( 1) 33(1) 39(1) -8(1) -2(1) -5(1) 
C(11) 46(2) 39(1) 50( 1) -2(1) -3(1) 5(1) 
C(l2) 63(2) 47(2) 69(2) -11(1) -15(2) 16(1) 
C(13) 49(2) 62(2) 92(2) -30(2) -13(2) 16(2) 
C(14) 41(2) 77(2) 90(2) -18(2) 15(2) -6(2) 
C(15) 44(2) 56(2) 65(2) -5(1) 10(1) -7( 1) 
C(16) 31(1) 32(1) 28(1) -2(1) -2(1) -3(1) 
C(17) 42(1) 41(1) 34( 1) 1 (l) 5(1) 4(1) 
C(l8) 5 1(2) 52(1) 37(1) 3(1) 13(1) -4( 1) 
C(l9) 67(2) 44(1) 34( 1) 7(1) 2(1) -12(1) 
C(20) 55(2) 40(1) 45( 1) 7(1) -12( I) 2(1) 
C(21) 38(1) 40(1) 37(1) 2(1) -3(1) 2(1) 
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Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 103) 
for 255. 
X y z U(eq) 
H(2) 8093(19) 2342(18) 2813(14) 44(6) 
H(3) 9640(20) 4000(20) 2889(16) 57(7) 
H(4) 9920(20) 5230(20) 1524(14) 51(6) 
H(5) 8618(19) 4783(17) 85(13) 36(5) 
H(6) 7110(20) 3140(17) -3(14) 41(6) 
H(9) 4764(18) -92( 17) 979(13) 35(5) 
H(11) 3930(20) 2040(20) -940(15) 53(7) 
H(l2) 1830(30) 2960(20) -1304(18) 76(8) 
H(l3) 50(30) 2390(30) -388(19) 103(10) 
H(l4) 430(30) 930(20) 928(19) 84(9) 
H(l5) 2540(20) 80(20) 1285(17) 68(8) 
H(17) 4476(19) 1719(18) 2504(13) 37(5) 
H(l8) 4050(20) 440(20) 3844(16) 66(7) 
H(l9) 5530(20) -1125(19) 4344(16) 51(6) 
H(20) 7490(20) -1460(20) 3559(14) 51(6) 
H(21) 7940(20) -218(19) 2183(15) 52(6) 
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Table 6. Torsion angles [0 ] for 255. 
C(6)-C( I )-C(2)-C(3) 
-0.9(3) 
C(7)-C( I )-C(2)-C(3) 
-179.03(19) 
C( I )-C(2)-C(3)-C( 4) 1.2(3) 
C(2)-C(3 )-C( 4 )-C(5) 
-0.6(3) 
C(3)-C( 4)-C(5)-C(6) 
-0.2(3) 
C( 4 )-C(5)-C(6)-C( I) 0.5(3) 
C(2)-C( I)-C(6)-C(5) 0.0(3) 
C(7)-C(l )-C(6)-C(5) 178.21(18) 
C(9)-N(8)-C(7)-C(I) 179.21(16) 
C(9)-N (8)-C(7)-C( 16) 
-1.8(3) 
C(2)-C(1 )-C(7)-N(8) 179.75(19) 
C( 6)-C( l)-C(7)-N(8) 1.6(3) 
C(2)-C( 1 )-C(7)-C( 16) 0.7(3) 
C(6)-C(I)-C(7)-C( 16) -177.45(18) 
C(7)-N(8)-C(9)-C( 10) 115.1(2) 
C(7)-N(8)-C(9)-C(9)# 1 -124.1(2) 
N(8)-C(9)-C( 1 0)-C( 15) -128.1(2) 
C(9)# I-C(9)-C( 1 0)-C( 15) 113.6(3) 
N(8)-C(9)-C(l0)-C(II) 52.1(2) 
C(9)# I-C(9)-C( I 0)-C( 11) -66.1 (3) 
C(15)-C(IO)-C(11)-C(l2) -0.9(3) 
C(9)-C( 10)-C( 11 )-C( 12) 178.9(2) 
C( I 0)-C( 11 )-C( 12)-C( 13) 0.6(4) 
C(11)-C(12)-C(l3)-C(I4) 0.1( 4) 
C( 12)-C( 13)-C(14)-C( 15) -0.6(4) 
C( 11 )-C( 1 0)-C( 15)-C( 14) 0.4(3) 
C(9)-C( I 0)-C( 15)-C( 14) -179.3(2) 
C( 13 )-C( 14 )-C( 15)-C( I 0) 0.3(4) 
N(8)-C(7)-C( 16)-C(21) I 03.3(2) 
C( 1 )-C(7)-C( 16)-C(21) -77.7(2) 
N(8)-C(7)-C(l6)-C( 17) -72.8(3) 
C( 1 )-C(7)-C( 16)-C( 17) 106.2(2) 
C(21 )-C( 16)-C( 17)-C( 18) -1.4(3) 
C(7)-C( 16)-C( 17)-C( 18) 174.77(19) 
C( 16)-C( 17)-C( 18)-C( 19) 0.3(3) 
C( 17)-C( 18 )-C( 19)-C(20) 0.8(3) 
C( 18)-C( 19)-C(20)-C(21) -0.9(3) 
C( 19)-C(20)-C(21)-C( 16) -0.2(3) 
174 
C( 17)-C( l6)-C(2l )-C(20) 
C(7)-C( l6)-C(21 )-C(20) 
Symmetry transformations used to generate equivalent atoms: 
#1 -x+1,-y,-z 
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Table 1. Crystal data and structure refinement for 301. 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta= 25.00° 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data I restraints I parameters 
Goodness-of-fit on F2 
Final R indices [l>2sigma(I)] 
R indices (all data) 
Largest diff. peak and hole 
C8 H10 03 
154.16 
296(2) K 
0.71073 A 
Monoclinic 
P 21/n 
a= 6.4218(19) A 
b = 6.4487(13) A 
c= 19.663(7)A 
812.3(4) A3 
4 
1.261 Mglm3 
0.096 mm· 1 
328 
0.30 x 0.30 x 0.30 mm3 
3.28 to 25.00°. 
-7<=h<=7, 0<=k<=7, -23<=1<=23 
2847. 
1426 [R(int) = 0.0272] 
99.7% 
None 
0.9717 and 0.9717 
Full-matrix least-squares on f2 
1426101140 
1.037 
R1 = 0.0436, wR2 = 0.1122 
R1 = 0.0666, wR2 = 0.1270 
0.159 and -0.093 e.A-3 
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Table 2. Atomic coordinates (X 104) and equivalent isotropic displacement parameters (A2x 103) 
for 301. U(eq) is defined as one third of the trace of the orthogonalized Uii tensor. 
X y z U(eq) 
0(1) 13700(3) 23648(2) 18977(1) 89(1) 
0(2) 13939(3) 25618(3) 18031(1) 86(1) 
0(3) 16160(2) 26143(3) 18965(1) 87(1) 
C(1) 17678(6) 22136(5) 18062(2) 1 04(1) 
C(2) 16501(4) 23224(4) 18308(1) 73(1) 
C(3) 15039(3) 24686(3) 18576(1) 56(1) 
C(4) 12205(5) 25015(4) 19254(2) 81(1) 
C(5) 12600(3) 27187(3) 190 11(1) 59(1) 
C(6) 14829(4) 27677(4) 19237(2) 80(1) 
C(7) 12456(5) 27125(5) 18252(1) 86(1) 
C(8) 11098(5) 28715(5) 19308(2) 93(1) 
177 
AppendLt A: Crystallogmphic data 
Table 3. Bond lengths [A] and angles [0 ] for 301. 
O(l)-C(3) 1.381(2) 
O(l)-C(4) 1.438(3) 
0(2)-C(3) 1.378(2) 
0(2)-C(7) 1.448(3) 
0(3)-C(3) 1.382(2) 
0(3)-C(6) 1.435(3) 
C( 1 )-C(2) 1.162(4) 
C(2)-C(3) 1.454(3) 
C(4)-C(5) 1.507(3) 
C(5)-C(7) 1.490(3) 
C(5)-C(6) 1.502(3) 
C(5)-C(8) 1.523(3) 
C(3 )-0( 1 )-C( 4) 112.27(16) 
C(3)-0(2)-C(7) 111.85(15) 
C(3 )-0(3 )-C( 6) 112.01(16) 
C(l )-C(2)-C(3) 175.9(3) 
0(2)-C(3)-0(1) 110.44(17) 
0(2)-C(3)-0(3) 110.58(18) 
0( 1 )-C(3 )-0(3) 109.52(16) 
0(2)-C(3)-C(2) 108.10(15) 
0( 1 )-C(3 )-C(2) 109.66(17) 
0(3)-C(3)-C(2) 1 08.48(16) 
0( 1 )-C( 4 )-C(5) 108.54(18) 
C(7)-C(5)-C(6) 107.0(2) 
C(7)-C(5)-C( 4) 107.0(2) 
C(6)-C(5)-C(4) 106.2(2) 
C(7)-C(5)-C(8) 113.9(2) 
C(6)-C(5)-C(8) 111.5(2) 
C( 4)-C(5)-C(8) 110.8(2) 
0(3)-C(6)-C(5) 108.97(18) 
0(2)-C(7)-C(5) 108.82(18) 
Symmetry transformations used to generate equivalent atoms: 
Table 4. Anisotropic displacement parameters (A2x 103) for 301. The anisotropic 
displacement factor exponent takes the form: -2£[ h2a*2U 11 + ... + 2 h k a* b* U 12 ] 
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U'' uzz U33 u23 Ul3 u12 
0(1) 108(1) 55(1) 110(1) 16( 1) 50(1) 10(1) 
0(2) 1 03(1) 1 06(1) 47(1) 6(1) -3(1) 30(1) 
0(3) 56(1) 95( 1) 108(1) -43(1) -9(1) 6(1) 
C(1) 110(2) 118(2) 84(2) -20(2) 11(2) 36(2) 
C(2) 83(2) 79(1) 58(1) -8(1) 6(1) 12(1) 
C(3) 60( 1) 61(1) 45(1) 1 (1) 1 (1) 0(1) 
C(4) 80(2) 71(2) 95(2) 11 (1) 30(1) 4(1) 
C(5) 57(1) 54( 1) 67(1) 2(1) 4(1) 2(1) 
C(6) 66(1) 71(2) 1 00(2) -24(1) -1 (1) 2(1) 
C(7) 91(2) 94(2) 72(2) 14( 1) -7(1) 26(2) 
C(8) 75(2) 75(2) 129(3) -9(2) 14(2) 15( I) 
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Table 5. Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 103) 
for 301. 
X y z U(eq) 
H(l) 18600(60) 21460(50) 17894( 18) 139(14) 
H(4A) 12350( 40) 24900(50) 19766(16) 115(9) 
H(4B) 10860(50) 24600(50) 19055(15) 121(11) 
H(6A) 15060(50) 27690(50) 19752(18) 130(11) 
H(6B) 15180(50) 29010(50) 19057(14) 110(1 0) 
H(7A) 12770(50) 28410(50) 18035(16) 126(11) 
H(7B) 11060(50) 26730(50) 18045(15) 117(10) 
H(8A) 11350(50) 30090(60) 19134(14) 113(10) 
H(8B) 9720(60) 28340(50) 19133(1 5) 117(10) 
H(8C) 11280(70) 28700(60) 19850(20) 181(17) 
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Table 6. Torsion angles [0 ] for 301 
C(7)-0(2)-C(3)-0( 1) 
C(7)-0(2)-C(3)-0(3) 
C(7)-0(2)-C(3)-C(2) 
C( 4 )-0( 1 )-C(3 )-0(2) 
C( 4 )-0( 1 )-C(3 )-0(3) 
C( 4)-0( 1)-C(3)-C(2) 
C(6)-0(3)-C(3 )-0(2) 
C( 6)-0(3 )-C(3)-0( I) 
C( 6)-0(3 )-C(3 )-C(2) 
C( 1 )-C(2)-C(3)-0(2) 
C( 1)-C(2)-C(3)-0(1) 
C( 1 )-C(2)-C(3 )-0(3) 
C(3)-0( 1)-C( 4)-C(S) 
0( 1)-C(4 )-C(5)-C(7) 
0( 1)-C(4)-C(5)-C(6) 
0( 1 )-C( 4 )-C(5)-C(8) 
C(3 )-0(3 )-C( 6)-C(S) 
C(7)-C( 5)-C( 6)-0(3) 
C( 4 )-C(5)-C(6)-0(3) 
C(8)-C(5)-C(6)-0(3) 
C(3 )-0(2)-C(7)-C(5) 
C(6)-C(5)-C(7)-0(2) 
C( 4 )-C(5)-C(7)-0(2) 
C(8)-C(5)-C(7)-0(2) 
Symmetry transformations used to generate equivalent atoms: 
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60.7(3) 
-60.7(2) 
-179.3(2) 
-60.7(3) 
61.3(3) 
-179.7(2) 
60.3(2) 
-61.6(2) 
178.7(2) 
32(4) 
153(4) 
-88(4) 
-0.1(3) 
57.0(3) 
-57 .0(3) 
-178.3(2) 
0.4(3) 
-57.2(3) 
56.9(3) 
177 .7(2) 
0.1(3) 
56.6(3) 
-56.9(3) 
-179.7(2) 
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